{"text_format":"3","workbook":"xlsx","n_sheets":2,"sheets":["删减版","总表"],"not_rendered":{"defined_names":1},"read":"whole","date_system":"1900"}

{"sheet":"删减版","index":0,"n_rows":251,"n_cols":11,"rows_kept":251,"merged":[[247,10,249,10]]}
["药品名称","规格","转换比","生产企业","代理企业","批准文号/注册证号","挂网价格(元)","申报类型","外省价格","核验结果","备注"]
["艾司奥美拉唑镁肠溶胶囊","按C₁₇H₁₉N₃O₃S计,20mg","28","双鹤药业(海南)有限责任公司","湖南银泽华浩生物科技有限公司","国药准字H20253416",53.2,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:53.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:53.20],[来源省份:湖北省,来源年份:2025,采购价:53.20]","通过","不高于未中选最低价"]
["注射用兰索拉唑","30mg","1","常州四药制药有限公司","常州四药制药有限公司","国药准字H20110008",13.49,"国家集采非中选药品申报","[来源省份:江西省,来源年份:2025,采购价:13.49],[来源省份:江苏省,来源年份:2025,采购价:13.49],[来源省份:天津市,来源年份:2025,采购价:13.49]","通过","不高于未中选最低价"]
["聚普瑞锌颗粒","75mg","6","湖南九典制药股份有限公司","湖南九典制药股份有限公司","国药准字H20254620",82.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:82.80],[来源省份:贵州省,来源年份:2025,采购价:82.80],[来源省份:江苏省,来源年份:2025,采购价:82.80]","通过","不高于中位价"]
["瑞巴派特片","0.1g","20","四川美大康华康药业有限公司","四川美大康华康药业有限公司","国药准字H20244429",21.9,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:甘肃省,来源年份:2025,采购价:21.90],[来源省份:湖南省,来源年份:2025,采购价:21.90],[来源省份:湖北省,来源年份:2025,采购价:21.90]","通过","不高于中位价"]
["盐酸屈他维林注射液","2ml∶40mg(按C₂₄H₃₁NO₄·HCl计)","1","康普药业股份有限公司","湖南慧泽生物医药科技有限公司","国药准字H20254030",32,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:32.52],[来源省份:贵州省,来源年份:2025,采购价:32.52],[来源省份:重庆市,来源年份:2025,采购价:32.52]","通过","不高于中位价"]
["间苯三酚口崩片","80mg(按C₆H₆O₃·2H₂O计)","10","浙江赛默制药有限公司","浙江沣华医药科技有限公司","国药准字H20253277",172.73,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:179.00],[来源省份:重庆市,来源年份:2025,采购价:179.00],[来源省份:江西省,来源年份:2025,采购价:179.00]","通过","不高于中位价"]
["西甲硅油乳剂","40mg/ml(聚二甲基硅氧烷:38.38mg/ml;二氧化硅:1.62mg/ml)(30ml/瓶)","1","成都倍特得诺药业有限公司","成都倍特得诺药业有限公司","国药准字H20254541",23.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:23.10],[来源省份:江苏省,来源年份:2025,采购价:23.10],[来源省份:贵州省,来源年份:2025,采购价:23.10]","通过","不高于中位价"]
["盐酸消旋山莨菪碱注射液","1ml:10mg","1","新乡市常乐制药有限责任公司","新乡市常乐制药有限责任公司","国药准字H20184056",2.29,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:2.29],[来源省份:湖南省,来源年份:2025,采购价:2.29],[来源省份:江苏省,来源年份:2025,采购价:2.29]","通过","同厂家符合差比"]
["盐酸昂丹司琼片","4mg(按C₁₈H₁₉N₃O计)","10","宁波美诺华天康药业有限公司","杭州沐源生物医药科技有限公司","国药准字H20254888",60,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:60.00],[来源省份:山东省,来源年份:2025,采购价:60.00],[来源省份:青海省,来源年份:2025,采购价:60.00]","通过","不高于中位价"]
["盐酸昂丹司琼片","8mg(按C₁₈H₁₉N₃O计)","10","宁波美诺华天康药业有限公司","杭州沐源生物医药科技有限公司","国药准字H20254887",102,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:102.00],[来源省份:山东省,来源年份:2025,采购价:102.00],[来源省份:青海省,来源年份:2025,采购价:102.00]","通过","不高于中位价"]
["复方甘草酸苷片","每片含甘草酸单铵盐(以甘草酸苷计)25mg、甘氨酸25mg、DL-蛋氨酸25mg。","75","浙江北生药业汉生制药有限公司","东阳祥昇医药科技有限公司","国药准字H20253068",53.05,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:53.05],[来源省份:江西省,来源年份:2025,采购价:53.05],[来源省份:贵州省,来源年份:2025,采购价:53.05]","通过","同厂家符合差比"]
["联苯双酯片","25mg","24","广东南国药业有限公司","广东南国药业有限公司","国药准字H44024625",66,"本企业已挂网药品新增包装规格","[来源省份:吉林省,来源年份:2024,采购价:66.00],[来源省份:江苏省,来源年份:2024,采购价:66.00],[来源省份:黑龙江省,来源年份:2024,采购价:66.00]","通过","同厂家符合差比"]
["复方聚乙二醇(3350)电解质散","6.9g/袋","10","南京厚生药业有限公司","翎耀生物科技（上海）有限公司","国药准字H20255005",36.9,"纳入国家医保目录准入价格谈判的药品","[来源省份:安徽省,来源年份:2025,采购价:36.90],[来源省份:海南省,来源年份:2025,采购价:36.90],[来源省份:甘肃省,来源年份:2025,采购价:36.90]","通过","申报价格不高于支付标准的国谈仿制药"]
["复方聚乙二醇(3350)电解质维C散","每袋A剂含聚乙二醇3350 100g、硫酸钠7.500g、氯化钠2.691g、氯化钾1.015g;每袋B剂含维生素C 4.700g、维生素C钠5.900g","2","南京正大天晴制药有限公司","南京正大天晴制药有限公司","国药准字H20254017",148,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:吉林省,来源年份:2025,采购价:148.00],[来源省份:辽宁省,来源年份:2025,采购价:148.00],[来源省份:重庆市,来源年份:2025,采购价:148.00],[来源省份:湖北省,来源年份:2025,采购价:148.00],[来源省份:海南省,来源年份:2025,采购价:148.00],[来源省份:贵州省,来源年份:2025,采购价:148.00],[来源省份:安徽省,来源年份:2025,采购价:148.00],[来源省份:江苏省,来源年份:2025,采购价:148.00],[来源省份:江西省,来源年份:2025,采购价:148.00],[来源省份:广东省,来源年份:2025,采购价:148.00]","通过","独家，提供10省"]
["聚乙二醇钠钾散","本品为复方制剂,每包含聚乙二醇3350为13.1250g、氯化钠0.3507g、氯化钾0.0466g、碳酸氢钠0.1785g","8","江苏欧歌制药有限公司","圣嘉（滨海）生物医药科技有限公司","国药准字H20253326",48.64,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:48.64],[来源省份:贵州省,来源年份:2025,采购价:48.64],[来源省份:山东省,来源年份:2025,采购价:48.64]","通过","不高于中位价"]
["硫酸镁钠钾口服用浓溶液","176ml:硫酸镁(按MgSO₄•7H₂O计)3.276g、硫酸钠17.510g与硫酸钾3.130g","2","南京海纳制药有限公司","广州市亿源医药有限公司","国药准字H20255031",81.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:81.80],[来源省份:山东省,来源年份:2025,采购价:81.80],[来源省份:江苏省,来源年份:2025,采购价:81.80]","通过","不高于中位价"]
["比沙可啶栓","10mg","7","山西同达药业有限公司","山西同达药业有限公司","国药准字H20065455",77,"已有10个省级平台挂网的独家药品","[来源省份:北京市,来源年份:2024,采购价:77.00],[来源省份:河北省,来源年份:2024,采购价:77.00],[来源省份:内蒙古自治区,来源年份:2024,采购价:77.00],[来源省份:湖北省,来源年份:2024,采购价:77.00],[来源省份:陕西省,来源年份:2024,采购价:77.00],[来源省份:辽宁省,来源年份:2024,采购价:77.00],[来源省份:江苏省,来源年份:2024,采购价:77.00],[来源省份:黑龙江省,来源年份:2024,采购价:77.00],[来源省份:新疆维吾尔自治区,来源年份:2024,采购价:77.00],[来源省份:安徽省,来源年份:2024,采购价:77.00]","通过","独家"]
["口服补液盐散(Ⅲ)","5.125g","6","海南海力制药有限公司","海南海力制药有限公司","国药准字H20183003",17,"急(抢)救药、妇儿专科非专利药品","[来源省份:海南省,来源年份:2025,采购价:17.00],[来源省份:安徽省,来源年份:2025,采购价:17.00],[来源省份:贵州省,来源年份:2025,采购价:17.00]","通过","不高于中位价"]
["乳酸菌素颗粒","1g(按乳酸菌素计算)","8","康芝药业股份有限公司","康芝药业股份有限公司","国药准字H20103529",12.4,"已有10个省级平台挂网的独家药品","[来源省份:江苏省,来源年份:2025,采购价:12.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:12.40],[来源省份:黑龙江省,来源年份:2025,采购价:12.40],[来源省份:河北省,来源年份:2018,采购价:12.40],[来源省份:四川省,来源年份:2025,采购价:12.40],[来源省份:陕西省,来源年份:2025,采购价:12.40],[来源省份:山东省,来源年份:2019,采购价:12.40],[来源省份:湖南省,来源年份:2025,采购价:12.40],[来源省份:吉林省,来源年份:2025,采购价:12.40],[来源省份:江西省,来源年份:2025,采购价:12.40]","通过","独家"]
["胰酶胆汁肠溶片","胰酶50mg(胰蛋白酶145单位、咦淀粉酶2115单位,胰脂肪酶750单位),猪胆膏50mg(牛黄猪去氧胆酸1mg)","36","陕西博森生物制药股份集团有限公司","陕西博森生物制药股份集团有限公司","国药准字H61022561",99,"已有10个省级平台挂网的独家药品","[来源省份:湖北省,来源年份:2024,采购价:99.00],[来源省份:黑龙江省,来源年份:2024,采购价:99.00],[来源省份:辽宁省,来源年份:2024,采购价:99.00],[来源省份:内蒙古自治区,来源年份:2024,采购价:99.00],[来源省份:安徽省,来源年份:2024,采购价:99.00],[来源省份:湖南省,来源年份:2024,采购价:99.00],[来源省份:广西壮族自治区,来源年份:2024,采购价:99.00],[来源省份:江苏省,来源年份:2024,采购价:99.00],[来源省份:陕西省,来源年份:2024,采购价:99.00],[来源省份:海南省,来源年份:2024,采购价:99.00]","通过","独家"]
["二甲双胍恩格列净片(Ⅰ)","每片含盐酸二甲双胍500mg与恩格列净5mg","60","山东朗诺制药有限公司","山东禾琦制药有限公司","国药准字H20253795",58.21,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:58.21],[来源省份:贵州省,来源年份:2025,采购价:58.21],[来源省份:广西壮族自治区,来源年份:2025,采购价:58.21]","通过","不高于中位价"]
["沙格列汀二甲双胍缓释片(Ⅰ)","每片含沙格列汀5mg和盐酸二甲双胍1000mg","18","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254115",114.65,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:114.65],[来源省份:广西壮族自治区,来源年份:2025,采购价:114.65],[来源省份:江苏省,来源年份:2025,采购价:114.65]","通过","不高于中位价"]
["沙格列汀二甲双胍缓释片(Ⅰ)","每片含沙格列汀5mg和盐酸二甲双胍1000mg","12","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254115",77.57,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:77.57],[来源省份:广东省,来源年份:2025,采购价:77.57],[来源省份:广西壮族自治区,来源年份:2025,采购价:77.57]","通过","不高于中位价"]
["沙格列汀二甲双胍缓释片(Ⅰ)","每片含沙格列汀5mg和盐酸二甲双胍1000mg","6","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254115",39.78,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:39.78],[来源省份:广西壮族自治区,来源年份:2025,采购价:39.78],[来源省份:江苏省,来源年份:2025,采购价:39.78]","通过","不高于中位价"]
["沙格列汀二甲双胍缓释片(Ⅲ)","每片含沙格列汀2.5mg和盐酸二甲双胍1000mg","18","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254116",67.44,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:67.44],[来源省份:辽宁省,来源年份:2025,采购价:67.44],[来源省份:广西壮族自治区,来源年份:2025,采购价:67.44]","通过","不高于中位价"]
["沙格列汀二甲双胍缓释片(Ⅲ)","每片含沙格列汀2.5mg和盐酸二甲双胍1000mg","12","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254116",45.63,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:45.63],[来源省份:辽宁省,来源年份:2025,采购价:45.63],[来源省份:广西壮族自治区,来源年份:2025,采购价:45.63]","通过","不高于中位价"]
["沙格列汀二甲双胍缓释片(Ⅲ)","每片含沙格列汀2.5mg和盐酸二甲双胍1000mg","6","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254116",23.4,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:23.40],[来源省份:辽宁省,来源年份:2025,采购价:23.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:23.40]","通过","不高于中位价"]
["贝那鲁肽注射液","4.2mg(42000U)(2.1ml)/支(预填充注射笔)","1","上海仁会生物制药股份有限公司","上海仁会生物制药股份有限公司","国药准字S20230042",2380,"创新生物制品：注册分类2-12类新药","[来源省份:上海市,来源年份:2025,采购价:2380.00],[来源省份:山东省,来源年份:2025,采购价:2380.00],[来源省份:湖北省,来源年份:2025,采购价:2380.00],[来源省份:广东省,来源年份:2025,采购价:2380.00],[来源省份:贵州省,来源年份:2025,采购价:2380.00],[来源省份:云南省,来源年份:2025,采购价:2380.00],[来源省份:陕西省,来源年份:2025,采购价:2380.00],[来源省份:黑龙江省,来源年份:2025,采购价:2380.00],[来源省份:天津市,来源年份:2025,采购价:2380.00],[来源省份:北京市,来源年份:2025,采购价:2380.00]","通过","适应症独家，提供10省"]
["达格列净片","5mg(按C₂₁H₂₅ClO₆计)","10","Hetero Labs Limited","江西省华药医药有限公司","国药准字HJ20250029",18.17,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:18.17],[来源省份:江西省,来源年份:2025,采购价:18.17],[来源省份:湖北省,来源年份:2025,采购价:18.17]","通过","不高于中位价"]
["达格列净片","10mg(按C₂₁H₂₅ClO₆计)","30","Hetero Labs Limited","江西省华药医药有限公司","国药准字HJ20250030",89.01,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:89.01],[来源省份:黑龙江省,来源年份:2025,采购价:89.01],[来源省份:广西壮族自治区,来源年份:2025,采购价:89.01]","通过","不高于中位价"]
["达格列净片","10mg(按C₂₁H₂₅ClO₆计)","10","Hetero Labs Limited","江西省华药医药有限公司","国药准字HJ20250030",30.89,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:30.89],[来源省份:黑龙江省,来源年份:2025,采购价:30.89],[来源省份:广西壮族自治区,来源年份:2025,采购价:30.89]","通过","不高于中位价"]
["维生素D2软胶囊","0.25mg(1万单位)","30","华润双鹤药业股份有限公司","华润双鹤药业股份有限公司","国药准字H11020642",200.7,"不高于同质量层次药品最低价申报","[来源省份:江苏省,来源年份:2025,采购价:200.70],[来源省份:广西壮族自治区,来源年份:2025,采购价:200.70],[来源省份:贵州省,来源年份:2025,采购价:200.70]","通过","不高于同组最低价"]
["维生素B2注射液","2ml:5mg","1","陕西顿斯制药有限公司","西安汤臣制药有限公司","国药准字H61021617",42.7,"不高于同质量层次药品最低价申报","[来源省份:广西壮族自治区,来源年份:2022,采购价:86.39],[来源省份:海南省,来源年份:2022,采购价:86.39],[来源省份:吉林省,来源年份:2024,采购价:86.39]","通过","不高于同组最低价"]
["阿魏酸哌嗪片","50mg","50","康普药业股份有限公司","康普药业股份有限公司","国药准字H43021760",8.29,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2020,采购价:8.29],[来源省份:北京市,来源年份:2022,采购价:8.29],[来源省份:浙江省,来源年份:2020,采购价:8.29]","通过","同厂家符合差比"]
["注射用重组人凝血因子Ⅶa N01","1mg(50KIU)/瓶","1","正大天晴药业集团南京顺欣制药有限公司","正大天晴药业集团南京顺欣制药有限公司","国药准字S20250034",4680,"已有10个省级平台挂网的独家药品","[来源省份:内蒙古自治区,来源年份:2025,采购价:4680.00],[来源省份:安徽省,来源年份:2025,采购价:4680.00],[来源省份:北京市,来源年份:2025,采购价:4680.00],[来源省份:辽宁省,来源年份:2025,采购价:4680.00],[来源省份:浙江省,来源年份:2025,采购价:4680.00],[来源省份:江西省,来源年份:2025,采购价:4680.00],[来源省份:广东省,来源年份:2025,采购价:4680.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:4680.00],[来源省份:重庆市,来源年份:2025,采购价:4680.00],[来源省份:四川省,来源年份:2025,采购价:4680.00]","通过","独家"]
["马来酸阿伐曲泊帕片","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","10","江苏诚康药业有限公司","山东新华制药股份有限公司","国药准字H20249585",1319,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:1319.00],[来源省份:山东省,来源年份:2025,采购价:1319.00],[来源省份:重庆市,来源年份:2025,采购价:1319.00]","通过","不高于中位价"]
["腺苷钴胺胶囊","0.5mg","30","广东华南药业集团有限公司","山东新华制药股份有限公司","国药准字H20253418",94.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:94.50],[来源省份:广西壮族自治区,来源年份:2025,采购价:94.50],[来源省份:山东省,来源年份:2025,采购价:94.50]","通过","不高于中位价"]
["复方醋酸钠葡萄糖注射液","500ml","1","河北仁合益康药业有限公司","仁合益康集团有限公司","国药准字H20254562",395,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:395.00],[来源省份:黑龙江省,来源年份:2025,采购价:395.00],[来源省份:江苏省,来源年份:2025,采购价:395.00]","通过","不高于中位价"]
["复方醋酸钠葡萄糖注射液","200ml","1","河北仁合益康药业有限公司","仁合益康集团有限公司","国药准字H20254561",195.87,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:195.87],[来源省份:江苏省,来源年份:2025,采购价:195.87],[来源省份:贵州省,来源年份:2025,采购价:195.87]","通过","不高于中位价"]
["氯化钾氯化钠注射液","250ml:氯化钾0.75g与氯化钠2.25g","1","石家庄四药有限公司","石家庄四药有限公司","国药准字H20254795",16.18,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:16.20],[来源省份:海南省,来源年份:2025,采购价:16.20],[来源省份:贵州省,来源年份:2025,采购价:16.20]","通过","不高于中位价"]
["氯化钾氯化钠注射液","500ml:氯化钾1.5g与氯化钠4.5g","1","石家庄四药有限公司","石家庄四药有限公司","国药准字H20254796",27.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:27.50],[来源省份:海南省,来源年份:2025,采购价:27.50],[来源省份:贵州省,来源年份:2025,采购价:27.50]","通过","不高于中位价"]
["碳酸氢钠注射液","10ml︰0.42g","1","广东星昊药业有限公司","广州合和医药有限公司","国药准字H20254426",7.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:7.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:7.80],[来源省份:江苏省,来源年份:2025,采购价:7.80]","通过","不高于中位价"]
["盐酸去氧肾上腺素注射液","1ml∶10mg","1","远大医药(中国)有限公司","远大医药（中国）有限公司","国药准字H20253388",6.69,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:6.69],[来源省份:江西省,来源年份:2025,采购价:6.69],[来源省份:贵州省,来源年份:2025,采购价:6.69]","通过","不高于中选价"]
["单硝酸异山梨酯喷雾剂","10ml:180mg,每喷2.5mg","1","深圳大佛药业股份有限公司","深圳大佛药业股份有限公司","国药准字H20020439",33.99,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:33.99],[来源省份:吉林省,来源年份:2025,采购价:33.99],[来源省份:贵州省,来源年份:2025,采购价:33.99],[来源省份:广西壮族自治区,来源年份:2025,采购价:33.99],[来源省份:黑龙江省,来源年份:2025,采购价:33.99],[来源省份:湖北省,来源年份:2025,采购价:33.99],[来源省份:湖南省,来源年份:2025,采购价:33.99],[来源省份:山东省,来源年份:2025,采购价:33.99],[来源省份:内蒙古自治区,来源年份:2025,采购价:33.99],[来源省份:辽宁省,来源年份:2025,采购价:33.99]","通过","独家"]
["单硝酸异山梨酯缓释胶囊(Ⅳ)","50mg","20","优时比(珠海)制药有限公司","珠海英联医药有限公司","国药准字H20031224",52.45,"本企业已挂网药品新增包装规格","[来源省份:辽宁省,来源年份:2022,采购价:52.45],[来源省份:江苏省,来源年份:2023,采购价:52.45],[来源省份:黑龙江省,来源年份:2024,采购价:52.45]","通过","同厂家符合差比"]
["硝酸甘油喷雾剂","每瓶200喷,每喷重量48mg含硝酸甘油0.4mg","1","北京双鹭药业股份有限公司","北京双鹭药业股份有限公司","国药准字H20253802",198,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:198.00],[来源省份:江西省,来源年份:2025,采购价:198.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:198.00]","通过","不高于中位价"]
["尼可地尔片","5mg","30","扬州市三药制药有限公司","北京沃邦医药科技有限公司","国药准字H20249805",28.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:28.10],[来源省份:广西壮族自治区,来源年份:2025,采购价:28.10],[来源省份:贵州省,来源年份:2025,采购价:28.10]","通过","不高于中位价"]
["呋塞米片","20mg","100","山西双雁药业有限公司","山西双雁药业有限公司","国药准字H14022360",14.38,"不高于同质量层次药品最低价申报","[来源省份:湖南省,来源年份:2025,采购价:14.38],[来源省份:贵州省,来源年份:2025,采购价:14.49],[来源省份:广西壮族自治区,来源年份:2025,采购价:14.49]","通过","不高于同组最低价"]
["己酮可可碱缓释片","0.4g","10","石药集团欧意药业有限公司","石药集团中诺药业（石家庄）有限公司","国药准字H20255008",49.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:49.20],[来源省份:广东省,来源年份:2025,采购价:49.20],[来源省份:山东省,来源年份:2025,采购价:49.20]","通过","不高于中位价"]
["聚多卡醇注射液","2ml:60mg","1","陕西天宇制药有限公司","陕西天宇制药有限公司","国药准字H20258099",760,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:760.00],[来源省份:江西省,来源年份:2025,采购价:760.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:760.00]","通过","不高于中位价"]
["聚多卡醇注射液","2ml:20mg","1","陕西天宇制药有限公司","陕西天宇制药有限公司","国药准字H20258100",327.76,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:327.76],[来源省份:贵州省,来源年份:2025,采购价:327.76],[来源省份:广西壮族自治区,来源年份:2025,采购价:327.76]","通过","不高于中位价"]
["聚多卡醇注射液","2ml:10mg","1","陕西天宇制药有限公司","陕西天宇制药有限公司","国药准字H20258098",192.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:192.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:192.80],[来源省份:江西省,来源年份:2025,采购价:192.80]","通过","不高于中位价"]
["芦丁片","20mg","100","天津力生制药股份有限公司","天津力生制药股份有限公司","国药准字H12020173",4.2,"已有10个省级平台挂网的独家药品","[来源省份:北京市,来源年份:2025,采购价:4.20],[来源省份:山东省,来源年份:2025,采购价:4.20],[来源省份:湖南省,来源年份:2025,采购价:4.20],[来源省份:云南省,来源年份:2025,采购价:4.20],[来源省份:内蒙古自治区,来源年份:2025,采购价:4.20],[来源省份:四川省,来源年份:2025,采购价:4.20],[来源省份:山西省,来源年份:2025,采购价:4.20],[来源省份:广东省,来源年份:2025,采购价:4.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:4.20],[来源省份:河北省,来源年份:2025,采购价:4.20]","通过","独家"]
["盐酸普萘洛尔片","10mg","100","北京海王中新药业股份有限公司","北京海王中新药业股份有限公司","国药准字H13020584",18,"国家集采非中选药品申报","[来源省份:黑龙江省,来源年份:2025,采购价:19.20],[来源省份:辽宁省,来源年份:2024,采购价:19.20],[来源省份:山东省,来源年份:2025,采购价:19.20]","通过","不高于未中选最低价"]
["酒石酸美托洛尔注射液","5ml:酒石酸美托洛尔5mg与氯化钠45mg","1","江苏朗欧药业有限公司","江苏朗欧药业有限公司","国药准字H20055270",39.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:39.60],[来源省份:黑龙江省,来源年份:2025,采购价:39.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:39.60]","通过","不高于中位价"]
["比索洛尔氨氯地平片","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅ClN₂O₅计)5mg","14","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254358",21.13,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:21.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:21.20],[来源省份:浙江省,来源年份:2025,采购价:21.13]","通过","同厂家符合差比"]
["比索洛尔氨氯地平片","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅ClN₂O₅计)5mg","10","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254358",15.28,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:15.33],[来源省份:广西壮族自治区,来源年份:2025,采购价:15.33],[来源省份:浙江省,来源年份:2025,采购价:15.28]","通过","同厂家符合差比"]
["盐酸贝尼地平片","4mg","30","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254764",60.35,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:62.97],[来源省份:广西壮族自治区,来源年份:2025,采购价:62.97],[来源省份:江苏省,来源年份:2025,采购价:62.97]","通过","不高于中位价"]
["盐酸贝尼地平片","4mg","20","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254764",40.83,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:42.61],[来源省份:广西壮族自治区,来源年份:2025,采购价:42.61],[来源省份:宁夏回族自治区,来源年份:2025,采购价:42.61]","通过","不高于中位价"]
["盐酸贝尼地平片","8mg","30","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254631",102.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:107.06],[来源省份:广西壮族自治区,来源年份:2025,采购价:107.06],[来源省份:江苏省,来源年份:2025,采购价:107.06]","通过","不高于中位价"]
["盐酸贝尼地平片","8mg","20","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254631",69.42,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:72.44],[来源省份:广西壮族自治区,来源年份:2025,采购价:72.44],[来源省份:江苏省,来源年份:2025,采购价:72.44]","通过","不高于中位价"]
["盐酸尼卡地平注射液","10ml:10mg","1","浙江华海药业股份有限公司","浙江华海药业股份有限公司","国药准字H20254793",42.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:42.70],[来源省份:青海省,来源年份:2025,采购价:42.70],[来源省份:山东省,来源年份:2025,采购价:42.70]","通过","不高于中位价"]
["盐酸尼卡地平注射液","10ml:10mg","1","齐鲁制药(海南)有限公司","齐鲁制药（海南）有限公司","国药准字H20255093",30,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:30.00],[来源省份:山东省,来源年份:2025,采购价:30.00],[来源省份:浙江省,来源年份:2025,采购价:30.00]","通过","不高于中位价"]
["盐酸尼卡地平注射液","10ml:10mg","1","浙江赛默制药有限公司","海南广升誉制药有限公司","国药准字H20254028",42.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:42.50],[来源省份:江西省,来源年份:2025,采购价:42.50],[来源省份:广西壮族自治区,来源年份:2025,采购价:42.50]","通过","不高于中位价"]
["盐酸尼卡地平注射液","2ml:2mg","1","浙江赛默制药有限公司","海南广升誉制药有限公司","国药准字H20254027",12.4,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:12.40],[来源省份:江西省,来源年份:2025,采购价:12.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:12.40]","通过","不高于中位价"]
["氨氯地平贝那普利胶囊","每粒含苯磺酸氨氯地平5mg(按C20H25N2O5CL计)与盐酸贝那普利10mg","30","江苏和晨药业有限公司","浙江高跖医药科技股份有限公司","国药准字H20253132",98.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:218.70],[来源省份:浙江省,来源年份:2025,采购价:98.60],[来源省份:安徽省,来源年份:2025,采购价:218.70],[来源省份:广西壮族自治区,来源年份:2025,采购价:218.70],[来源省份:黑龙江省,来源年份:2025,采购价:98.60],[来源省份:湖北省,来源年份:2025,采购价:218.70],[来源省份:湖南省,来源年份:2025,采购价:98.60],[来源省份:内蒙古自治区,来源年份:2025,采购价:218.70],[来源省份:贵州省,来源年份:2025,采购价:206.80],[来源省份:江西省,来源年份:2025,采购价:206.80]","通过","不高于中位价"]
["氨氯地平贝那普利胶囊","每粒含苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)与盐酸贝那普利10mg","7","江苏和晨药业有限公司","浙江皓格药业有限公司","国药准字H20254193",40.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:40.60],[来源省份:江苏省,来源年份:2025,采购价:40.60],[来源省份:山东省,来源年份:2025,采购价:40.60]","通过","不高于中位价"]
["培哚普利氨氯地平片(Ⅲ)","每片含精氨酸培哚普利10mg、苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","10","成都硕德药业有限公司","成都硕德药业有限公司","国药准字H20254925",41.3,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:41.30],[来源省份:江苏省,来源年份:2025,采购价:41.30],[来源省份:广东省,来源年份:2025,采购价:41.30]","通过","不高于中位价"]
["厄贝沙坦氢氯噻嗪片","每片含厄贝沙坦150mg,氢氯噻嗪12.5mg","27","石家庄市普力制药有限公司","河北新石制药有限公司","国药准字H20233451",18.11,"本企业已挂网药品新增包装规格","[来源省份:湖北省,来源年份:2025,采购价:18.11],[来源省份:黑龙江省,来源年份:2025,采购价:18.11],[来源省份:河北省,来源年份:2025,采购价:18.11]","通过","同厂家符合差比"]
["厄贝沙坦氢氯噻嗪片","每片含厄贝沙坦150mg,氢氯噻嗪12.5mg","21","石家庄市普力制药有限公司","河北新石制药有限公司","国药准字H20233451",14.22,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2025,采购价:14.22],[来源省份:黑龙江省,来源年份:2025,采购价:14.22],[来源省份:湖北省,来源年份:2025,采购价:14.22]","通过","同厂家符合差比"]
["替米沙坦氨氯地平片","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","10","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254324",68.67,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:68.67],[来源省份:江苏省,来源年份:2025,采购价:68.67],[来源省份:山东省,来源年份:2025,采购价:68.67]","通过","同厂家符合差比"]
["替米沙坦氨氯地平片","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","7","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254324",48.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:48.70],[来源省份:江苏省,来源年份:2025,采购价:48.70],[来源省份:湖北省,来源年份:2025,采购价:48.70]","通过","同厂家符合差比"]
["替米沙坦氨氯地平片","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","7","四川科伦药业股份有限公司","湖南慧泽生物医药科技有限公司","国药准字H20254641",34.93,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:34.93],[来源省份:广西壮族自治区,来源年份:2025,采购价:34.93],[来源省份:江苏省,来源年份:2025,采购价:34.93]","通过","不高于中位价"]
["替米沙坦氨氯地平片(II)","每片含替米沙坦40mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","7","常州市阳光药业有限公司","常州市阳光药业有限公司","国药准字H20254352",41.33,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:41.33],[来源省份:贵州省,来源年份:2025,采购价:41.33],[来源省份:江西省,来源年份:2025,采购价:41.33],[来源省份:陕西省,来源年份:2025,采购价:41.33],[来源省份:湖北省,来源年份:2025,采购价:41.33],[来源省份:安徽省,来源年份:2025,采购价:41.33],[来源省份:宁夏回族自治区,来源年份:2025,采购价:41.33],[来源省份:黑龙江省,来源年份:2025,采购价:41.33],[来源省份:广西壮族自治区,来源年份:2025,采购价:41.33],[来源省份:江苏省,来源年份:2025,采购价:41.33]","通过","独家"]
["缬沙坦氨氯地平片(Ⅱ)","每片含缬沙坦160mg,氨氯地平5mg","7","石家庄市华新药业有限责任公司","浙江众延医药科技有限公司","国药准字H20254234",48.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:48.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:48.60],[来源省份:江苏省,来源年份:2025,采购价:48.60],[来源省份:黑龙江省,来源年份:2025,采购价:48.60]","通过","不高于中位价"]
["沙库巴曲阿利沙坦钙片","按C₄₆H₅₀ClN₇O₇计:240mg(沙库巴曲116mg/阿利沙坦124mg)","7","深圳信立泰药业股份有限公司","深圳信立泰药业股份有限公司","国药准字H20250017",63.56,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:63.56],[来源省份:广东省,来源年份:2025,采购价:63.56],[来源省份:湖南省,来源年份:2025,采购价:63.56],[来源省份:贵州省,来源年份:2025,采购价:63.56],[来源省份:安徽省,来源年份:2025,采购价:63.56],[来源省份:四川省,来源年份:2025,采购价:63.56],[来源省份:黑龙江省,来源年份:2025,采购价:63.56],[来源省份:甘肃省,来源年份:2025,采购价:63.56],[来源省份:江西省,来源年份:2025,采购价:63.56],[来源省份:江苏省,来源年份:2025,采购价:63.56]","通过","独家"]
["非诺贝特片","0.1g","100","广州康和药业有限公司","广州康和药业有限公司","国药准字H44021698",52,"不高于同质量层次药品最低价申报","[来源省份:贵州省,来源年份:2025,采购价:52.00],[来源省份:海南省,来源年份:2025,采购价:52.00],[来源省份:安徽省,来源年份:2025,采购价:52.00]","通过","不高于同组最低价"]
["非诺贝特酸胆碱缓释胶囊","135mg(按C₁₇H₁₅ClO₄计)","12","湖南九典制药股份有限公司","湖南九典制药股份有限公司","国药准字H20254583",36.96,"纳入国家医保目录准入价格谈判的药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:36.96],[来源省份:湖北省,来源年份:2025,采购价:36.96],[来源省份:江苏省,来源年份:2025,采购价:36.96]","通过","申报价格不高于支付标准的国谈竞价药"]
["阿昔莫司胶囊","0.25g","20","浙江赛默制药有限公司","浙江沣华医药科技有限公司","国药准字H20244607",41.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:41.20],[来源省份:江西省,来源年份:2025,采购价:41.20],[来源省份:黑龙江省,来源年份:2025,采购价:41.20]","通过","不高于中位价"]
["盐酸阿莫罗芬搽剂","5%(2.5ml:125mg,按C₂₁H₃₅NO计)","1","福元药业有限公司","福元药业有限公司","国药准字H20254685",199.28,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:199.28],[来源省份:江苏省,来源年份:2025,采购价:199.28],[来源省份:湖北省,来源年份:2025,采购价:199.28]","通过","不高于中位价"]
["莫匹罗星软膏","2%(15g:0.3g)","2","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","国药准字H20254639",58.56,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:58.56],[来源省份:黑龙江省,来源年份:2025,采购价:58.56],[来源省份:宁夏回族自治区,来源年份:2025,采购价:58.56]","通过","不高于中位价"]
["醋酸氢化可的松乳膏","1%(20g/支)","2","上海正大通用药业股份有限公司","上海正大通用药业股份有限公司","国药准字H31021275",67.2,"本企业已挂网药品新增包装规格","[来源省份:江苏省,来源年份:2025,采购价:67.20],[来源省份:浙江省,来源年份:2025,采购价:67.20],[来源省份:黑龙江省,来源年份:2025,采购价:67.20]","通过","同厂家符合差比"]
["丙酸氟替卡松乳膏","0.05%(15g:7.5mg)","1","重庆华邦制药有限公司","重庆华邦制药有限公司","国药准字H20254589",33.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:33.20],[来源省份:江苏省,来源年份:2025,采购价:33.20],[来源省份:江西省,来源年份:2025,采购价:33.20]","通过","不高于中位价"]
["克林霉素磷酸酯栓","0.1g","7","昆山培力药品有限公司","昆山培力药品有限公司","国药准字H20080810",105,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖南省,来源年份:2025,采购价:105.00],[来源省份:黑龙江省,来源年份:2025,采购价:105.00],[来源省份:江苏省,来源年份:2025,采购价:105.00]","通过","不高于中位价"]
["鱼腥草素钠栓","20mg(以鱼腥草素钠计)","7","黑龙江省济仁药业有限公司","黑龙江省济仁药业有限公司","国药准字H20057018",20.51,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2025,采购价:20.51],[来源省份:广西壮族自治区,来源年份:2025,采购价:20.51],[来源省份:广东省,来源年份:2025,采购价:20.51],[来源省份:重庆市,来源年份:2025,采购价:20.51],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:20.51],[来源省份:四川省,来源年份:2025,采购价:20.51],[来源省份:西藏自治区,来源年份:2025,采购价:20.51],[来源省份:陕西省,来源年份:2025,采购价:20.51],[来源省份:贵州省,来源年份:2025,采购价:20.51],[来源省份:江西省,来源年份:2025,采购价:20.51]","通过","独家"]
["黄体酮软胶囊","0.1g","30","人福普克药业(武汉)有限公司","武汉九珑人福药业有限责任公司","国药准字H20254199",58.39,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:70.20],[来源省份:江苏省,来源年份:2025,采购价:70.20],[来源省份:吉林省,来源年份:2025,采购价:70.20]","通过","不高于中位价"]
["黄体酮软胶囊","0.2g","14","人福普克药业(武汉)有限公司","武汉九珑人福药业有限责任公司","国药准字H20254198",47.63,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:55.69],[来源省份:海南省,来源年份:2025,采购价:55.69],[来源省份:吉林省,来源年份:2025,采购价:55.69]","通过","不高于中位价"]
["左卡尼汀口服溶液","10ml:1g","6","湖南九典制药股份有限公司","江苏百奥信康医药科技有限公司","国药准字H20249495",36,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:36.00],[来源省份:黑龙江省,来源年份:2025,采购价:36.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:36.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:36.00],[来源省份:贵州省,来源年份:2025,采购价:36.00]","通过","不高于中位价"]
["丙硫氧嘧啶片","50mg","100","精华制药集团股份有限公司","精华制药集团股份有限公司","国药准字H32020795",39,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2022,采购价:39.00],[来源省份:海南省,来源年份:2024,采购价:39.00],[来源省份:四川省,来源年份:2024,采购价:39.00]","通过","不高于中位价"]
["注射用苯唑西林钠","1.0g(按C₁₉H₁₉N₃O₅S计)","1","福安药业集团庆余堂制药有限公司","福安药业集团庆余堂制药有限公司","国药准字H20254447",26.66,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:26.66],[来源省份:贵州省,来源年份:2025,采购价:29.12],[来源省份:广西壮族自治区,来源年份:2025,采购价:29.12]","通过","不高于未过评价格"]
["注射用苯唑西林钠","2.0g(按C₁₉H₁₉N₃O₅S计)","1","福安药业集团庆余堂制药有限公司","福安药业集团庆余堂制药有限公司","国药准字H20254446",45.32,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:49.51],[来源省份:贵州省,来源年份:2025,采购价:49.51],[来源省份:宁夏回族自治区,来源年份:2025,采购价:45.32]","通过","不高于未过评价格"]
["注射用苯唑西林钠","2.0g(按C₁₉H₁₉N₃O₅S计)","1","中孚药业股份有限公司","山东道齐生物医药科技有限公司","国药准字H20254491",30.62,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:33.71],[来源省份:湖北省,来源年份:2025,采购价:33.71],[来源省份:广西壮族自治区,来源年份:2025,采购价:33.71]","通过","不高于未过评价格"]
["注射用苯唑西林钠","1.0g(按C₁₉H₁₉N₃O₅S计)","1","中孚药业股份有限公司","山东道齐生物医药科技有限公司","国药准字H20254490",18.01,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:19.83],[来源省份:湖北省,来源年份:2025,采购价:19.83],[来源省份:广西壮族自治区,来源年份:2025,采购价:19.83]","通过","不高于未过评价格"]
["注射用阿莫西林钠克拉维酸钾","1.2g(C16H19N3O5S1g与C8H9NO50.2g)","1","石药集团中诺药业(石家庄)有限公司","石药集团中诺药业（石家庄）有限公司","国药准字H20023212",8.3,"国家集采非中选药品申报","[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:8.30],[来源省份:湖南省,来源年份:2025,采购价:8.30],[来源省份:贵州省,来源年份:2025,采购价:8.30]","通过","不高于未中选最低价"]
["头孢地尼颗粒","50mg","6","国药集团致君(深圳)制药有限公司","国药集团致君（深圳）制药有限公司","国药准字H20253170",35.4,"国家集采非中选药品申报","[来源省份:黑龙江省,来源年份:2025,采购价:35.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:35.40],[来源省份:山东省,来源年份:2025,采购价:35.40]","通过","不高于中选价"]
["注射用氨曲南阿维巴坦钠","2.0g(C₁₃H₁₇N₅O₈S₂1.5g与C₇H₁₁N₃O₆S0.5g)","1","Hospira Australia Pty Ltd","上药控股有限公司","国药准字HJ20250078",1455,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:1455.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:1455.00],[来源省份:甘肃省,来源年份:2025,采购价:1455.00],[来源省份:陕西省,来源年份:2025,采购价:1455.00],[来源省份:湖南省,来源年份:2025,采购价:1455.00],[来源省份:重庆市,来源年份:2025,采购价:1455.00],[来源省份:广东省,来源年份:2025,采购价:1455.00],[来源省份:江西省,来源年份:2025,采购价:1455.00],[来源省份:安徽省,来源年份:2025,采购价:1455.00],[来源省份:江苏省,来源年份:2025,采购价:1455.00]","通过","独家，提供10省"]
["注射用美罗培南","0.5g(按C₁₇H₂₅N₃O₅S计)","1","齐鲁安替制药有限公司","齐鲁安替制药有限公司","国药准字H20233960",9.2,"国家集采非中选药品申报","[来源省份:浙江省,来源年份:2025,采购价:9.20],[来源省份:山东省,来源年份:2025,采购价:9.20],[来源省份:甘肃省,来源年份:2025,采购价:9.20]","通过","不高于中选价"]
["克拉霉素分散片","0.25g","6","四川省旺林堂药业有限公司","四川省旺林堂药业有限公司","国药准字H20000127",8.06,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:8.06],[来源省份:黑龙江省,来源年份:2025,采购价:8.06],[来源省份:湖北省,来源年份:2025,采购价:8.06]","通过","不高于未中选最低价"]
["克拉霉素分散片","0.25g","7","四川省旺林堂药业有限公司","四川省旺林堂药业有限公司","国药准字H20000127",9.35,"国家集采非中选药品申报","[来源省份:内蒙古自治区,来源年份:2025,采购价:9.35],[来源省份:山东省,来源年份:2025,采购价:9.35],[来源省份:安徽省,来源年份:2025,采购价:9.35]","通过","不高于未中选最低价"]
["左氧氟沙星氯化钠注射液","100ml:左氧氟沙星(按C₁₈H₂₀FN₃O₄计)0.5g与氯化钠0.9g","1","石药银湖制药有限公司","石药银湖制药有限公司","国药准字H20249701",4.98,"国家集采非中选药品申报","[来源省份:广东省,来源年份:2025,采购价:4.98],[来源省份:河北省,来源年份:2025,采购价:4.98],[来源省份:安徽省,来源年份:2025,采购价:4.98]","通过","不高于未中选最低价"]
["吗啉硝唑氯化钠注射液","100ml:吗啉硝唑0.5g与氯化钠0.9g","1","江苏悦兴药业有限公司","南京卡文迪许生物工程技术有限公司","国药准字H20249624",58.09,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:67.80],[来源省份:贵州省,来源年份:2025,采购价:67.80],[来源省份:海南省,来源年份:2025,采购价:67.80]","通过","不高于中位价"]
["吗啉硝唑氯化钠注射液","100ml:吗啉硝唑0.5g与氯化钠0.9g","1","成都正康药业有限公司","成都国为生物医药有限公司","国药准字H20249460",58.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:86.00],[来源省份:黑龙江省,来源年份:2025,采购价:86.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:86.00]","通过","不高于中位价"]
["左奥硝唑片","0.25g","6","湖南华纳大药厂股份有限公司","湖南华纳大药厂股份有限公司","国药准字H20170018",96.53,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2025,采购价:96.53],[来源省份:内蒙古自治区,来源年份:2025,采购价:96.53],[来源省份:贵州省,来源年份:2025,采购价:96.53]","通过","同厂家符合差比"]
["左奥硝唑分散片","0.25g","6","湖南华纳大药厂股份有限公司","湖南明瑞制药股份有限公司","国药准字H20220003",96.53,"不高于同质量层次药品最低价申报","[来源省份:贵州省,来源年份:2022,采购价:96.53],[来源省份:云南省,来源年份:2022,采购价:96.53],[来源省份:辽宁省,来源年份:2025,采购价:96.53]","通过","不高于同组最低价"]
["利奈唑胺片","600mg","10","Alkem Laboratories Limited","中诺凯琳健康产业（海南）有限公司","国药准字HJ20240065",157,"国家集采非中选药品申报","[来源省份:广东省,来源年份:2025,采购价:157.00],[来源省份:重庆市,来源年份:2025,采购价:157.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:157.00]","通过","不高于中选价"]
["注射用磷酸特地唑胺","200mg","1","重庆圣华曦药业股份有限公司","重庆圣华曦药业股份有限公司","国药准字H20254693",227,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:227.00],[来源省份:广东省,来源年份:2025,采购价:227.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:227.00]","通过","不高于未中选最低价"]
["注射用硫酸艾沙康唑","0.2g(按C₂₂H₁₇F₂N₅OS计)","1","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20255036",964,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:964.00],[来源省份:江苏省,来源年份:2025,采购价:964.00],[来源省份:贵州省,来源年份:2025,采购价:964.00]","通过","不高于中位价"]
["注射用硫酸艾沙康唑","0.2g(按C₂₂H₁₇F₂N₅OS计)","1","山西德元堂药业有限公司","山东力诺制药有限公司","国药准字H20254537",965,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:965.00],[来源省份:江苏省,来源年份:2025,采购价:965.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:965.00]","通过","不高于中位价"]
["伏立康唑干混悬剂","45g:3g,配制成混悬液后伏立康唑浓度为40mg/ml","1","南京易亨制药有限公司","南京易亨制药有限公司","国药准字H20254630",900,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:960.00],[来源省份:湖北省,来源年份:2025,采购价:960.00],[来源省份:江苏省,来源年份:2025,采购价:960.00]","通过","不高于中位价"]
["环丝氨酸胶囊","0.25g","12","湖南华纳大药厂股份有限公司","湖南埃威格林医药科技有限公司","国药准字H20254423",273,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:273.60],[来源省份:贵州省,来源年份:2025,采购价:273.60],[来源省份:江西省,来源年份:2025,采购价:273.60]","通过","不高于中位价"]
["磷酸奥司他韦颗粒","0.9g(按C₁₆H₂₈N₂O₄计)","1","湖南嘉恒制药有限公司","湖南慧泽生物医药科技有限公司","国药准字H20254848",99,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:99.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:99.00],[来源省份:江苏省,来源年份:2025,采购价:99.00]","通过","不高于中位价"]
["静注乙型肝炎人免疫球蛋白(pH4)","2500IU(50ml)/瓶","1","哈尔滨派斯菲科生物制药有限公司","哈尔滨派斯菲科生物制药有限公司","国药准字S20110019",2895,"不高于同质量层次药品最低价申报","[来源省份:江西省,来源年份:2025,采购价:2895.00],[来源省份:湖南省,来源年份:2025,采购价:2895.00],[来源省份:湖北省,来源年份:2025,采购价:2895.00]","通过","不高于同组最低价"]
["盐酸阿思尼布片","40mg(按C₂₀H₁₈ClF₂N₅O₃计)","60","Novartis Pharma Stein AG","北京诺华制药有限公司","国药准字HJ20250056",26000,"已有10个省级平台挂网的独家药品","[来源省份:安徽省,来源年份:2025,采购价:26000.00],[来源省份:重庆市,来源年份:2025,采购价:26000.00],[来源省份:辽宁省,来源年份:2025,采购价:26000.00],[来源省份:江西省,来源年份:2025,采购价:26000.00],[来源省份:江苏省,来源年份:2025,采购价:26000.00],[来源省份:黑龙江省,来源年份:2025,采购价:26000.00],[来源省份:贵州省,来源年份:2025,采购价:26000.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:26000.00],[来源省份:广东省,来源年份:2025,采购价:26000.00],[来源省份:北京市,来源年份:2025,采购价:26000.00]","通过","独家"]
["乙磺酸尼达尼布软胶囊","100mg(按C₃₁H₃₃N₅O₄计)","30","沈阳红旗制药有限公司","沈阳红旗制药有限公司","国药准字H20254599",1020,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:1020.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:1020.00],[来源省份:贵州省,来源年份:2025,采购价:1020.00]","通过","不高于中位价"]
["注射用维恩妥尤单抗","30mg/瓶","1","Baxter Oncology GmbH","科园信海（北京）医疗用品贸易有限公司","国药准字SJ20240035",7117,"本企业已挂网药品新增包装规格","[来源省份:浙江省,来源年份:2025,采购价:7117.00],[来源省份:贵州省,来源年份:2025,采购价:7117.00],[来源省份:广东省,来源年份:2025,采购价:7117.00]","通过","同厂家符合差比"]
["奥沙利铂注射液","10ml:50mg","1","吉斯美(武汉)制药有限公司","吉斯美（武汉）制药有限公司","国药准字H20244951",86,"国家集采非中选药品申报","[来源省份:贵州省,来源年份:2025,采购价:192.00],[来源省份:江苏省,来源年份:2025,采购价:192.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:192.00]","通过","不高于未中选最低价"]
["卡铂注射液","15ml:150mg","1","吉斯美(武汉)制药有限公司","吉斯美（武汉）制药有限公司","国药准字H20249664",106,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:150.00],[来源省份:贵州省,来源年份:2025,采购价:150.00],[来源省份:江西省,来源年份:2025,采购价:150.00]","通过","不高于中位价"]
["醋酸阿比特龙片","0.25g","120","武汉九珑人福药业有限责任公司","武汉九珑人福药业有限责任公司","国药准字H20244845",2675,"国家集采非中选药品申报","[来源省份:山东省,来源年份:2025,采购价:2675.00],[来源省份:安徽省,来源年份:2025,采购价:2675.00],[来源省份:江苏省,来源年份:2025,采购价:2675.00]","通过","不高于未中选最低价"]
["麦考酚钠肠溶片","0.18g(按C17H20O6计)","50","华益药业科技(安徽)有限公司","浙江美迪深生物医药有限公司","国药准字H20254003",290,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:290.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:290.00],[来源省份:贵州省,来源年份:2025,采购价:290.00]","通过","同厂家符合差比"]
["他克莫司胶囊","0.5mg","100","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司","国药准字HJ20240167",796,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:796.00],[来源省份:贵州省,来源年份:2025,采购价:796.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:796.00]","通过","不高于中位价"]
["他克莫司胶囊","1mg","100","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司","国药准字HJ20240166",1353.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:1353.20],[来源省份:贵州省,来源年份:2025,采购价:1353.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:1353.20]","通过","不高于中位价"]
["他克莫司缓释胶囊","1mg","50","江苏和晨药业有限公司","江苏和晨药业有限公司","国药准字H20254680",919,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:919.00],[来源省份:贵州省,来源年份:2025,采购价:919.00],[来源省份:江苏省,来源年份:2025,采购价:919.00]","通过","不高于中位价"]
["美洛昔康注射液(Ⅱ)","1ml:30mg","1","南京健友生化制药股份有限公司","南京清普生物科技有限公司","国药准字H20250012",466,"已有10个省级平台挂网的独家药品","[来源省份:广东省,来源年份:2025,采购价:466.00],[来源省份:海南省,来源年份:2025,采购价:466.00],[来源省份:安徽省,来源年份:2025,采购价:466.00],[来源省份:陕西省,来源年份:2025,采购价:466.00],[来源省份:黑龙江省,来源年份:2025,采购价:466.00],[来源省份:贵州省,来源年份:2025,采购价:466.00],[来源省份:辽宁省,来源年份:2025,采购价:466.00],[来源省份:河北省,来源年份:2025,采购价:466.00],[来源省份:江西省,来源年份:2025,采购价:466.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:466.00]","通过","独家"]
["美洛昔康注射液(Ⅲ)","1ml:30mg","1","石药集团中诺药业(石家庄)有限公司","石药集团中诺药业（石家庄）有限公司","国药准字H20254568",468,"已有10个省级平台挂网的独家药品","[来源省份:安徽省,来源年份:2025,采购价:468.00],[来源省份:广东省,来源年份:2025,采购价:468.00],[来源省份:贵州省,来源年份:2025,采购价:468.00],[来源省份:海南省,来源年份:2025,采购价:468.00],[来源省份:河北省,来源年份:2025,采购价:468.00],[来源省份:黑龙江省,来源年份:2025,采购价:468.00],[来源省份:湖北省,来源年份:2025,采购价:468.00],[来源省份:江西省,来源年份:2025,采购价:468.00],[来源省份:辽宁省,来源年份:2025,采购价:468.00],[来源省份:陕西省,来源年份:2025,采购价:468.00]","通过","独家"]
["布洛芬混悬液","100ml:2g","1","山东益康药业股份有限公司","新华制药（高密）有限公司","国药准字H20233008",13.16,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山西省,来源年份:2024,采购价:13.16],[来源省份:广东省,来源年份:2023,采购价:13.16],[来源省份:山东省,来源年份:2023,采购价:13.16]","通过","不高于中位价"]
["洛索洛芬钠凝胶贴膏","每贴(14cm×10cm)含膏体10g,含洛索洛芬钠100mg(以C₁₅H₁₇NaO₃计)","7","武汉法玛星制药有限公司","武汉法玛星制药有限公司","国药准字H20253634",109.06,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:109.06],[来源省份:广东省,来源年份:2025,采购价:109.06],[来源省份:湖南省,来源年份:2025,采购价:109.06]","通过","不高于中位价"]
["酮洛芬贴片","每片7cm×10cm,含酮洛芬20mg","5","贵州联盛药业有限公司","贵州联盛药业有限公司","国药准字H20173047",49.95,"本企业已挂网药品新增包装规格","[来源省份:湖南省,来源年份:2025,采购价:49.95],[来源省份:辽宁省,来源年份:2025,采购价:49.95],[来源省份:山东省,来源年份:2025,采购价:49.95]","通过","同厂家符合差比"]
["盐酸氨基葡萄糖胶囊","0.24g(以盐酸氨基葡萄糖计)","180","北京葡立药业有限公司","北京葡立药业有限公司","国药准字H20173212",175.59,"本企业已挂网药品新增包装规格","[来源省份:云南省,来源年份:2024,采购价:175.59],[来源省份:山东省,来源年份:2025,采购价:175.59],[来源省份:陕西省,来源年份:2025,采购价:175.59]","通过","同厂家符合差比"]
["艾拉莫德片","按C₁₇H₁₄N₂O₆S计25mg","14","重庆圣华曦药业股份有限公司","重庆圣华曦药业股份有限公司","国药准字H20254383",125.97,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:125.97],[来源省份:广西壮族自治区,来源年份:2025,采购价:125.97],[来源省份:贵州省,来源年份:2025,采购价:125.97]","通过","不高于中位价"]
["艾拉莫德片","按C₁₇H₁₄N₂O₆S计25mg","7","重庆圣华曦药业股份有限公司","重庆圣华曦药业股份有限公司","国药准字H20254383",64.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:64.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:64.60],[来源省份:贵州省,来源年份:2025,采购价:64.60]","通过","不高于中位价"]
["双氯芬酸二乙胺乳胶剂","1%(20g:0.2g,按C₁₄H₁₀Cl₂NNaO₂计)","3","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","国药准字H20254434",51.45,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:51.45],[来源省份:广西壮族自治区,来源年份:2025,采购价:51.45],[来源省份:湖北省,来源年份:2025,采购价:51.45]","通过","不高于中位价"]
["双氯芬酸二乙胺乳胶剂","1%(20g:0.2g,按C₁₄H₁₀Cl₂NNaO₂计)","2","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","国药准字H20254434",34.3,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:34.30],[来源省份:广西壮族自治区,来源年份:2025,采购价:34.30],[来源省份:湖北省,来源年份:2025,采购价:34.30]","通过","不高于中位价"]
["盐酸替扎尼定片","1mg(按C₉H₈ClN₅S计)","48","江苏亚邦爱普森药业有限公司","江苏亚邦爱普森药业有限公司","国药准字H20041750",59.81,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:59.81],[来源省份:贵州省,来源年份:2025,采购价:59.81],[来源省份:广西壮族自治区,来源年份:2025,采购价:59.81]","通过","不高于中位价"]
["秋水仙碱片","0.5mg","40","云南昊邦制药有限公司","云南昊邦制药有限公司","国药准字H53021798",6.9,"不高于同质量层次药品最低价申报","[来源省份:江苏省,来源年份:2024,采购价:6.90],[来源省份:吉林省,来源年份:2024,采购价:6.90],[来源省份:广东省,来源年份:2024,采购价:6.90]","通过","不高于同组最低价"]
["骨肽片","0.3g(每片含多肽类物质不低于40mg)","36","南京新百药业有限公司","南京新百药业有限公司","国药准字H32020002",21.6,"不高于同质量层次药品最低价申报","[来源省份:内蒙古自治区,来源年份:2025,采购价:21.60],[来源省份:湖南省,来源年份:2025,采购价:21.60],[来源省份:江苏省,来源年份:2025,采购价:21.60]","通过","不高于同组最低价"]
["依托咪酯中/长链脂肪乳注射液","10ml:20mg","1","扬子江药业集团有限公司","扬子江药业集团有限公司","国药准字H20249023",33.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:33.60],[来源省份:贵州省,来源年份:2025,采购价:33.60],[来源省份:黑龙江省,来源年份:2025,采购价:33.60]","通过","不高于中位价"]
["利丙双卡因乳膏","5g:利多卡因125mg与丙胺卡因125mg","1","福元药业有限公司","福元药业有限公司","国药准字H20254749",54.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:54.60],[来源省份:黑龙江省,来源年份:2025,采购价:54.60],[来源省份:江苏省,来源年份:2025,采购价:54.60]","通过","不高于中位价"]
["利丙双卡因乳膏","5g:利多卡因125mg与丙胺卡因125mg","2","浙江鼎泰药业股份有限公司","浙江高跖医药科技股份有限公司","国药准字H20253877",149.9,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:149.90],[来源省份:黑龙江省,来源年份:2025,采购价:149.90],[来源省份:江苏省,来源年份:2025,采购价:149.90]","通过","不高于中位价"]
["喷他佐辛注射液","1ml∶30mg","1","天津药物研究院药业有限责任公司","天津药物研究院药业有限责任公司","国药准字H20253995",118,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:118.00],[来源省份:黑龙江省,来源年份:2025,采购价:118.00],[来源省份:重庆市,来源年份:2025,采购价:118.00]","通过","不高于中位价"]
["小儿贝诺酯散","0.2g","10","成都长青制药有限公司","成都长青制药有限公司","国药准字H51023837",65,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2024,采购价:65.00],[来源省份:广东省,来源年份:2018,采购价:65.00],[来源省份:湖南省,来源年份:2023,采购价:65.00],[来源省份:湖北省,来源年份:2022,采购价:65.00],[来源省份:内蒙古自治区,来源年份:2019,采购价:65.00],[来源省份:山西省,来源年份:2023,采购价:65.00],[来源省份:河北省,来源年份:2020,采购价:65.00],[来源省份:山东省,来源年份:2015,采购价:65.00],[来源省份:江苏省,来源年份:2023,采购价:65.00],[来源省份:辽宁省,来源年份:2022,采购价:65.00]","通过","独家"]
["琥珀酸呋罗曲坦片","2.5mg(按C₁₄H₁₇N₃O 计)","4","青岛国信制药有限公司","正大制药（青岛）有限公司","国药准字H20244535",470.76,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:470.76],[来源省份:江西省,来源年份:2025,采购价:470.76],[来源省份:安徽省,来源年份:2025,采购价:470.76],[来源省份:贵州省,来源年份:2025,采购价:470.76],[来源省份:海南省,来源年份:2025,采购价:470.76],[来源省份:辽宁省,来源年份:2025,采购价:470.76],[来源省份:广东省,来源年份:2025,采购价:470.76],[来源省份:广西壮族自治区,来源年份:2025,采购价:470.76],[来源省份:重庆市,来源年份:2025,采购价:470.76],[来源省份:四川省,来源年份:2025,采购价:470.76]","通过","独家，提供10省"]
["氯硝西泮注射液","1ml:1mg","1","江苏恩华药业股份有限公司","江苏恩华药业股份有限公司","国药准字H20249045",79.8,"不高于同质量层次药品最低价申报","[来源省份:江西省,来源年份:2025,采购价:79.80],[来源省份:辽宁省,来源年份:2025,采购价:79.80],[来源省份:陕西省,来源年份:2025,采购价:79.80]","通过","不高于同组最低价"]
["丙戊酸钠缓释片(Ⅰ)","0.5g(以丙戊酸钠计)","30","湖南省湘中制药有限公司","湖南省湘中制药有限公司","国药准字H20249693",45.3,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:45.30],[来源省份:广东省,来源年份:2025,采购价:51.60],[来源省份:安徽省,来源年份:2025,采购价:51.60]","通过","不高于中位价"]
["盐酸罗匹尼罗缓释片","2mg(以C₁₆H₂₄N₂O计)","28","广州玻思韬控释药业有限公司","杭州和泽坤元药业有限公司","国药准字H20249538",195.16,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:195.16],[来源省份:安徽省,来源年份:2025,采购价:195.16],[来源省份:贵州省,来源年份:2025,采购价:195.16]","通过","不高于中位价"]
["氟哌啶醇片","2mg","100","浙江京新药业股份有限公司","浙江京新药业股份有限公司","国药准字H20254337",27.25,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:27.25],[来源省份:重庆市,来源年份:2025,采购价:27.25],[来源省份:广西壮族自治区,来源年份:2025,采购价:27.25]","通过","不高于中位价"]
["盐酸鲁拉西酮片","按C₂₈H₃₆N₄O₂S·HCl计:40mg","30","重庆药友制药有限责任公司","重庆药友制药有限责任公司","国药准字H20243106",117,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:117.00],[来源省份:江西省,来源年份:2025,采购价:117.00],[来源省份:贵州省,来源年份:2025,采购价:117.00]","通过","不高于中选价"]
["奥氮平氟西汀胶囊","奥氮平3mg与氟西汀25mg","7","江苏长泰药业股份有限公司","江苏长泰药业股份有限公司","国药准字H20233848",208.29,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:208.29],[来源省份:贵州省,来源年份:2025,采购价:208.29],[来源省份:江西省,来源年份:2025,采购价:208.29]","通过","同厂家符合差比"]
["佐匹克隆片","7.5mg","7","广东华润顺峰药业有限公司","广东华润顺峰药业有限公司","国药准字H10980247",18.1,"本企业已挂网药品新增包装规格","[来源省份:安徽省,来源年份:2024,采购价:18.91],[来源省份:天津市,来源年份:2025,采购价:18.91],[来源省份:吉林省,来源年份:2022,采购价:18.10]","通过","同厂家符合差比"]
["草酸艾司西酞普兰片","20mg(以C20H21FN2O计)","12","浙江赛默制药有限公司","浙江百代医药科技有限公司","国药准字H20213475",24.9,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:24.90],[来源省份:河北省,来源年份:2025,采购价:24.90],[来源省份:江苏省,来源年份:2025,采购价:24.90]","通过","不高于中选价"]
["马来酸氟伏沙明片","100mg","30","安徽省先锋制药有限公司","安徽省先锋制药有限公司","国药准字H20249544",99.95,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:99.95],[来源省份:浙江省,来源年份:2025,采购价:99.95],[来源省份:黑龙江省,来源年份:2025,采购价:99.95]","通过","同厂家符合差比"]
["马来酸氟伏沙明片","50mg","36","安徽省先锋制药有限公司","安徽省先锋制药有限公司","国药准字H20249543",70.08,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:浙江省,来源年份:2025,采购价:70.08],[来源省份:宁夏回族自治区,来源年份:2025,采购价:70.08],[来源省份:江苏省,来源年份:2025,采购价:70.08]","通过","同厂家符合差比"]
["马来酸氟伏沙明片","50mg","30","安徽艾立德制药有限公司","安徽艾立德制药有限公司","国药准字H20254643",60.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:60.50],[来源省份:贵州省,来源年份:2025,采购价:60.50],[来源省份:安徽省,来源年份:2025,采购价:60.50]","通过","不高于中位价"]
["阿戈美拉汀片","25mg","14","杭州领业医药科技有限公司","杭州领业医药科技有限公司","国药准字H20249652",137.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:137.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:137.20],[来源省份:江苏省,来源年份:2025,采购价:137.20]","通过","不高于中位价"]
["盐酸曲唑酮片","50mg","30","吉林天衡英睿制药有限公司","深圳市泛谷药业股份有限公司","国药准字H20254458",66,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:66.00],[来源省份:贵州省,来源年份:2025,采购价:66.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:66.00]","通过","不高于中位价"]
["盐酸曲唑酮片","100mg","30","吉林天衡英睿制药有限公司","深圳市泛谷药业股份有限公司","国药准字H20254459",112.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:112.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:112.20],[来源省份:贵州省,来源年份:2025,采购价:112.20]","通过","不高于中位价"]
["盐酸曲唑酮片","50mg","20","江西科睿药业有限公司","江西科睿药业有限公司","国药准字H20254738",44.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:海南省,来源年份:2025,采购价:44.60],[来源省份:江苏省,来源年份:2025,采购价:44.60],[来源省份:贵州省,来源年份:2025,采购价:44.60]","通过","不高于中位价"]
["盐酸甲氯芬酯胶囊","0.1g","12","华润紫竹药业有限公司","华润紫竹药业有限公司","国药准字H11021375",69.6,"不高于同质量层次药品最低价申报","[来源省份:江苏省,来源年份:2025,采购价:69.60],[来源省份:贵州省,来源年份:2025,采购价:69.90],[来源省份:广西壮族自治区,来源年份:2025,采购价:69.60]","通过","不高于同组最低价"]
["盐酸甲氯芬酯胶囊","0.1g","12","上海旭东海普药业有限公司","上海旭东海普药业有限公司","国药准字H31022146",69.6,"不高于同质量层次药品最低价申报","[来源省份:广东省,来源年份:2025,采购价:69.60],[来源省份:江苏省,来源年份:2025,采购价:69.60],[来源省份:河北省,来源年份:2025,采购价:69.60]","通过","不高于同组最低价"]
["盐酸倍他司汀片","8mg","24","济南永宁制药股份有限公司","森淼(山东)药业有限公司","国药准字H20243912",53.72,"本企业已挂网药品新增包装规格","[来源省份:山东省,来源年份:2025,采购价:53.72],[来源省份:浙江省,来源年份:2025,采购价:53.72],[来源省份:黑龙江省,来源年份:2025,采购价:53.72]","通过","同厂家符合差比"]
["胞磷胆碱钠注射液","2ml:0.5g(按C₁₄H₂₆N₄O₁₁P₂计)","1","石家庄四药有限公司","石家庄四药有限公司","国药准字H20258144",2.53,"本企业已挂网药品新增包装规格","[来源省份:江苏省,来源年份:2025,采购价:2.53],[来源省份:海南省,来源年份:2025,采购价:2.53],[来源省份:山东省,来源年份:2025,采购价:2.53]","通过","同厂家符合差比"]
["环索奈德气雾剂","每瓶100揿,每揿含环索奈德100μg","1","安徽威尔曼制药有限公司","安徽威尔曼制药有限公司","国药准字H20120114",226,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:226.00],[来源省份:辽宁省,来源年份:2025,采购价:226.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:226.00],[来源省份:黑龙江省,来源年份:2025,采购价:226.00],[来源省份:甘肃省,来源年份:2025,采购价:226.00],[来源省份:吉林省,来源年份:2025,采购价:226.00],[来源省份:贵州省,来源年份:2025,采购价:226.00],[来源省份:江苏省,来源年份:2025,采购价:226.00],[来源省份:云南省,来源年份:2025,采购价:226.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:226.00]","通过","独家"]
["盐酸丙卡特罗吸入溶液","按C₁₆H₂₂N₂O₃·HCl·½H₂O计0.5ml:50μg","10","浙江赛默制药有限公司","国铭制药（海南）有限公司","国药准字H20253328",149.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:149.80],[来源省份:江西省,来源年份:2025,采购价:149.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:149.80]","通过","不高于中位价"]
["富马酸福莫特罗吸入溶液","2ml:20µg[按(C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计]","10","长风药业股份有限公司","长风药业股份有限公司","国药准字H20253076",430,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:435.00],[来源省份:黑龙江省,来源年份:2025,采购价:435.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:435.00]","通过","不高于中位价"]
["氨溴特罗口服溶液","60ml:盐酸氨溴索90mg与盐酸克仑特罗60μg","1","湖北午时药业股份有限公司","湖北午时药业股份有限公司","国药准字H20249809",23.88,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:23.88],[来源省份:广东省,来源年份:2025,采购价:23.88],[来源省份:黑龙江省,来源年份:2025,采购价:23.88]","通过","不高于中位价"]
["盐酸丙卡特罗口服溶液","60ml:0.30mg","1","安徽环球药业股份有限公司","安徽环球药业股份有限公司","国药准字H20244975",31,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:47.10],[来源省份:广西壮族自治区,来源年份:2025,采购价:47.10],[来源省份:湖北省,来源年份:2025,采购价:47.10],[来源省份:四川省,来源年份:2025,采购价:47.10]","通过","不高于中位价"]
["盐酸丙卡特罗口服溶液","100ml:0.5mg","1","河北仁合益康药业有限公司","仁合益康集团有限公司","国药准字H20254528",31.23,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:31.23],[来源省份:贵州省,来源年份:2025,采购价:31.23],[来源省份:江苏省,来源年份:2025,采购价:31.23]","通过","不高于中位价"]
["多索茶碱注射液","10ml︰0.1g","1","湖北午时药业股份有限公司","湖北午时药业股份有限公司","国药准字H20253668",3.24,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:3.24],[来源省份:江西省,来源年份:2025,采购价:3.24],[来源省份:重庆市,来源年份:2025,采购价:3.24]","通过","不高于中选价"]
["孟鲁司特钠咀嚼片","5mg(以孟鲁司特计)","10","四川依科制药有限公司","四川依科制药有限公司","国药准字H20244957",9.95,"国家集采非中选药品申报","[来源省份:安徽省,来源年份:2025,采购价:9.95],[来源省份:甘肃省,来源年份:2025,采购价:9.95],[来源省份:江西省,来源年份:2025,采购价:9.95],[来源省份:陕西省,来源年份:2025,采购价:9.95],[来源省份:湖北省,来源年份:2025,采购价:9.95],[来源省份:广东省,来源年份:2025,采购价:9.95]","通过","不高于未中选最低价"]
["孟鲁司特钠咀嚼片","5mg(以孟鲁司特计)","20","四川依科制药有限公司","四川依科制药有限公司","国药准字H20244957",19.9,"国家集采非中选药品申报","[来源省份:江西省,来源年份:2025,采购价:19.90],[来源省份:海南省,来源年份:2025,采购价:19.90],[来源省份:四川省,来源年份:2025,采购价:19.90],[来源省份:湖南省,来源年份:2025,采购价:19.90]","通过","不高于未中选最低价"]
["福多司坦口服溶液","100ml:8g(100ml/瓶)","1","南京海纳制药有限公司","江苏联环药业股份有限公司","国药准字H20253714",48,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:48.00],[来源省份:贵州省,来源年份:2025,采购价:48.00],[来源省份:江苏省,来源年份:2025,采购价:48.00]","通过","不高于中位价"]
["福多司坦口服溶液","100ml:8g(100ml/瓶)","1","太极集团四川太极制药有限公司","四川益生智同医药生物科技发展有限公司","国药准字H20253709",44.55,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:44.55],[来源省份:山东省,来源年份:2025,采购价:44.55],[来源省份:江西省,来源年份:2025,采购价:44.55]","通过","不高于中位价"]
["盐酸溴己新口服溶液","100ml:0.16g","1","安徽永生堂药业有限责任公司","合肥国药诺和药业有限公司","国药准字H20244507",29.67,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:35.80],[来源省份:江苏省,来源年份:2025,采购价:35.80],[来源省份:湖北省,来源年份:2025,采购价:35.80]","通过","不高于中位价"]
["盐酸溴己新口服溶液","100ml:0.2g","1","浙江赛默制药有限公司","海南康成药业有限公司","国药准字H20254405",35.18,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:35.18],[来源省份:湖北省,来源年份:2025,采购价:35.18],[来源省份:广西壮族自治区,来源年份:2025,采购价:35.18]","通过","不高于中位价"]
["吸入用乙酰半胱氨酸溶液","3ml:0.3g","6","朗天药业(湖北)有限公司","朗天药业（湖北）有限公司","国药准字H20254647",55.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:55.80],[来源省份:江苏省,来源年份:2025,采购价:58.80],[来源省份:贵州省,来源年份:2025,采购价:58.80]","通过","不高于中位价"]
["复方桔梗麻黄碱糖浆","复方(120ml/瓶)","1","湖北盛通药业有限公司","湖北盛通药业有限公司","国药准字H42022871",18.17,"已有10个省级平台挂网的独家药品","[来源省份:宁夏回族自治区,来源年份:2024,采购价:18.17],[来源省份:海南省,来源年份:2024,采购价:18.17],[来源省份:湖南省,来源年份:2025,采购价:18.17],[来源省份:吉林省,来源年份:2024,采购价:18.17],[来源省份:陕西省,来源年份:2024,采购价:18.17],[来源省份:云南省,来源年份:2024,采购价:18.17],[来源省份:内蒙古自治区,来源年份:2024,采购价:18.17],[来源省份:黑龙江省,来源年份:2024,采购价:18.17],[来源省份:江西省,来源年份:2024,采购价:18.17],[来源省份:广西壮族自治区,来源年份:2024,采购价:18.17]","通过","独家"]
["复方甘草氯化铵糖浆","复方(100ml/瓶)","1","成都长青制药有限公司","成都长青制药有限公司","国药准字H51023320",39.8,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2024,采购价:39.80],[来源省份:辽宁省,来源年份:2022,采购价:39.80],[来源省份:江苏省,来源年份:2024,采购价:39.80],[来源省份:山东省,来源年份:2015,采购价:39.80],[来源省份:河北省,来源年份:2020,采购价:39.80],[来源省份:山西省,来源年份:2017,采购价:39.80],[来源省份:内蒙古自治区,来源年份:2020,采购价:39.80],[来源省份:湖北省,来源年份:2022,采购价:39.80],[来源省份:湖南省,来源年份:2016,采购价:39.80],[来源省份:广东省,来源年份:2021,采购价:39.80]","通过","独家"]
["咖酚伪麻片","每片含主要成份对乙酰氨基酚500毫克,盐酸伪麻黄碱20毫克,咖啡因10毫克。","36","内蒙古通辽制药股份有限公司","内蒙古通辽制药股份有限公司","国药准字H10960142",41.05,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:41.94],[来源省份:安徽省,来源年份:2025,采购价:41.94],[来源省份:湖南省,来源年份:2025,采购价:41.94]","通过","同厂家符合差比"]
["愈美片","愈创木酚甘油醚100mg、氢溴酸右美沙芬15mg","10","山西兰花药业股份有限公司","山西兰花药业股份有限公司","国药准字H19990039",30.65,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:30.65],[来源省份:江西省,来源年份:2025,采购价:30.65],[来源省份:黑龙江省,来源年份:2025,采购价:30.65]","通过","同厂家符合差比"]
["茶苯海明片","25mg","18","江苏黄河药业股份有限公司","江苏黄河药业股份有限公司","国药准字H32025845",35.47,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2024,采购价:35.47],[来源省份:云南省,来源年份:2024,采购价:35.47],[来源省份:新疆生产建设兵团,来源年份:2024,采购价:35.47],[来源省份:黑龙江省,来源年份:2024,采购价:35.47],[来源省份:辽宁省,来源年份:2025,采购价:35.47],[来源省份:江西省,来源年份:2024,采购价:35.47],[来源省份:湖北省,来源年份:2024,采购价:35.47],[来源省份:海南省,来源年份:2024,采购价:35.47],[来源省份:安徽省,来源年份:2024,采购价:35.47],[来源省份:内蒙古自治区,来源年份:2024,采购价:35.47]","通过","同厂家符合差比"]
["阿伐斯汀胶囊","8mg","30","重庆华邦制药有限公司","重庆华邦制药有限公司","国药准字H20083406",30.33,"本企业已挂网药品新增包装规格","[来源省份:甘肃省,来源年份:2025,采购价:30.33],[来源省份:江苏省,来源年份:2025,采购价:30.33],[来源省份:浙江省,来源年份:2025,采购价:30.33]","通过","同厂家符合差比"]
["依巴斯汀片","10mg","10","上海理想制药有限公司","上海理想制药有限公司","国药准字H20249121",16.89,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:16.89],[来源省份:浙江省,来源年份:2025,采购价:16.89],[来源省份:贵州省,来源年份:2025,采购价:16.89]","通过","同厂家符合差比"]
["妥布霉素滴眼液","0.4ml:1.2mg","10","珠海亿胜生物制药有限公司","珠海亿胜生物制药有限公司","国药准字H20163363",30,"本企业已挂网药品新增包装规格","[来源省份:北京市,来源年份:2024,采购价:30.00],[来源省份:湖北省,来源年份:2022,采购价:30.00],[来源省份:安徽省,来源年份:2023,采购价:30.00]","通过","同厂家符合差比"]
["普拉洛芬滴眼液","0.1%(5ml:5mg)","1","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20244177",20.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2024,采购价:33.90],[来源省份:新疆维吾尔自治区,来源年份:2024,采购价:33.90],[来源省份:广西壮族自治区,来源年份:2024,采购价:33.90]","通过","不高于中位价"]
["普拉洛芬滴眼液","0.1%(5ml﹕5mg)","1","杭州民生药业股份有限公司","广州仁恒医药科技股份有限公司","国药准字H20244176",20.45,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:辽宁省,来源年份:2025,采购价:20.45],[来源省份:广东省,来源年份:2025,采购价:20.45],[来源省份:广西壮族自治区,来源年份:2025,采购价:20.45]","通过","不高于中位价"]
["溴芬酸钠滴眼液","0.1%(0.4ml:0.4mg,按C₁₅H₁₁BrNNaO₃•1½H₂O计)","10","中山万汉制药有限公司","中山万汉制药有限公司","国药准字H20243868",43.2,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:45.39],[来源省份:江西省,来源年份:2025,采购价:45.39],[来源省份:江苏省,来源年份:2025,采购价:45.39]","通过","同厂家符合差比"]
["酒石酸溴莫尼定滴眼液","0.2%(5ml∶10mg)","1","广东众生药业股份有限公司","广东众生药业股份有限公司","国药准字H20253121",41.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:41.70],[来源省份:江苏省,来源年份:2025,采购价:41.70],[来源省份:湖北省,来源年份:2025,采购价:41.70]","通过","不高于中位价"]
["复方托吡卡胺滴眼液","10ml∶托吡卡胺50mg与盐酸去氧肾上腺素50mg","1","苏州乐珠制药有限公司","苏州乐珠制药有限公司","国药准字H20253480",24.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:24.10],[来源省份:宁夏回族自治区,来源年份:2025,采购价:24.10],[来源省份:贵州省,来源年份:2025,采购价:24.10]","通过","不高于中位价"]
["亚叶酸钙注射液","10ml:0.1g","1","重庆药友制药有限责任公司","重庆药友制药有限责任公司","国药准字H20010615",24,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:新疆维吾尔自治区,来源年份:2022,采购价:24.00],[来源省份:四川省,来源年份:2021,采购价:24.00],[来源省份:贵州省,来源年份:2022,采购价:24.00]","通过","不高于中位价"]
["亚叶酸钙注射液","10ml:0.1g(按C₂₀H₂₃N₇O₇计)","1","马鞍山丰原制药有限公司","江苏瑜兴医药科技有限公司","国药准字H20253950",23.97,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:31.38],[来源省份:黑龙江省,来源年份:2025,采购价:31.38],[来源省份:江苏省,来源年份:2025,采购价:31.38]","通过","不高于中位价"]
["碘普罗胺注射液","100ml:76.89g","1","四川科伦药业股份有限公司","四川科伦药业股份有限公司","国药准字H20249781",268.96,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:269.00],[来源省份:江苏省,来源年份:2025,采购价:269.00],[来源省份:重庆市,来源年份:2025,采购价:269.00]","通过","同厂家符合差比"]
["感冒清热颗粒","每袋装3克","8","江西京通美联药业有限公司","江西京通美联药业有限公司","国药准字Z36021225",17.6,"本企业已挂网药品新增包装规格","[来源省份:山东省,来源年份:2023,采购价:17.60],[来源省份:湖南省,来源年份:2024,采购价:17.60],[来源省份:云南省,来源年份:2024,采购价:17.60]","通过","同厂家符合差比"]
["小儿保安丸","每丸重1.5g","6","广州白云山中一药业有限公司","广州白云山中一药业有限公司","国药准字Z44020070",108,"已有10个省级平台挂网的独家药品","[来源省份:四川省,来源年份:2025,采购价:108.00],[来源省份:陕西省,来源年份:2025,采购价:108.00],[来源省份:海南省,来源年份:2025,采购价:108.00],[来源省份:贵州省,来源年份:2025,采购价:108.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:108.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:108.00],[来源省份:黑龙江省,来源年份:2025,采购价:108.00],[来源省份:江西省,来源年份:2025,采购价:108.00],[来源省份:广东省,来源年份:2025,采购价:108.00],[来源省份:安徽省,来源年份:2025,采购价:108.00]","通过","独家"]
["小儿感冒颗粒","每袋装12g","15","恒拓集团南宁仁盛制药有限公司","恒拓集团南宁仁盛制药有限公司","国药准字Z45020936",17.55,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:17.55],[来源省份:安徽省,来源年份:2025,采购价:17.55],[来源省份:广东省,来源年份:2025,采购价:17.55]","通过","同厂家符合差比"]
["防风通圣丸","每20丸重1克,6g/袋","14","河北永丰药业有限公司","河北永丰药业有限公司","国药准字Z13020419",55.95,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:55.95],[来源省份:重庆市,来源年份:2025,采购价:55.95],[来源省份:广东省,来源年份:2025,采购价:55.95]","通过","同厂家符合差比"]
["小柴胡颗粒","每袋装10g","15","四川逢春制药有限公司","四川逢春制药有限公司","国药准字Z51020112",8.7,"本企业已挂网药品新增包装规格","[来源省份:北京市,来源年份:2025,采购价:8.70],[来源省份:广东省,来源年份:2025,采购价:8.70],[来源省份:河北省,来源年份:2025,采购价:8.70]","通过","同厂家符合差比"]
["熊胆粉","0.3g/瓶","10","瑞丽彩云南集团药业有限公司","瑞丽彩云南集团药业有限公司","国药准字Z19991017",858,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:858.00],[来源省份:江苏省,来源年份:2025,采购价:858.00],[来源省份:湖南省,来源年份:2025,采购价:858.00],[来源省份:贵州省,来源年份:2025,采购价:858.00],[来源省份:安徽省,来源年份:2025,采购价:858.00],[来源省份:黑龙江省,来源年份:2025,采购价:858.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:858.00],[来源省份:海南省,来源年份:2025,采购价:858.00],[来源省份:湖北省,来源年份:2025,采购价:858.00],[来源省份:江西省,来源年份:2025,采购价:858.00]","通过","独家"]
["解毒活血栓","每粒重2g","8","珠海星光制药有限公司","珠海星光制药有限公司","国药准字Z20080064",40.63,"本企业已挂网药品新增包装规格","[来源省份:内蒙古自治区,来源年份:2024,采购价:40.63],[来源省份:陕西省,来源年份:2025,采购价:40.63],[来源省份:贵州省,来源年份:2025,采购价:40.63],[来源省份:湖北省,来源年份:2022,采购价:40.63],[来源省份:云南省,来源年份:2025,采购价:40.63],[来源省份:江西省,来源年份:2025,采购价:40.63],[来源省份:广西壮族自治区,来源年份:2024,采购价:40.63],[来源省份:湖南省,来源年份:2025,采购价:40.63],[来源省份:新疆生产建设兵团,来源年份:2025,采购价:40.63],[来源省份:河北省,来源年份:2023,采购价:40.63]","通过","同厂家符合差比"]
["热炎宁颗粒","每袋装16g","6","河北康芝制药有限公司","康芝药业股份有限公司","国药准字Z11020047",39,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2024,采购价:39.00],[来源省份:贵州省,来源年份:2023,采购价:39.00],[来源省份:安徽省,来源年份:2024,采购价:39.00],[来源省份:黑龙江省,来源年份:2024,采购价:39.00],[来源省份:辽宁省,来源年份:2024,采购价:39.00],[来源省份:重庆市,来源年份:2025,采购价:39.00],[来源省份:宁夏回族自治区,来源年份:2024,采购价:39.00],[来源省份:陕西省,来源年份:2024,采购价:39.00],[来源省份:新疆维吾尔自治区,来源年份:2024,采购价:39.00],[来源省份:江西省,来源年份:2025,采购价:39.00]","通过","独家"]
["小儿清解颗粒","每袋重10g","6","康芝药业股份有限公司","康芝药业股份有限公司","国药准字Z11020051",45.6,"已有10个省级平台挂网的独家药品","[来源省份:甘肃省,来源年份:2025,采购价:45.60],[来源省份:江苏省,来源年份:2025,采购价:45.60],[来源省份:吉林省,来源年份:2025,采购价:45.60],[来源省份:黑龙江省,来源年份:2025,采购价:45.60],[来源省份:海南省,来源年份:2025,采购价:45.60],[来源省份:重庆市,来源年份:2025,采购价:45.60],[来源省份:宁夏回族自治区,来源年份:2025,采购价:45.60],[来源省份:贵州省,来源年份:2025,采购价:45.60],[来源省份:广东省,来源年份:2025,采购价:45.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:45.60]","通过","独家"]
["肿节风片","片心重0.25g","60","江西康恩贝天施康药业有限公司","江西康恩贝天施康药业有限公司","国药准字Z36021677",25.72,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2023,采购价:25.72],[来源省份:江西省,来源年份:2024,采购价:25.72],[来源省份:贵州省,来源年份:2022,采购价:25.72]","通过","不高于同组最低价"]
["鱼腥草注射液","2ml","1","四川升和药业股份有限公司","四川升和药业股份有限公司","国药准字Z51021473",5.8,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2023,采购价:5.80],[来源省份:辽宁省,来源年份:2022,采购价:5.80],[来源省份:广西壮族自治区,来源年份:2022,采购价:5.80]","通过","不高于同组最低价"]
["大黄利胆胶囊","每粒装0.3g(相当于饮片0.3g)","36","贵州瑞和制药有限公司","贵州瑞和制药有限公司","国药准字Z20153052",69.23,"本企业已挂网药品新增包装规格","[来源省份:安徽省,来源年份:2025,采购价:69.23],[来源省份:广西壮族自治区,来源年份:2025,采购价:69.23],[来源省份:北京市,来源年份:2025,采购价:69.23],[来源省份:贵州省,来源年份:2025,采购价:69.23],[来源省份:黑龙江省,来源年份:2025,采购价:69.23],[来源省份:河北省,来源年份:2025,采购价:69.23],[来源省份:江西省,来源年份:2025,采购价:69.23],[来源省份:辽宁省,来源年份:2025,采购价:69.23],[来源省份:宁夏回族自治区,来源年份:2025,采购价:69.23],[来源省份:浙江省,来源年份:2024,采购价:69.23]","通过","同厂家符合差比"]
["胆胃康胶囊","每粒装0.3g","36","云南保元堂药业有限责任公司","云南保元堂药业有限责任公司","国药准字Z20025134",43.37,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2023,采购价:43.37],[来源省份:辽宁省,来源年份:2021,采购价:43.37],[来源省份:黑龙江省,来源年份:2022,采购价:43.37]","通过","同厂家符合差比"]
["四逆汤","每支装10ml","10","湖北民康制药有限公司","湖北民康制药有限公司","国药准字Z42021418",98,"已有10个省级平台挂网的独家药品","[来源省份:陕西省,来源年份:2023,采购价:98.00],[来源省份:山东省,来源年份:2024,采购价:98.00],[来源省份:广东省,来源年份:2021,采购价:98.00],[来源省份:福建省,来源年份:2020,采购价:98.00],[来源省份:新疆维吾尔自治区,来源年份:2022,采购价:98.00],[来源省份:海南省,来源年份:2023,采购价:98.00],[来源省份:河北省,来源年份:2023,采购价:98.00],[来源省份:湖南省,来源年份:2025,采购价:98.00],[来源省份:山西省,来源年份:2023,采购价:98.00],[来源省份:四川省,来源年份:2021,采购价:98.00]","通过","独家"]
["标准桃金娘油肠溶胶囊(儿童装)","每粒装0.240g(含120mg标准桃金娘油)","10","G. Pohl-Boskamp GmbH & Co. KG","国药控股分销中心有限公司","国药准字ZJ20100007",36,"已有10个省级平台挂网的独家药品","[来源省份:北京市,来源年份:2023,采购价:36.00],[来源省份:云南省,来源年份:2023,采购价:36.00],[来源省份:四川省,来源年份:2023,采购价:36.00],[来源省份:广东省,来源年份:2022,采购价:36.00],[来源省份:广西壮族自治区,来源年份:2022,采购价:36.00],[来源省份:贵州省,来源年份:2022,采购价:36.00],[来源省份:河北省,来源年份:2023,采购价:36.00],[来源省份:湖南省,来源年份:2023,采购价:36.00],[来源省份:江西省,来源年份:2023,采购价:36.00],[来源省份:陕西省,来源年份:2022,采购价:36.00]","通过","独家"]
["小儿清热止咳颗粒","每1克相当于饮片1.7克(每袋装3g)","9","天大药业(珠海)有限公司","天大药业（珠海）有限公司","国药准字Z20033093",58.8,"已有10个省级平台挂网的独家药品","[来源省份:西藏自治区,来源年份:2022,采购价:58.80],[来源省份:重庆市,来源年份:2021,采购价:58.80],[来源省份:湖南省,来源年份:2025,采购价:58.80],[来源省份:广东省,来源年份:2024,采购价:58.80],[来源省份:甘肃省,来源年份:2021,采购价:58.80],[来源省份:青海省,来源年份:2023,采购价:58.80],[来源省份:江苏省,来源年份:2022,采购价:58.80],[来源省份:山东省,来源年份:2020,采购价:58.80],[来源省份:山西省,来源年份:2021,采购价:58.80],[来源省份:云南省,来源年份:2022,采购价:58.80]","通过","独家"]
["小儿腹泻散","每袋装2g","10","北京顺鑫祥云药业有限责任公司","北京顺鑫祥云药业有限责任公司","国药准字Z11020050",66,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2025,采购价:66.00],[来源省份:安徽省,来源年份:2025,采购价:66.00],[来源省份:广东省,来源年份:2025,采购价:66.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:66.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:66.00],[来源省份:陕西省,来源年份:2025,采购价:66.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:66.00],[来源省份:重庆市,来源年份:2025,采购价:66.00],[来源省份:湖南省,来源年份:2025,采购价:66.00],[来源省份:贵州省,来源年份:2025,采购价:66.00]","通过","独家"]
["阿胶","250g/盒","1","伊犁全鹿制药有限公司","伊犁全鹿制药有限公司","国药准字Z65020138",700,"不高于同质量层次药品最低价申报","[来源省份:安徽省,来源年份:2025,采购价:700.00],[来源省份:重庆市,来源年份:2025,采购价:700.00],[来源省份:贵州省,来源年份:2025,采购价:700.00]","通过","不高于同组最低价"]
["归脾胶囊","每粒装0.3g","180","安徽省先锋制药有限公司,宝龙药业有限公司","安徽省先锋制药有限公司","国药准字Z20123063",279.27,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2024,采购价:300.60],[来源省份:吉林省,来源年份:2024,采购价:300.60],[来源省份:安徽省,来源年份:2025,采购价:300.60]","通过","同厂家符合差比"]
["归脾丸(浓缩丸)","每8丸相当于饮片3克","296","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021321",22.94,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:22.94],[来源省份:广东省,来源年份:2025,采购价:22.94],[来源省份:黑龙江省,来源年份:2025,采购价:22.94]","通过","同厂家符合差比"]
["知柏地黄丸(浓缩丸)","每10丸重1.7克(每8丸相当于原生药3克)","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021330",19.76,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:19.76],[来源省份:广东省,来源年份:2025,采购价:19.76],[来源省份:黑龙江省,来源年份:2025,采购价:19.76]","通过","同厂家符合差比"]
["杞菊地黄丸(浓缩丸)","每8丸相当于原药材3克","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021332",19.38,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:19.38],[来源省份:广东省,来源年份:2025,采购价:19.38],[来源省份:广西壮族自治区,来源年份:2025,采购价:19.38]","通过","同厂家符合差比"]
["桂附地黄丸(浓缩丸)","每8丸相当于原生药3克","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021322",22.8,"本企业已挂网药品新增包装规格","[来源省份:广东省,来源年份:2025,采购价:22.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:22.80],[来源省份:黑龙江省,来源年份:2025,采购价:22.80]","通过","同厂家符合差比"]
["补肾益寿片","每片重0.4g","180","康普药业股份有限公司","康普药业股份有限公司","国药准字Z20060306",598,"已有10个省级平台挂网的独家药品","[来源省份:重庆市,来源年份:2025,采购价:598.00],[来源省份:四川省,来源年份:2025,采购价:598.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:598.00],[来源省份:吉林省,来源年份:2025,采购价:598.00],[来源省份:黑龙江省,来源年份:2025,采购价:598.00],[来源省份:贵州省,来源年份:2025,采购价:598.00],[来源省份:广东省,来源年份:2025,采购价:598.00],[来源省份:陕西省,来源年份:2025,采购价:598.00],[来源省份:江西省,来源年份:2025,采购价:598.00],[来源省份:西藏自治区,来源年份:2025,采购价:598.00]","通过","独家"]
["人参养荣丸","每袋装6克","6","石家庄御和堂药业股份有限公司","石家庄御和堂药业股份有限公司","国药准字Z20194085",98.4,"本企业已挂网药品新增包装规格","[来源省份:湖北省,来源年份:2024,采购价:328.00],[来源省份:辽宁省,来源年份:2024,采购价:328.00],[来源省份:陕西省,来源年份:2023,采购价:328.00]","通过","同厂家符合差比"]
["枣仁安神颗粒","每袋装5g","10","台州南峰药业有限公司","台州南峰药业有限公司","国药准字Z20003313",48.22,"不高于同质量层次药品最低价申报","[来源省份:贵州省,来源年份:2025,采购价:48.22],[来源省份:湖南省,来源年份:2025,采购价:48.22],[来源省份:河北省,来源年份:2024,采购价:48.22]","通过","不高于同组最低价"]
["枣仁安神颗粒","每袋装5g","6","台州南峰药业有限公司","台州南峰药业有限公司","国药准字Z20003313",28.93,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2024,采购价:28.93],[来源省份:贵州省,来源年份:2025,采购价:28.93],[来源省份:湖南省,来源年份:2025,采购价:28.93]","通过","不高于同组最低价"]
["枣仁安神液","每支装10ml","7","辽宁仙草堂药业有限公司","辽宁仙草堂药业有限公司","国药准字Z20044140",65.19,"不高于同质量层次药品最低价申报","[来源省份:吉林省,来源年份:2025,采购价:65.19],[来源省份:北京市,来源年份:2025,采购价:65.19],[来源省份:广西壮族自治区,来源年份:2025,采购价:65.19],[来源省份:云南省,来源年份:2025,采购价:65.19],[来源省份:江西省,来源年份:2025,采购价:65.19],[来源省份:黑龙江省,来源年份:2025,采购价:65.19],[来源省份:内蒙古自治区,来源年份:2025,采购价:65.19],[来源省份:浙江省,来源年份:2025,采购价:65.19],[来源省份:辽宁省,来源年份:2025,采购价:65.19],[来源省份:湖北省,来源年份:2025,采购价:65.19]","通过","不高于同组最低价"]
["黄杨宁片","每片含环维黄杨星D1mg","24","山西同达药业有限公司","山西同达药业有限公司","国药准字Z20083153",25.92,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:25.92],[来源省份:宁夏回族自治区,来源年份:2024,采购价:25.92],[来源省份:山西省,来源年份:2024,采购价:25.92],[来源省份:四川省,来源年份:2025,采购价:25.92],[来源省份:湖南省,来源年份:2025,采购价:25.92],[来源省份:云南省,来源年份:2025,采购价:25.92],[来源省份:新疆生产建设兵团,来源年份:2025,采购价:25.92],[来源省份:内蒙古自治区,来源年份:2024,采购价:25.92],[来源省份:河北省,来源年份:2024,采购价:25.92],[来源省份:北京市,来源年份:2024,采购价:25.92]","通过","独家"]
["利脑心片","每片重0.42g","42","吉林省通化博祥药业股份有限公司","吉林省通化博祥药业股份有限公司","国药准字Z20090470",71.21,"本企业已挂网药品新增包装规格","[来源省份:北京市,来源年份:2025,采购价:71.21],[来源省份:天津市,来源年份:2025,采购价:71.21],[来源省份:河北省,来源年份:2025,采购价:71.21]","通过","同厂家符合差比"]
["消栓通络胶囊","0.35g","60","西安高科陕西金方药业公司","西安高科陕西金方药业公司","国药准字Z20043707",28.4,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2025,采购价:28.40],[来源省份:北京市,来源年份:2020,采购价:28.40],[来源省份:陕西省,来源年份:2020,采购价:28.40]","通过","不高于同组最低价"]
["康媛颗粒","每袋装18g","9","黑龙江省济仁药业有限公司","黑龙江省济仁药业有限公司","国药准字Z20053338",98,"已有10个省级平台挂网的独家药品","[来源省份:广东省,来源年份:2025,采购价:98.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:98.00],[来源省份:贵州省,来源年份:2025,采购价:98.00],[来源省份:黑龙江省,来源年份:2025,采购价:98.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:98.00],[来源省份:湖南省,来源年份:2025,采购价:98.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:98.00],[来源省份:陕西省,来源年份:2025,采购价:98.00],[来源省份:四川省,来源年份:2025,采购价:98.00],[来源省份:天津市,来源年份:2025,采购价:98.00]","通过","独家"]
["慢肝解郁胶囊","每粒装0.25g","36","重庆迪康中药制药有限公司","重庆迪康中药制药有限公司","国药准字Z50020041",36.8,"已有10个省级平台挂网的独家药品","[来源省份:安徽省,来源年份:2025,采购价:36.80],[来源省份:江西省,来源年份:2025,采购价:36.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:36.80],[来源省份:贵州省,来源年份:2025,采购价:36.80],[来源省份:辽宁省,来源年份:2025,采购价:36.80],[来源省份:重庆市,来源年份:2025,采购价:36.80],[来源省份:广东省,来源年份:2025,采购价:36.80],[来源省份:内蒙古自治区,来源年份:2025,采购价:36.80],[来源省份:湖南省,来源年份:2025,采购价:36.80],[来源省份:黑龙江省,来源年份:2025,采购价:36.80]","通过","独家"]
["保和片","无","80","广东万年青制药股份有限公司","广东万年青制药股份有限公司","国药准字Z44021184",25.36,"不高于同质量层次药品最低价申报","[来源省份:内蒙古自治区,来源年份:2023,采购价:25.36],[来源省份:四川省,来源年份:2024,采购价:25.36],[来源省份:云南省,来源年份:2023,采购价:25.36]","通过","不高于同组最低价"]
["祛风止痛胶囊","每粒装0.3g","72","陕西步长制药有限公司","陕西步长制药有限公司","国药准字Z10970038",35.4,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:35.40],[来源省份:贵州省,来源年份:2025,采购价:35.40],[来源省份:辽宁省,来源年份:2025,采购价:35.40]","通过","同厂家符合差比"]
["痔疮外洗药","50g","1","沈阳红药集团股份有限公司","沈阳红药集团股份有限公司","国药准字Z21021859",78,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:78.00],[来源省份:安徽省,来源年份:2025,采购价:78.00],[来源省份:贵州省,来源年份:2025,采购价:78.00],[来源省份:海南省,来源年份:2025,采购价:78.00],[来源省份:广东省,来源年份:2025,采购价:78.00],[来源省份:江西省,来源年份:2025,采购价:78.00],[来源省份:陕西省,来源年份:2025,采购价:78.00],[来源省份:四川省,来源年份:2025,采购价:78.00],[来源省份:重庆市,来源年份:2025,采购价:78.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:78.00]","通过","独家"]
["内消瘰疬丸","每袋装9g","10","吉林紫鑫药业股份有限公司","吉林紫鑫药业股份有限公司","国药准字Z22022806",25.9,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:25.90],[来源省份:浙江省,来源年份:2025,采购价:25.90],[来源省份:广西壮族自治区,来源年份:2025,采购价:25.90]","通过","同厂家符合差比"]
["内消瘰疬丸","每袋装9g","18","吉林紫鑫药业股份有限公司","吉林紫鑫药业股份有限公司","国药准字Z22022806",46.62,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:46.62],[来源省份:广西壮族自治区,来源年份:2025,采购价:46.62],[来源省份:浙江省,来源年份:2025,采购价:46.62]","通过","同厂家符合差比"]
["清肺散结丸","3g(每100丸重0.45g)","6","海南国瑞制药有限公司","海南龙圣堂制药有限公司","国药准字Z20026833",700,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2021,采购价:700.00],[来源省份:安徽省,来源年份:2019,采购价:700.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:700.00],[来源省份:陕西省,来源年份:2024,采购价:700.00],[来源省份:云南省,来源年份:2025,采购价:700.00],[来源省份:湖北省,来源年份:2022,采购价:700.00],[来源省份:广西壮族自治区,来源年份:2022,采购价:700.00],[来源省份:山西省,来源年份:2021,采购价:700.00],[来源省份:四川省,来源年份:2021,采购价:700.00],[来源省份:西藏自治区,来源年份:2022,采购价:700.00]","通过","独家"]
["少腹逐瘀胶囊","每粒装0.45g","54","杨凌生物医药科技股份有限公司","山东济仁堂制药有限公司","国药准字Z20000085",37.46,"本企业已挂网药品新增包装规格","[来源省份:浙江省,来源年份:2025,采购价:37.46],[来源省份:贵州省,来源年份:2025,采购价:37.46],[来源省份:陕西省,来源年份:2025,采购价:37.46]","通过","同厂家符合差比"]
["安坤赞育丸","每丸重9g","2","石家庄御和堂药业股份有限公司","石家庄御和堂药业股份有限公司","国药准字Z20204062",199.6,"本企业已挂网药品新增包装规格","[来源省份:江苏省,来源年份:2023,采购价:998.00],[来源省份:浙江省,来源年份:2021,采购价:998.00],[来源省份:辽宁省,来源年份:2024,采购价:998.00]","通过","同厂家符合差比"]
["乐孕宁口服液","10ml","9","陕西关爱制药有限公司","陕西关爱制药有限公司","国药准字Z20043697",168,"已有10个省级平台挂网的独家药品","[来源省份:贵州省,来源年份:2023,采购价:168.00],[来源省份:四川省,来源年份:2023,采购价:168.00],[来源省份:广东省,来源年份:2022,采购价:168.00],[来源省份:广西壮族自治区,来源年份:2023,采购价:168.00],[来源省份:海南省,来源年份:2023,采购价:168.00],[来源省份:黑龙江省,来源年份:2023,采购价:168.00],[来源省份:辽宁省,来源年份:2023,采购价:168.00],[来源省份:陕西省,来源年份:2023,采购价:168.00],[来源省份:西藏自治区,来源年份:2023,采购价:168.00],[来源省份:云南省,来源年份:2023,采购价:168.00]","通过","独家"]
["板蓝根滴眼液","每1ml相当于饮片0.5g(每瓶装8ml)","2","四川禾亿制药有限公司","四川禾亿制药有限公司","国药准字Z20153072",75.66,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2025,采购价:75.66],[来源省份:北京市,来源年份:2025,采购价:75.66],[来源省份:广西壮族自治区,来源年份:2025,采购价:75.66]","通过","同厂家符合差比"]
["明目地黄丸(浓缩丸)","每8丸相当于原生药3克","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021326",21.28,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:21.28],[来源省份:广东省,来源年份:2025,采购价:21.28],[来源省份:黑龙江省,来源年份:2025,采购价:21.28]","通过","同厂家符合差比"]
["耳聋左慈丸(浓缩丸)","每8丸相当于原生药3克","296","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z10983071",17.23,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:17.23],[来源省份:黑龙江省,来源年份:2025,采购价:17.23],[来源省份:广东省,来源年份:2025,采购价:17.23]","通过","同厂家符合差比"]
["鼻咽清毒颗粒","每袋装20g","10","广州白云山和记黄埔中药有限公司","广州白云山和记黄埔中药有限公司","国药准字Z44022139",602.68,"已有10个省级平台挂网的独家药品","[来源省份:陕西省,来源年份:2022,采购价:602.68],[来源省份:宁夏回族自治区,来源年份:2022,采购价:602.68],[来源省份:北京市,来源年份:2021,采购价:602.68],[来源省份:甘肃省,来源年份:2022,采购价:602.68],[来源省份:内蒙古自治区,来源年份:2022,采购价:602.68],[来源省份:广东省,来源年份:2022,采购价:602.68],[来源省份:山东省,来源年份:2022,采购价:602.68],[来源省份:江西省,来源年份:2022,采购价:602.68],[来源省份:吉林省,来源年份:2022,采购价:602.68],[来源省份:四川省,来源年份:2022,采购价:602.68]","通过","独家"]
["小儿咽扁颗粒","每袋装4g","12","黑龙江龙桂制药有限公司","黑龙江龙桂制药有限公司","国药准字Z23021992",7.34,"不高于同质量层次药品最低价申报","[来源省份:湖南省,来源年份:2025,采购价:7.34],[来源省份:广西壮族自治区,来源年份:2023,采购价:7.34],[来源省份:贵州省,来源年份:2025,采购价:7.34]","通过","不高于同组最低价"]
["小儿咽扁颗粒","每袋装4g","10","黑龙江龙桂制药有限公司","黑龙江龙桂制药有限公司","国药准字Z23021992",6.12,"不高于同质量层次药品最低价申报","[来源省份:湖南省,来源年份:2025,采购价:6.12],[来源省份:广西壮族自治区,来源年份:2023,采购价:6.12],[来源省份:四川省,来源年份:2025,采购价:6.12]","通过","不高于同组最低价"]
["复方牙痛酊","每瓶装5毫升","1","国药集团同济堂(贵州)制药有限公司","国药集团同济堂（贵州）制药有限公司","国药准字Z20025807",41.58,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2025,采购价:41.58],[来源省份:陕西省,来源年份:2025,采购价:41.58],[来源省份:贵州省,来源年份:2024,采购价:49.80]","通过","同厂家符合差比"]
["复方硫黄乳膏","每盒250g","1","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021466",25,"不高于同质量层次药品最低价申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:25.00],[来源省份:江西省,来源年份:2025,采购价:25.00],[来源省份:重庆市,来源年份:2025,采购价:25.00]","通过","不高于同组最低价"]
["参芪温阳阴道膨胀栓","每粒含药基质重2.3g","1","哈尔滨田美药业股份有限公司","哈尔滨田美药业股份有限公司","国药准字B20020476",158,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2025,采购价:158.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:158.00],[来源省份:四川省,来源年份:2025,采购价:158.00],[来源省份:江苏省,来源年份:2025,采购价:158.00],[来源省份:广东省,来源年份:2025,采购价:158.00],[来源省份:贵州省,来源年份:2025,采购价:158.00],[来源省份:安徽省,来源年份:2025,采购价:158.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:158.00],[来源省份:北京市,来源年份:2025,采购价:158.00],[来源省份:湖北省,来源年份:2025,采购价:158.00]","通过","独家"]
["富马酸亚铁胶囊","0.2克(以铁计66毫克)","12","钓鱼台医药集团吉林长青药业股份有限公司","钓鱼台医药集团吉林长青药业股份有限公司","国药准字H22022074",44.5,"本企业已挂网药品新增包装规格","[来源省份:内蒙古自治区,来源年份:2024,采购价:89.00],[来源省份:黑龙江省,来源年份:2024,采购价:89.00],[来源省份:陕西省,来源年份:2024,采购价:89.00]","通过","同厂家符合差比"]
["甲钴胺片","0.5mg","30","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254372",9.07,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:9.07],[来源省份:山东省,来源年份:2025,采购价:9.07],[来源省份:贵州省,来源年份:2025,采购价:9.07]","通过","同厂家符合差比"]
["达沙替尼片","20mg","60","Dr. Reddy's Laboratories Limited","昆山龙灯瑞迪医药有限公司","国药准字HJ20240086",742.31,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:742.31],[来源省份:贵州省,来源年份:2025,采购价:742.31],[来源省份:重庆市,来源年份:2025,采购价:742.31]","通过","过评，同厂家符合差比"]
["双氯芬酸钾栓","12.5mg","10","昆山培力药品有限公司","昆山培力药品有限公司","国药准字H20040193",24.57,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:吉林省,来源年份:无,采购价:45.83],[来源省份:上海市,来源年份:无,采购价:45.83],[来源省份:陕西省,来源年份:2025,采购价:24.57],[来源省份:山东省,来源年份:2025,采购价:24.57],[来源省份:云南省,来源年份:无,采购价:45.83],[来源省份:安徽省,来源年份:无,采购价:45.83],[来源省份:北京市,来源年份:无,采购价:45.83],[来源省份:贵州省,来源年份:无,采购价:45.83],[来源省份:甘肃省,来源年份:2025,采购价:24.57],[来源省份:辽宁省,来源年份:无,采购价:45.83]","通过","同厂家符合差比"]
["双氯芬酸钾栓","12.5mg","6","昆山培力药品有限公司","昆山培力药品有限公司","国药准字H20040193",14.74,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:甘肃省,来源年份:2025,采购价:14.74],[来源省份:云南省,来源年份:2024,采购价:27.50],[来源省份:上海市,来源年份:2024,采购价:27.50],[来源省份:陕西省,来源年份:2025,采购价:14.74],[来源省份:山东省,来源年份:2025,采购价:14.74],[来源省份:辽宁省,来源年份:2024,采购价:27.50],[来源省份:吉林省,来源年份:2024,采购价:27.50],[来源省份:安徽省,来源年份:2024,采购价:27.50],[来源省份:北京市,来源年份:2024,采购价:27.50],[来源省份:贵州省,来源年份:2024,采购价:27.50]","通过","同厂家符合差比"]
["聚乙烯醇滴眼液","1.4%(0.4毫升:5.6毫克)","15","浙江赛默制药有限公司","四川海梦智森生物制药有限公司","国药准字H20249198",62.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:吉林省,来源年份:2025,采购价:62.10],[来源省份:陕西省,来源年份:2025,采购价:62.10],[来源省份:海南省,来源年份:2025,采购价:62.10]","通过","《关于进一步规范我省药品挂网采购工作的通知》（豫医保办【2022】45号）“同质量层次、同通用名、同剂型的药品视为同一品种，同品种、同一企业不同规格的按照相关药品差比价规则进行折算，差比价计算参照国家发展改革委《关于印发《药品差比价规则》的通知》（发改价格[2011]2452号）中规格（装量差异按照含量差比价计算）”同厂家不同规格，装量差异按照含量差比计算，同厂家符合差比。"]
["聚乙烯醇滴眼液","1.4%(0.4毫升:5.6毫克)","10","浙江赛默制药有限公司","四川海梦智森生物制药有限公司","国药准字H20249198",41.4,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:海南省,来源年份:2025,采购价:41.40],[来源省份:吉林省,来源年份:2025,采购价:41.40],[来源省份:陕西省,来源年份:2025,采购价:41.40],[来源省份:江西省,来源年份:2025,采购价:41.40],[来源省份:黑龙江省,来源年份:2025,采购价:41.40],[来源省份:甘肃省,来源年份:2025,采购价:41.40],[来源省份:四川省,来源年份:2025,采购价:41.40],[来源省份:北京市,来源年份:2025,采购价:41.40]","通过"]
["聚乙烯醇滴眼液","1.4%(0.4毫升:5.6毫克)","5","浙江赛默制药有限公司","四川海梦智森生物制药有限公司","国药准字H20249198",20.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:20.70],[来源省份:北京市,来源年份:2025,采购价:20.70],[来源省份:四川省,来源年份:2025,采购价:20.70],[来源省份:甘肃省,来源年份:2025,采购价:20.70],[来源省份:吉林省,来源年份:2025,采购价:20.70],[来源省份:黑龙江省,来源年份:2025,采购价:20.70],[来源省份:海南省,来源年份:2025,采购价:20.70],[来源省份:陕西省,来源年份:2025,采购价:20.70]","通过"]
["聚乙烯醇滴眼液","1.4%(0.4ml:5.6mg)","20","浙江赛默制药有限公司","浙江百代医药科技有限公司","国药准字H20254877",60,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:60.00],[来源省份:贵州省,来源年份:2025,采购价:60.00],[来源省份:江苏省,来源年份:2025,采购价:60.00]","通过","《关于进一步规范我省药品挂网采购工作的通知》（豫医保办【2022】45号）“同质量层次、同通用名、同剂型的药品视为同一品种，同品种、同一企业不同规格的按照相关药品差比价规则进行折算，差比价计算参照国家发展改革委《关于印发《药品差比价规则》的通知》（发改价格[2011]2452号）中规格（装量差异按照含量差比价计算）”同厂家不同规格，装量差异按照含量差比计算，不高于中位价。"]

{"sheet":"总表","index":1,"n_rows":251,"n_cols":14,"rows_kept":251,"merged":[[247,13,249,13]]}
["产品代码","药品统一编码","药品名称","剂型","规格","转换比","生产企业","代理企业","批准文号/注册证号","挂网价格(元)","申报类型","外省价格","核验结果","备注"]
[3115618,"XA02BCA081E005020183641","艾司奥美拉唑镁肠溶胶囊","胶囊剂","按C₁₇H₁₉N₃O₃S计,20mg","28","双鹤药业(海南)有限责任公司","湖南银泽华浩生物科技有限公司","国药准字H20253416",53.2,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:53.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:53.20],[来源省份:湖北省,来源年份:2025,采购价:53.20]","通过","不高于未中选最低价"]
[3114658,"XA02BCL033B001010101389","注射用兰索拉唑","注射剂","30mg","1","常州四药制药有限公司","常州四药制药有限公司","国药准字H20110008",13.49,"国家集采非中选药品申报","[来源省份:江西省,来源年份:2025,采购价:13.49],[来源省份:江苏省,来源年份:2025,采购价:13.49],[来源省份:天津市,来源年份:2025,采购价:13.49]","通过","不高于未中选最低价"]
[3116055,"XA02BXJ204N001010304942","聚普瑞锌颗粒","颗粒剂","75mg","6","湖南九典制药股份有限公司","湖南九典制药股份有限公司","国药准字H20254620",82.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:82.80],[来源省份:贵州省,来源年份:2025,采购价:82.80],[来源省份:江苏省,来源年份:2025,采购价:82.80]","通过","不高于中位价"]
[3115467,"XA02BXR065A001010102087","瑞巴派特片","片剂","0.1g","20","四川美大康华康药业有限公司","四川美大康华康药业有限公司","国药准字H20244429",21.9,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:甘肃省,来源年份:2025,采购价:21.90],[来源省份:湖南省,来源年份:2025,采购价:21.90],[来源省份:湖北省,来源年份:2025,采购价:21.90]","通过","不高于中位价"]
[3113033,"XA03ADQ116B002010283916","盐酸屈他维林注射液","注射剂","2ml∶40mg(按C₂₄H₃₁NO₄·HCl计)","1","康普药业股份有限公司","湖南慧泽生物医药科技有限公司","国药准字H20254030",32,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:32.52],[来源省份:贵州省,来源年份:2025,采购价:32.52],[来源省份:重庆市,来源年份:2025,采购价:32.52]","通过","不高于中位价"]
[3111724,"XA03AXJ096A022010184235","间苯三酚口崩片","片剂","80mg(按C₆H₆O₃·2H₂O计)","10","浙江赛默制药有限公司","浙江沣华医药科技有限公司","国药准字H20253277",172.73,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:179.00],[来源省份:重庆市,来源年份:2025,采购价:179.00],[来源省份:江西省,来源年份:2025,采购价:179.00]","通过","不高于中位价"]
[3116432,"XA03AXX007X003010182338","西甲硅油乳剂","口服乳剂","40mg/ml(聚二甲基硅氧烷:38.38mg/ml;二氧化硅:1.62mg/ml)(30ml/瓶)","1","成都倍特得诺药业有限公司","成都倍特得诺药业有限公司","国药准字H20254541",23.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:23.10],[来源省份:江苏省,来源年份:2025,采购价:23.10],[来源省份:贵州省,来源年份:2025,采购价:23.10]","通过","不高于中位价"]
[3115578,"XA03BAX232B002010203216","盐酸消旋山莨菪碱注射液","注射剂","1ml:10mg","1","新乡市常乐制药有限责任公司","新乡市常乐制药有限责任公司","国药准字H20184056",2.29,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:2.29],[来源省份:湖南省,来源年份:2025,采购价:2.29],[来源省份:江苏省,来源年份:2025,采购价:2.29]","通过","同厂家符合差比"]
[3116029,"XA04AAA202A001020184135","盐酸昂丹司琼片","片剂","4mg(按C₁₈H₁₉N₃O计)","10","宁波美诺华天康药业有限公司","杭州沐源生物医药科技有限公司","国药准字H20254888",60,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:60.00],[来源省份:山东省,来源年份:2025,采购价:60.00],[来源省份:青海省,来源年份:2025,采购价:60.00]","通过","不高于中位价"]
[3116030,"XA04AAA202A001010184135","盐酸昂丹司琼片","片剂","8mg(按C₁₈H₁₉N₃O计)","10","宁波美诺华天康药业有限公司","杭州沐源生物医药科技有限公司","国药准字H20254887",102,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:102.00],[来源省份:山东省,来源年份:2025,采购价:102.00],[来源省份:青海省,来源年份:2025,采购价:102.00]","通过","不高于中位价"]
[3116500,"XA05BAF632A001011084294","复方甘草酸苷片","片剂(薄膜衣片)","每片含甘草酸单铵盐(以甘草酸苷计)25mg、甘氨酸25mg、DL-蛋氨酸25mg。","75","浙江北生药业汉生制药有限公司","东阳祥昇医药科技有限公司","国药准字H20253068",53.05,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:53.05],[来源省份:江西省,来源年份:2025,采购价:53.05],[来源省份:贵州省,来源年份:2025,采购价:53.05]","通过","同厂家符合差比"]
[3116088,"XA05BAL080A001010200315","联苯双酯片","片剂","25mg","24","广东南国药业有限公司","广东南国药业有限公司","国药准字H44024625",66,"本企业已挂网药品新增包装规格","[来源省份:吉林省,来源年份:2024,采购价:66.00],[来源省份:江苏省,来源年份:2024,采购价:66.00],[来源省份:黑龙江省,来源年份:2024,采购价:66.00]","通过","同厂家符合差比"]
[3115417,"XA06ADF336P001010183356","复方聚乙二醇(3350)电解质散","散剂","6.9g/袋","10","南京厚生药业有限公司","翎耀生物科技（上海）有限公司","国药准字H20255005",36.9,"纳入国家医保目录准入价格谈判的药品","[来源省份:安徽省,来源年份:2025,采购价:36.90],[来源省份:海南省,来源年份:2025,采购价:36.90],[来源省份:甘肃省,来源年份:2025,采购价:36.90]","通过","申报价格不高于支付标准的国谈仿制药"]
[3114484,"XA06ADF748P001010101606","复方聚乙二醇(3350)电解质维C散","散剂","每袋A剂含聚乙二醇3350 100g、硫酸钠7.500g、氯化钠2.691g、氯化钾1.015g;每袋B剂含维生素C 4.700g、维生素C钠5.900g","2","南京正大天晴制药有限公司","南京正大天晴制药有限公司","国药准字H20254017",148,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:吉林省,来源年份:2025,采购价:148.00],[来源省份:辽宁省,来源年份:2025,采购价:148.00],[来源省份:重庆市,来源年份:2025,采购价:148.00],[来源省份:湖北省,来源年份:2025,采购价:148.00],[来源省份:海南省,来源年份:2025,采购价:148.00],[来源省份:贵州省,来源年份:2025,采购价:148.00],[来源省份:安徽省,来源年份:2025,采购价:148.00],[来源省份:江苏省,来源年份:2025,采购价:148.00],[来源省份:江西省,来源年份:2025,采购价:148.00],[来源省份:广东省,来源年份:2025,采购价:148.00]","通过","独家，提供10省"]
[3116049,"XA06ADJ165P001010284450","聚乙二醇钠钾散","散剂","本品为复方制剂,每包含聚乙二醇3350为13.1250g、氯化钠0.3507g、氯化钾0.0466g、碳酸氢钠0.1785g","8","江苏欧歌制药有限公司","圣嘉（滨海）生物医药科技有限公司","国药准字H20253326",48.64,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:48.64],[来源省份:贵州省,来源年份:2025,采购价:48.64],[来源省份:山东省,来源年份:2025,采购价:48.64]","通过","不高于中位价"]
[3115561,"XA06ADL397X019010184691","硫酸镁钠钾口服用浓溶液","口服溶液剂","176ml:硫酸镁(按MgSO₄•7H₂O计)3.276g、硫酸钠17.510g与硫酸钾3.130g","2","南京海纳制药有限公司","广州市亿源医药有限公司","国药准字H20255031",81.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:81.80],[来源省份:山东省,来源年份:2025,采购价:81.80],[来源省份:江苏省,来源年份:2025,采购价:81.80]","通过","不高于中位价"]
[3004522,"XA06AGB086D001010102927","比沙可啶栓","栓剂","10mg","7","山西同达药业有限公司","山西同达药业有限公司","国药准字H20065455",77,"已有10个省级平台挂网的独家药品","[来源省份:北京市,来源年份:2024,采购价:77.00],[来源省份:河北省,来源年份:2024,采购价:77.00],[来源省份:内蒙古自治区,来源年份:2024,采购价:77.00],[来源省份:湖北省,来源年份:2024,采购价:77.00],[来源省份:陕西省,来源年份:2024,采购价:77.00],[来源省份:辽宁省,来源年份:2024,采购价:77.00],[来源省份:江苏省,来源年份:2024,采购价:77.00],[来源省份:黑龙江省,来源年份:2024,采购价:77.00],[来源省份:新疆维吾尔自治区,来源年份:2024,采购价:77.00],[来源省份:安徽省,来源年份:2024,采购价:77.00]","通过","独家"]
[3116057,"XA07CAB163P001010105774","口服补液盐散(Ⅲ)","散剂","5.125g","6","海南海力制药有限公司","海南海力制药有限公司","国药准字H20183003",17,"急(抢)救药、妇儿专科非专利药品","[来源省份:海南省,来源年份:2025,采购价:17.00],[来源省份:安徽省,来源年份:2025,采购价:17.00],[来源省份:贵州省,来源年份:2025,采购价:17.00]","通过","不高于中位价"]
[3114635,"XA07FAR055N001010105844","乳酸菌素颗粒","颗粒剂","1g(按乳酸菌素计算)","8","康芝药业股份有限公司","康芝药业股份有限公司","国药准字H20103529",12.4,"已有10个省级平台挂网的独家药品","[来源省份:江苏省,来源年份:2025,采购价:12.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:12.40],[来源省份:黑龙江省,来源年份:2025,采购价:12.40],[来源省份:河北省,来源年份:2018,采购价:12.40],[来源省份:四川省,来源年份:2025,采购价:12.40],[来源省份:陕西省,来源年份:2025,采购价:12.40],[来源省份:山东省,来源年份:2019,采购价:12.40],[来源省份:湖南省,来源年份:2025,采购价:12.40],[来源省份:吉林省,来源年份:2025,采购价:12.40],[来源省份:江西省,来源年份:2025,采购价:12.40]","通过","独家"]
[3116452,"XA09AAY350A012010102463","胰酶胆汁肠溶片","肠溶片","胰酶50mg(胰蛋白酶145单位、咦淀粉酶2115单位,胰脂肪酶750单位),猪胆膏50mg(牛黄猪去氧胆酸1mg)","36","陕西博森生物制药股份集团有限公司","陕西博森生物制药股份集团有限公司","国药准字H61022561",99,"已有10个省级平台挂网的独家药品","[来源省份:湖北省,来源年份:2024,采购价:99.00],[来源省份:黑龙江省,来源年份:2024,采购价:99.00],[来源省份:辽宁省,来源年份:2024,采购价:99.00],[来源省份:内蒙古自治区,来源年份:2024,采购价:99.00],[来源省份:安徽省,来源年份:2024,采购价:99.00],[来源省份:湖南省,来源年份:2024,采购价:99.00],[来源省份:广西壮族自治区,来源年份:2024,采购价:99.00],[来源省份:江苏省,来源年份:2024,采购价:99.00],[来源省份:陕西省,来源年份:2024,采购价:99.00],[来源省份:海南省,来源年份:2024,采购价:99.00]","通过","独家"]
[3116480,"XA10BDE082A001010110323","二甲双胍恩格列净片(Ⅰ)","片剂","每片含盐酸二甲双胍500mg与恩格列净5mg","60","山东朗诺制药有限公司","山东禾琦制药有限公司","国药准字H20253795",58.21,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:58.21],[来源省份:贵州省,来源年份:2025,采购价:58.21],[来源省份:广西壮族自治区,来源年份:2025,采购价:58.21]","通过","不高于中位价"]
[3115624,"XA10BDS251A010010501503","沙格列汀二甲双胍缓释片(Ⅰ)","片剂","每片含沙格列汀5mg和盐酸二甲双胍1000mg","18","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254115",114.65,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:114.65],[来源省份:广西壮族自治区,来源年份:2025,采购价:114.65],[来源省份:江苏省,来源年份:2025,采购价:114.65]","通过","不高于中位价"]
[3115623,"XA10BDS251A010010601503","沙格列汀二甲双胍缓释片(Ⅰ)","片剂","每片含沙格列汀5mg和盐酸二甲双胍1000mg","12","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254115",77.57,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:77.57],[来源省份:广东省,来源年份:2025,采购价:77.57],[来源省份:广西壮族自治区,来源年份:2025,采购价:77.57]","通过","不高于中位价"]
[3115622,"XA10BDS251A010010101503","沙格列汀二甲双胍缓释片(Ⅰ)","片剂","每片含沙格列汀5mg和盐酸二甲双胍1000mg","6","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254115",39.78,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:39.78],[来源省份:广西壮族自治区,来源年份:2025,采购价:39.78],[来源省份:江苏省,来源年份:2025,采购价:39.78]","通过","不高于中位价"]
[3115621,"XA10BDS253A010010401503","沙格列汀二甲双胍缓释片(Ⅲ)","片剂","每片含沙格列汀2.5mg和盐酸二甲双胍1000mg","18","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254116",67.44,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:67.44],[来源省份:辽宁省,来源年份:2025,采购价:67.44],[来源省份:广西壮族自治区,来源年份:2025,采购价:67.44]","通过","不高于中位价"]
[3115620,"XA10BDS253A010010601503","沙格列汀二甲双胍缓释片(Ⅲ)","片剂","每片含沙格列汀2.5mg和盐酸二甲双胍1000mg","12","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254116",45.63,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:45.63],[来源省份:辽宁省,来源年份:2025,采购价:45.63],[来源省份:广西壮族自治区,来源年份:2025,采购价:45.63]","通过","不高于中位价"]
[3115619,"XA10BDS253A010010301503","沙格列汀二甲双胍缓释片(Ⅲ)","片剂","每片含沙格列汀2.5mg和盐酸二甲双胍1000mg","6","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20254116",23.4,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:23.40],[来源省份:辽宁省,来源年份:2025,采购价:23.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:23.40]","通过","不高于中位价"]
[3115640,"XA10BJB219B002020180532","贝那鲁肽注射液","注射剂","4.2mg(42000U)(2.1ml)/支(预填充注射笔)","1","上海仁会生物制药股份有限公司","上海仁会生物制药股份有限公司","国药准字S20230042",2380,"创新生物制品：注册分类2-12类新药","[来源省份:上海市,来源年份:2025,采购价:2380.00],[来源省份:山东省,来源年份:2025,采购价:2380.00],[来源省份:湖北省,来源年份:2025,采购价:2380.00],[来源省份:广东省,来源年份:2025,采购价:2380.00],[来源省份:贵州省,来源年份:2025,采购价:2380.00],[来源省份:云南省,来源年份:2025,采购价:2380.00],[来源省份:陕西省,来源年份:2025,采购价:2380.00],[来源省份:黑龙江省,来源年份:2025,采购价:2380.00],[来源省份:天津市,来源年份:2025,采购价:2380.00],[来源省份:北京市,来源年份:2025,采购价:2380.00]","通过","适应症独家，提供10省"]
[3115054,"XA10BKD256A001010579426","达格列净片","片剂","5mg(按C₂₁H₂₅ClO₆计)","10","Hetero Labs Limited","江西省华药医药有限公司","国药准字HJ20250029",18.17,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:18.17],[来源省份:江西省,来源年份:2025,采购价:18.17],[来源省份:湖北省,来源年份:2025,采购价:18.17]","通过","不高于中位价"]
[3115565,"XA10BKD256A001020679426","达格列净片","片剂","10mg(按C₂₁H₂₅ClO₆计)","30","Hetero Labs Limited","江西省华药医药有限公司","国药准字HJ20250030",89.01,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:89.01],[来源省份:黑龙江省,来源年份:2025,采购价:89.01],[来源省份:广西壮族自治区,来源年份:2025,采购价:89.01]","通过","不高于中位价"]
[3115564,"XA10BKD256A001020379426","达格列净片","片剂","10mg(按C₂₁H₂₅ClO₆计)","10","Hetero Labs Limited","江西省华药医药有限公司","国药准字HJ20250030",30.89,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:30.89],[来源省份:黑龙江省,来源年份:2025,采购价:30.89],[来源省份:广西壮族自治区,来源年份:2025,采购价:30.89]","通过","不高于中位价"]
[3115551,"XA11CCW047E002010100144","维生素D2软胶囊","胶囊剂","0.25mg(1万单位)","30","华润双鹤药业股份有限公司","华润双鹤药业股份有限公司","国药准字H11020642",200.7,"不高于同质量层次药品最低价申报","[来源省份:江苏省,来源年份:2025,采购价:200.70],[来源省份:广西壮族自治区,来源年份:2025,采购价:200.70],[来源省份:贵州省,来源年份:2025,采购价:200.70]","通过","不高于同组最低价"]
[3116058,"XA11HAW039B002010202503","维生素B2注射液","注射剂","2ml:5mg","1","陕西顿斯制药有限公司","西安汤臣制药有限公司","国药准字H61021617",42.7,"不高于同质量层次药品最低价申报","[来源省份:广西壮族自治区,来源年份:2022,采购价:86.39],[来源省份:海南省,来源年份:2022,采购价:86.39],[来源省份:吉林省,来源年份:2024,采购价:86.39]","通过","不高于同组最低价"]
[78645,"XB01AXA073A001010104945","阿魏酸哌嗪片","片剂","50mg","50","康普药业股份有限公司","康普药业股份有限公司","国药准字H43021760",8.29,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2020,采购价:8.29],[来源省份:北京市,来源年份:2022,采购价:8.29],[来源省份:浙江省,来源年份:2020,采购价:8.29]","通过","同厂家符合差比"]
[3116688,"XB02BDC180B001010182983","注射用重组人凝血因子Ⅶa N01","注射剂","1mg(50KIU)/瓶","1","正大天晴药业集团南京顺欣制药有限公司","正大天晴药业集团南京顺欣制药有限公司","国药准字S20250034",4680,"已有10个省级平台挂网的独家药品","[来源省份:内蒙古自治区,来源年份:2025,采购价:4680.00],[来源省份:安徽省,来源年份:2025,采购价:4680.00],[来源省份:北京市,来源年份:2025,采购价:4680.00],[来源省份:辽宁省,来源年份:2025,采购价:4680.00],[来源省份:浙江省,来源年份:2025,采购价:4680.00],[来源省份:江西省,来源年份:2025,采购价:4680.00],[来源省份:广东省,来源年份:2025,采购价:4680.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:4680.00],[来源省份:重庆市,来源年份:2025,采购价:4680.00],[来源省份:四川省,来源年份:2025,采购价:4680.00]","通过","独家"]
[3116163,"XB02BXA336A001010184850","马来酸阿伐曲泊帕片","片剂","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","10","江苏诚康药业有限公司","山东新华制药股份有限公司","国药准字H20249585",1319,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:1319.00],[来源省份:山东省,来源年份:2025,采购价:1319.00],[来源省份:重庆市,来源年份:2025,采购价:1319.00]","通过","不高于中位价"]
[3116147,"XB03BAX052E001010283184","腺苷钴胺胶囊","胶囊剂","0.5mg","30","广东华南药业集团有限公司","山东新华制药股份有限公司","国药准字H20253418",94.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:94.50],[来源省份:广西壮族自治区,来源年份:2025,采购价:94.50],[来源省份:山东省,来源年份:2025,采购价:94.50]","通过","不高于中位价"]
[3115533,"XB05BBF742B002010183033","复方醋酸钠葡萄糖注射液","注射剂","500ml","1","河北仁合益康药业有限公司","仁合益康集团有限公司","国药准字H20254562",395,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:395.00],[来源省份:黑龙江省,来源年份:2025,采购价:395.00],[来源省份:江苏省,来源年份:2025,采购价:395.00]","通过","不高于中位价"]
[3115530,"XB05BBF742B002020283033","复方醋酸钠葡萄糖注射液","注射剂","200ml","1","河北仁合益康药业有限公司","仁合益康集团有限公司","国药准字H20254561",195.87,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:195.87],[来源省份:江苏省,来源年份:2025,采购价:195.87],[来源省份:贵州省,来源年份:2025,采购价:195.87]","通过","不高于中位价"]
[3116378,"XB05XAL209B002010102763","氯化钾氯化钠注射液","注射剂","250ml:氯化钾0.75g与氯化钠2.25g","1","石家庄四药有限公司","石家庄四药有限公司","国药准字H20254795",16.18,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:16.20],[来源省份:海南省,来源年份:2025,采购价:16.20],[来源省份:贵州省,来源年份:2025,采购价:16.20]","通过","不高于中位价"]
[3116379,"XB05XAL209B002020102763","氯化钾氯化钠注射液","注射剂","500ml:氯化钾1.5g与氯化钠4.5g","1","石家庄四药有限公司","石家庄四药有限公司","国药准字H20254796",27.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:27.50],[来源省份:海南省,来源年份:2025,采购价:27.50],[来源省份:贵州省,来源年份:2025,采购价:27.50]","通过","不高于中位价"]
[3115576,"XB05XAT018B002010185013","碳酸氢钠注射液","注射剂","10ml︰0.42g","1","广东星昊药业有限公司","广州合和医药有限公司","国药准字H20254426",7.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:7.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:7.80],[来源省份:江苏省,来源年份:2025,采购价:7.80]","通过","不高于中位价"]
[3115630,"XC01CAQ130B002010183383","盐酸去氧肾上腺素注射液","注射剂","1ml∶10mg","1","远大医药(中国)有限公司","远大医药（中国）有限公司","国药准字H20253388",6.69,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:6.69],[来源省份:江西省,来源年份:2025,采购价:6.69],[来源省份:贵州省,来源年份:2025,采购价:6.69]","通过","不高于中选价"]
[3004947,"XC01DAD024L002010100500","单硝酸异山梨酯喷雾剂","喷雾剂","10ml:180mg,每喷2.5mg","1","深圳大佛药业股份有限公司","深圳大佛药业股份有限公司","国药准字H20020439",33.99,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:33.99],[来源省份:吉林省,来源年份:2025,采购价:33.99],[来源省份:贵州省,来源年份:2025,采购价:33.99],[来源省份:广西壮族自治区,来源年份:2025,采购价:33.99],[来源省份:黑龙江省,来源年份:2025,采购价:33.99],[来源省份:湖北省,来源年份:2025,采购价:33.99],[来源省份:湖南省,来源年份:2025,采购价:33.99],[来源省份:山东省,来源年份:2025,采购价:33.99],[来源省份:内蒙古自治区,来源年份:2025,采购价:33.99],[来源省份:辽宁省,来源年份:2025,采购价:33.99]","通过","独家"]
[3116386,"XC01DAD227E003010200610","单硝酸异山梨酯缓释胶囊(Ⅳ)","胶囊剂(缓释胶囊)","50mg","20","优时比(珠海)制药有限公司","珠海英联医药有限公司","国药准字H20031224",52.45,"本企业已挂网药品新增包装规格","[来源省份:辽宁省,来源年份:2022,采购价:52.45],[来源省份:江苏省,来源年份:2023,采购价:52.45],[来源省份:黑龙江省,来源年份:2024,采购价:52.45]","通过","同厂家符合差比"]
[3115498,"XC01DAX072L002010100148","硝酸甘油喷雾剂","喷雾剂","每瓶200喷,每喷重量48mg含硝酸甘油0.4mg","1","北京双鹭药业股份有限公司","北京双鹭药业股份有限公司","国药准字H20253802",198,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:198.00],[来源省份:江西省,来源年份:2025,采购价:198.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:198.00]","通过","不高于中位价"]
[3115279,"XC01DXN039A001010183273","尼可地尔片","片剂","5mg","30","扬州市三药制药有限公司","北京沃邦医药科技有限公司","国药准字H20249805",28.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:28.10],[来源省份:广西壮族自治区,来源年份:2025,采购价:28.10],[来源省份:贵州省,来源年份:2025,采购价:28.10]","通过","不高于中位价"]
[3115436,"XC03CAF056A001010202954","呋塞米片","片剂","20mg","100","山西双雁药业有限公司","山西双雁药业有限公司","国药准字H14022360",14.38,"不高于同质量层次药品最低价申报","[来源省份:湖南省,来源年份:2025,采购价:14.38],[来源省份:贵州省,来源年份:2025,采购价:14.49],[来源省份:广西壮族自治区,来源年份:2025,采购价:14.49]","通过","不高于同组最低价"]
[3116641,"XC04ADJ014A010010102777","己酮可可碱缓释片","片剂","0.4g","10","石药集团欧意药业有限公司","石药集团中诺药业（石家庄）有限公司","国药准字H20255008",49.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:49.20],[来源省份:广东省,来源年份:2025,采购价:49.20],[来源省份:山东省,来源年份:2025,采购价:49.20]","通过","不高于中位价"]
[3115556,"XC05BBJ209B002020102433","聚多卡醇注射液","注射剂","2ml:60mg","1","陕西天宇制药有限公司","陕西天宇制药有限公司","国药准字H20258099",760,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:760.00],[来源省份:江西省,来源年份:2025,采购价:760.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:760.00]","通过","不高于中位价"]
[3115557,"XC05BBJ209B002030102433","聚多卡醇注射液","注射剂","2ml:20mg","1","陕西天宇制药有限公司","陕西天宇制药有限公司","国药准字H20258100",327.76,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:327.76],[来源省份:贵州省,来源年份:2025,采购价:327.76],[来源省份:广西壮族自治区,来源年份:2025,采购价:327.76]","通过","不高于中位价"]
[3115558,"XC05BBJ209B002010102433","聚多卡醇注射液","注射剂","2ml:10mg","1","陕西天宇制药有限公司","陕西天宇制药有限公司","国药准字H20258098",192.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:192.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:192.80],[来源省份:江西省,来源年份:2025,采购价:192.80]","通过","不高于中位价"]
[3116454,"XC05CAL170A001010100886","芦丁片","片剂","20mg","100","天津力生制药股份有限公司","天津力生制药股份有限公司","国药准字H12020173",4.2,"已有10个省级平台挂网的独家药品","[来源省份:北京市,来源年份:2025,采购价:4.20],[来源省份:山东省,来源年份:2025,采购价:4.20],[来源省份:湖南省,来源年份:2025,采购价:4.20],[来源省份:云南省,来源年份:2025,采购价:4.20],[来源省份:内蒙古自治区,来源年份:2025,采购价:4.20],[来源省份:四川省,来源年份:2025,采购价:4.20],[来源省份:山西省,来源年份:2025,采购价:4.20],[来源省份:广东省,来源年份:2025,采购价:4.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:4.20],[来源省份:河北省,来源年份:2025,采购价:4.20]","通过","独家"]
[140965,"XC07AAP101A001010102831","盐酸普萘洛尔片","片剂","10mg","100","北京海王中新药业股份有限公司","北京海王中新药业股份有限公司","国药准字H13020584",18,"国家集采非中选药品申报","[来源省份:黑龙江省,来源年份:2025,采购价:19.20],[来源省份:辽宁省,来源年份:2024,采购价:19.20],[来源省份:山东省,来源年份:2025,采购价:19.20]","通过","不高于未中选最低价"]
[3115493,"XC07ABM062B002010101723","酒石酸美托洛尔注射液","注射剂","5ml:酒石酸美托洛尔5mg与氯化钠45mg","1","江苏朗欧药业有限公司","江苏朗欧药业有限公司","国药准字H20055270",39.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:39.60],[来源省份:黑龙江省,来源年份:2025,采购价:39.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:39.60]","通过","不高于中位价"]
[3116490,"XC07FBB249A001010204145","比索洛尔氨氯地平片","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅ClN₂O₅计)5mg","14","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254358",21.13,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:21.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:21.20],[来源省份:浙江省,来源年份:2025,采购价:21.13]","通过","同厂家符合差比"]
[3116492,"XC07FBB249A001010304145","比索洛尔氨氯地平片","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按C₂₀H₂₅ClN₂O₅计)5mg","10","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254358",15.28,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:15.33],[来源省份:广西壮族自治区,来源年份:2025,采购价:15.33],[来源省份:浙江省,来源年份:2025,采购价:15.28]","通过","同厂家符合差比"]
[3116618,"XC08CAB037A001020400177","盐酸贝尼地平片","片剂","4mg","30","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254764",60.35,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:62.97],[来源省份:广西壮族自治区,来源年份:2025,采购价:62.97],[来源省份:江苏省,来源年份:2025,采购价:62.97]","通过","不高于中位价"]
[3116620,"XC08CAB037A001020100177","盐酸贝尼地平片","片剂","4mg","20","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254764",40.83,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:42.61],[来源省份:广西壮族自治区,来源年份:2025,采购价:42.61],[来源省份:宁夏回族自治区,来源年份:2025,采购价:42.61]","通过","不高于中位价"]
[3116622,"XC08CAB037A001010300177","盐酸贝尼地平片","片剂","8mg","30","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254631",102.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:107.06],[来源省份:广西壮族自治区,来源年份:2025,采购价:107.06],[来源省份:江苏省,来源年份:2025,采购价:107.06]","通过","不高于中位价"]
[3116623,"XC08CAB037A001010100177","盐酸贝尼地平片","片剂","8mg","20","北京福元医药股份有限公司","北京福元医药股份有限公司","国药准字H20254631",69.42,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:72.44],[来源省份:广西壮族自治区,来源年份:2025,采购价:72.44],[来源省份:江苏省,来源年份:2025,采购价:72.44]","通过","不高于中位价"]
[3116436,"XC08CAN038B002010204647","盐酸尼卡地平注射液","注射剂","10ml:10mg","1","浙江华海药业股份有限公司","浙江华海药业股份有限公司","国药准字H20254793",42.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:42.70],[来源省份:青海省,来源年份:2025,采购价:42.70],[来源省份:山东省,来源年份:2025,采购价:42.70]","通过","不高于中位价"]
[3116619,"XC08CAN038B002010105847","盐酸尼卡地平注射液","注射剂","10ml:10mg","1","齐鲁制药(海南)有限公司","齐鲁制药（海南）有限公司","国药准字H20255093",30,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:30.00],[来源省份:山东省,来源年份:2025,采购价:30.00],[来源省份:浙江省,来源年份:2025,采购价:30.00]","通过","不高于中位价"]
[3116031,"XC08CAN038B002020281251","盐酸尼卡地平注射液","注射剂","10ml:10mg","1","浙江赛默制药有限公司","海南广升誉制药有限公司","国药准字H20254028",42.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:42.50],[来源省份:江西省,来源年份:2025,采购价:42.50],[来源省份:广西壮族自治区,来源年份:2025,采购价:42.50]","通过","不高于中位价"]
[3116032,"XC08CAN038B002010281251","盐酸尼卡地平注射液","注射剂","2ml:2mg","1","浙江赛默制药有限公司","海南广升誉制药有限公司","国药准字H20254027",12.4,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:12.40],[来源省份:江西省,来源年份:2025,采购价:12.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:12.40]","通过","不高于中位价"]
[3109643,"XC09BBA396E001010184221","氨氯地平贝那普利胶囊","胶囊剂","每粒含苯磺酸氨氯地平5mg(按C20H25N2O5CL计)与盐酸贝那普利10mg","30","江苏和晨药业有限公司","浙江高跖医药科技股份有限公司","国药准字H20253132",98.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:218.70],[来源省份:浙江省,来源年份:2025,采购价:98.60],[来源省份:安徽省,来源年份:2025,采购价:218.70],[来源省份:广西壮族自治区,来源年份:2025,采购价:218.70],[来源省份:黑龙江省,来源年份:2025,采购价:98.60],[来源省份:湖北省,来源年份:2025,采购价:218.70],[来源省份:湖南省,来源年份:2025,采购价:98.60],[来源省份:内蒙古自治区,来源年份:2025,采购价:218.70],[来源省份:贵州省,来源年份:2025,采购价:206.80],[来源省份:江西省,来源年份:2025,采购价:206.80]","通过","不高于中位价"]
[3116495,"XC09BBA396E001010184887","氨氯地平贝那普利胶囊","胶囊剂","每粒含苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)与盐酸贝那普利10mg","7","江苏和晨药业有限公司","浙江皓格药业有限公司","国药准字H20254193",40.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:40.60],[来源省份:江苏省,来源年份:2025,采购价:40.60],[来源省份:山东省,来源年份:2025,采购价:40.60]","通过","不高于中位价"]
[3115545,"XC09BBP131A001010183830","培哚普利氨氯地平片(Ⅲ)","片剂","每片含精氨酸培哚普利10mg、苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","10","成都硕德药业有限公司","成都硕德药业有限公司","国药准字H20254925",41.3,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:41.30],[来源省份:江苏省,来源年份:2025,采购价:41.30],[来源省份:广东省,来源年份:2025,采购价:41.30]","通过","不高于中位价"]
[3116692,"XC09DAE004A001011305356","厄贝沙坦氢氯噻嗪片","片剂(薄膜衣片)","每片含厄贝沙坦150mg,氢氯噻嗪12.5mg","27","石家庄市普力制药有限公司","河北新石制药有限公司","国药准字H20233451",18.11,"本企业已挂网药品新增包装规格","[来源省份:湖北省,来源年份:2025,采购价:18.11],[来源省份:黑龙江省,来源年份:2025,采购价:18.11],[来源省份:河北省,来源年份:2025,采购价:18.11]","通过","同厂家符合差比"]
[3116690,"XC09DAE004A001010405356","厄贝沙坦氢氯噻嗪片","片剂(薄膜衣片)","每片含厄贝沙坦150mg,氢氯噻嗪12.5mg","21","石家庄市普力制药有限公司","河北新石制药有限公司","国药准字H20233451",14.22,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2025,采购价:14.22],[来源省份:黑龙江省,来源年份:2025,采购价:14.22],[来源省份:湖北省,来源年份:2025,采购价:14.22]","通过","同厂家符合差比"]
[3116038,"XC09DBT176A001010404145","替米沙坦氨氯地平片","片剂","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","10","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254324",68.67,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:68.67],[来源省份:江苏省,来源年份:2025,采购价:68.67],[来源省份:山东省,来源年份:2025,采购价:68.67]","通过","同厂家符合差比"]
[3115538,"XC09DBT176A001010304145","替米沙坦氨氯地平片","片剂","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅N₂O₅Cl计)","7","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254324",48.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:48.70],[来源省份:江苏省,来源年份:2025,采购价:48.70],[来源省份:湖北省,来源年份:2025,采购价:48.70]","通过","同厂家符合差比"]
[3115230,"XC09DBT176A001010183916","替米沙坦氨氯地平片","片剂","每片含替米沙坦80mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","7","四川科伦药业股份有限公司","湖南慧泽生物医药科技有限公司","国药准字H20254641",34.93,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:34.93],[来源省份:广西壮族自治区,来源年份:2025,采购价:34.93],[来源省份:江苏省,来源年份:2025,采购价:34.93]","通过","不高于中位价"]
[3115439,"XC09DBT195A001010309665","替米沙坦氨氯地平片(II)","片剂","每片含替米沙坦40mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)","7","常州市阳光药业有限公司","常州市阳光药业有限公司","国药准字H20254352",41.33,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:41.33],[来源省份:贵州省,来源年份:2025,采购价:41.33],[来源省份:江西省,来源年份:2025,采购价:41.33],[来源省份:陕西省,来源年份:2025,采购价:41.33],[来源省份:湖北省,来源年份:2025,采购价:41.33],[来源省份:安徽省,来源年份:2025,采购价:41.33],[来源省份:宁夏回族自治区,来源年份:2025,采购价:41.33],[来源省份:黑龙江省,来源年份:2025,采购价:41.33],[来源省份:广西壮族自治区,来源年份:2025,采购价:41.33],[来源省份:江苏省,来源年份:2025,采购价:41.33]","通过","独家"]
[3116503,"XC09DBX221A001010384225","缬沙坦氨氯地平片(Ⅱ)","片剂","每片含缬沙坦160mg,氨氯地平5mg","7","石家庄市华新药业有限责任公司","浙江众延医药科技有限公司","国药准字H20254234",48.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:48.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:48.60],[来源省份:江苏省,来源年份:2025,采购价:48.60],[来源省份:黑龙江省,来源年份:2025,采购价:48.60]","通过","不高于中位价"]
[3113923,"XC09DXS309A001020300553","沙库巴曲阿利沙坦钙片","片剂(薄膜衣片)","按C₄₆H₅₀ClN₇O₇计:240mg(沙库巴曲116mg/阿利沙坦124mg)","7","深圳信立泰药业股份有限公司","深圳信立泰药业股份有限公司","国药准字H20250017",63.56,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:63.56],[来源省份:广东省,来源年份:2025,采购价:63.56],[来源省份:湖南省,来源年份:2025,采购价:63.56],[来源省份:贵州省,来源年份:2025,采购价:63.56],[来源省份:安徽省,来源年份:2025,采购价:63.56],[来源省份:四川省,来源年份:2025,采购价:63.56],[来源省份:黑龙江省,来源年份:2025,采购价:63.56],[来源省份:甘肃省,来源年份:2025,采购价:63.56],[来源省份:江西省,来源年份:2025,采购价:63.56],[来源省份:江苏省,来源年份:2025,采购价:63.56]","通过","独家"]
[3116387,"XC10ABF021A001010100401","非诺贝特片","片剂","0.1g","100","广州康和药业有限公司","广州康和药业有限公司","国药准字H44021698",52,"不高于同质量层次药品最低价申报","[来源省份:贵州省,来源年份:2025,采购价:52.00],[来源省份:海南省,来源年份:2025,采购价:52.00],[来源省份:安徽省,来源年份:2025,采购价:52.00]","通过","不高于同组最低价"]
[3115552,"XC10ABF728E003010104942","非诺贝特酸胆碱缓释胶囊","缓释胶囊","135mg(按C₁₇H₁₅ClO₄计)","12","湖南九典制药股份有限公司","湖南九典制药股份有限公司","国药准字H20254583",36.96,"纳入国家医保目录准入价格谈判的药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:36.96],[来源省份:湖北省,来源年份:2025,采购价:36.96],[来源省份:江苏省,来源年份:2025,采购价:36.96]","通过","申报价格不高于支付标准的国谈竞价药"]
[3115485,"XC10AXA076E001010383549","阿昔莫司胶囊","胶囊剂","0.25g","20","浙江赛默制药有限公司","浙江沣华医药科技有限公司","国药准字H20244607",41.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:41.20],[来源省份:江西省,来源年份:2025,采购价:41.20],[来源省份:黑龙江省,来源年份:2025,采购价:41.20]","通过","不高于中位价"]
[3115536,"XD01AEA039T001010180651","盐酸阿莫罗芬搽剂","搽剂","5%(2.5ml:125mg,按C₂₁H₃₅NO计)","1","福元药业有限公司","福元药业有限公司","国药准字H20254685",199.28,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:199.28],[来源省份:江苏省,来源年份:2025,采购价:199.28],[来源省份:湖北省,来源年份:2025,采购价:199.28]","通过","不高于中位价"]
[3116679,"XD06AXM119F001010384221","莫匹罗星软膏","软膏剂","2%(15g:0.3g)","2","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","国药准字H20254639",58.56,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:58.56],[来源省份:黑龙江省,来源年份:2025,采购价:58.56],[来源省份:宁夏回族自治区,来源年份:2025,采购价:58.56]","通过","不高于中位价"]
[3115479,"XD07AAQ060F002020200774","醋酸氢化可的松乳膏","乳膏剂","1%(20g/支)","2","上海正大通用药业股份有限公司","上海正大通用药业股份有限公司","国药准字H31021275",67.2,"本企业已挂网药品新增包装规格","[来源省份:江苏省,来源年份:2025,采购价:67.20],[来源省份:浙江省,来源年份:2025,采购价:67.20],[来源省份:黑龙江省,来源年份:2025,采购价:67.20]","通过","同厂家符合差比"]
[3116472,"XD07ACF095F002010101003","丙酸氟替卡松乳膏","乳膏剂","0.05%(15g:7.5mg)","1","重庆华邦制药有限公司","重庆华邦制药有限公司","国药准字H20254589",33.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:33.20],[来源省份:江苏省,来源年份:2025,采购价:33.20],[来源省份:江西省,来源年份:2025,采购价:33.20]","通过","不高于中位价"]
[3110223,"XG01AAK073D003010101534","克林霉素磷酸酯栓","阴道栓","0.1g","7","昆山培力药品有限公司","昆山培力药品有限公司","国药准字H20080810",105,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖南省,来源年份:2025,采购价:105.00],[来源省份:黑龙江省,来源年份:2025,采购价:105.00],[来源省份:江苏省,来源年份:2025,采购价:105.00]","通过","不高于中位价"]
[3115492,"XG02CCY209D001010303767","鱼腥草素钠栓","栓剂","20mg(以鱼腥草素钠计)","7","黑龙江省济仁药业有限公司","黑龙江省济仁药业有限公司","国药准字H20057018",20.51,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2025,采购价:20.51],[来源省份:广西壮族自治区,来源年份:2025,采购价:20.51],[来源省份:广东省,来源年份:2025,采购价:20.51],[来源省份:重庆市,来源年份:2025,采购价:20.51],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:20.51],[来源省份:四川省,来源年份:2025,采购价:20.51],[来源省份:西藏自治区,来源年份:2025,采购价:20.51],[来源省份:陕西省,来源年份:2025,采购价:20.51],[来源省份:贵州省,来源年份:2025,采购价:20.51],[来源省份:江西省,来源年份:2025,采购价:20.51]","通过","独家"]
[3115126,"XG03DAH056E002010183319","黄体酮软胶囊","胶囊剂","0.1g","30","人福普克药业(武汉)有限公司","武汉九珑人福药业有限责任公司","国药准字H20254199",58.39,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:70.20],[来源省份:江苏省,来源年份:2025,采购价:70.20],[来源省份:吉林省,来源年份:2025,采购价:70.20]","通过","不高于中位价"]
[3115127,"XG03DAH056E002020183319","黄体酮软胶囊","胶囊剂","0.2g","14","人福普克药业(武汉)有限公司","武汉九珑人福药业有限责任公司","国药准字H20254198",47.63,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:55.69],[来源省份:海南省,来源年份:2025,采购价:55.69],[来源省份:吉林省,来源年份:2025,采购价:55.69]","通过","不高于中位价"]
[3116382,"XG04BXZ059X001010184329","左卡尼汀口服溶液","口服溶液剂","10ml:1g","6","湖南九典制药股份有限公司","江苏百奥信康医药科技有限公司","国药准字H20249495",36,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:36.00],[来源省份:黑龙江省,来源年份:2025,采购价:36.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:36.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:36.00],[来源省份:贵州省,来源年份:2025,采购价:36.00]","通过","不高于中位价"]
[106341,"XH03BAB129A001010201622","丙硫氧嘧啶片","片剂","50mg","100","精华制药集团股份有限公司","精华制药集团股份有限公司","国药准字H32020795",39,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2022,采购价:39.00],[来源省份:海南省,来源年份:2024,采购价:39.00],[来源省份:四川省,来源年份:2024,采购价:39.00]","通过","不高于中位价"]
[3116631,"XJ01CFB083B001010201877","注射用苯唑西林钠","注射剂","1.0g(按C₁₉H₁₉N₃O₅S计)","1","福安药业集团庆余堂制药有限公司","福安药业集团庆余堂制药有限公司","国药准字H20254447",26.66,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:26.66],[来源省份:贵州省,来源年份:2025,采购价:29.12],[来源省份:广西壮族自治区,来源年份:2025,采购价:29.12]","通过","不高于未过评价格"]
[3116632,"XJ01CFB083B001020201877","注射用苯唑西林钠","注射剂","2.0g(按C₁₉H₁₉N₃O₅S计)","1","福安药业集团庆余堂制药有限公司","福安药业集团庆余堂制药有限公司","国药准字H20254446",45.32,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:49.51],[来源省份:贵州省,来源年份:2025,采购价:49.51],[来源省份:宁夏回族自治区,来源年份:2025,采购价:45.32]","通过","不高于未过评价格"]
[3115603,"XJ01CFB083B001020283960","注射用苯唑西林钠","注射剂","2.0g(按C₁₉H₁₉N₃O₅S计)","1","中孚药业股份有限公司","山东道齐生物医药科技有限公司","国药准字H20254491",30.62,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:33.71],[来源省份:湖北省,来源年份:2025,采购价:33.71],[来源省份:广西壮族自治区,来源年份:2025,采购价:33.71]","通过","不高于未过评价格"]
[3115602,"XJ01CFB083B001010283960","注射用苯唑西林钠","注射剂","1.0g(按C₁₉H₁₉N₃O₅S计)","1","中孚药业股份有限公司","山东道齐生物医药科技有限公司","国药准字H20254490",18.01,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:19.83],[来源省份:湖北省,来源年份:2025,采购价:19.83],[来源省份:广西壮族自治区,来源年份:2025,采购价:19.83]","通过","不高于未过评价格"]
[3116446,"XJ01CRA042B001030202777","注射用阿莫西林钠克拉维酸钾","注射剂","1.2g(C16H19N3O5S1g与C8H9NO50.2g)","1","石药集团中诺药业(石家庄)有限公司","石药集团中诺药业（石家庄）有限公司","国药准字H20023212",8.3,"国家集采非中选药品申报","[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:8.30],[来源省份:湖南省,来源年份:2025,采购价:8.30],[来源省份:贵州省,来源年份:2025,采购价:8.30]","通过","不高于未中选最低价"]
[3115292,"XJ01DDT068N001010200555","头孢地尼颗粒","颗粒剂","50mg","6","国药集团致君(深圳)制药有限公司","国药集团致君（深圳）制药有限公司","国药准字H20253170",35.4,"国家集采非中选药品申报","[来源省份:黑龙江省,来源年份:2025,采购价:35.40],[来源省份:广西壮族自治区,来源年份:2025,采购价:35.40],[来源省份:山东省,来源年份:2025,采购价:35.40]","通过","不高于中选价"]
[3116677,"XJ01DFA428B001010282879","注射用氨曲南阿维巴坦钠","注射剂","2.0g(C₁₃H₁₇N₅O₈S₂1.5g与C₇H₁₁N₃O₆S0.5g)","1","Hospira Australia Pty Ltd","上药控股有限公司","国药准字HJ20250078",1455,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:1455.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:1455.00],[来源省份:甘肃省,来源年份:2025,采购价:1455.00],[来源省份:陕西省,来源年份:2025,采购价:1455.00],[来源省份:湖南省,来源年份:2025,采购价:1455.00],[来源省份:重庆市,来源年份:2025,采购价:1455.00],[来源省份:广东省,来源年份:2025,采购价:1455.00],[来源省份:江西省,来源年份:2025,采购价:1455.00],[来源省份:安徽省,来源年份:2025,采购价:1455.00],[来源省份:江苏省,来源年份:2025,采购价:1455.00]","通过","独家，提供10省"]
[3116606,"XJ01DHM046B001010104019","注射用美罗培南","注射剂","0.5g(按C₁₇H₂₅N₃O₅S计)","1","齐鲁安替制药有限公司","齐鲁安替制药有限公司","国药准字H20233960",9.2,"国家集采非中选药品申报","[来源省份:浙江省,来源年份:2025,采购价:9.20],[来源省份:山东省,来源年份:2025,采购价:9.20],[来源省份:甘肃省,来源年份:2025,采购价:9.20]","通过","不高于中选价"]
[3111875,"XJ01FAK067A006010102238","克拉霉素分散片","分散片","0.25g","6","四川省旺林堂药业有限公司","四川省旺林堂药业有限公司","国药准字H20000127",8.06,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:8.06],[来源省份:黑龙江省,来源年份:2025,采购价:8.06],[来源省份:湖北省,来源年份:2025,采购价:8.06]","通过","不高于未中选最低价"]
[3115481,"XJ01FAK067A006010302238","克拉霉素分散片","分散片","0.25g","7","四川省旺林堂药业有限公司","四川省旺林堂药业有限公司","国药准字H20000127",9.35,"国家集采非中选药品申报","[来源省份:内蒙古自治区,来源年份:2025,采购价:9.35],[来源省份:山东省,来源年份:2025,采购价:9.35],[来源省份:安徽省,来源年份:2025,采购价:9.35]","通过","不高于未中选最低价"]
[3116085,"XJ01MAZ083B002030102964","左氧氟沙星氯化钠注射液","注射剂","100ml:左氧氟沙星(按C₁₈H₂₀FN₃O₄计)0.5g与氯化钠0.9g","1","石药银湖制药有限公司","石药银湖制药有限公司","国药准字H20249701",4.98,"国家集采非中选药品申报","[来源省份:广东省,来源年份:2025,采购价:4.98],[来源省份:河北省,来源年份:2025,采购价:4.98],[来源省份:安徽省,来源年份:2025,采购价:4.98]","通过","不高于未中选最低价"]
[3115733,"XJ01XDM152B002010183302","吗啉硝唑氯化钠注射液","注射剂","100ml:吗啉硝唑0.5g与氯化钠0.9g","1","江苏悦兴药业有限公司","南京卡文迪许生物工程技术有限公司","国药准字H20249624",58.09,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:67.80],[来源省份:贵州省,来源年份:2025,采购价:67.80],[来源省份:海南省,来源年份:2025,采购价:67.80]","通过","不高于中位价"]
[3004747,"XJ01XDM152B002010184044","吗啉硝唑氯化钠注射液","注射剂","100ml:吗啉硝唑0.5g与氯化钠0.9g","1","成都正康药业有限公司","成都国为生物医药有限公司","国药准字H20249460",58.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:86.00],[来源省份:黑龙江省,来源年份:2025,采购价:86.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:86.00]","通过","不高于中位价"]
[3116461,"XJ01XDZ100A001010104929","左奥硝唑片","片剂","0.25g","6","湖南华纳大药厂股份有限公司","湖南华纳大药厂股份有限公司","国药准字H20170018",96.53,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2025,采购价:96.53],[来源省份:内蒙古自治区,来源年份:2025,采购价:96.53],[来源省份:贵州省,来源年份:2025,采购价:96.53]","通过","同厂家符合差比"]
[3115684,"XJ01XDZ100A006010104929","左奥硝唑分散片","分散片","0.25g","6","湖南华纳大药厂股份有限公司","湖南明瑞制药股份有限公司","国药准字H20220003",96.53,"不高于同质量层次药品最低价申报","[来源省份:贵州省,来源年份:2022,采购价:96.53],[来源省份:云南省,来源年份:2022,采购价:96.53],[来源省份:辽宁省,来源年份:2025,采购价:96.53]","通过","不高于同组最低价"]
[3114582,"XJ01XXL070A001010185328","利奈唑胺片","片剂(薄膜衣片)","600mg","10","Alkem Laboratories Limited","中诺凯琳健康产业（海南）有限公司","国药准字HJ20240065",157,"国家集采非中选药品申报","[来源省份:广东省,来源年份:2025,采购价:157.00],[来源省份:重庆市,来源年份:2025,采购价:157.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:157.00]","通过","不高于中选价"]
[3116680,"XJ01XXT182B001010109568","注射用磷酸特地唑胺","注射剂","200mg","1","重庆圣华曦药业股份有限公司","重庆圣华曦药业股份有限公司","国药准字H20254693",227,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:227.00],[来源省份:广东省,来源年份:2025,采购价:227.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:227.00]","通过","不高于未中选最低价"]
[3116034,"XJ02ACA370B001010104145","注射用硫酸艾沙康唑","注射剂","0.2g(按C₂₂H₁₇F₂N₅OS计)","1","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20255036",964,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:964.00],[来源省份:江苏省,来源年份:2025,采购价:964.00],[来源省份:贵州省,来源年份:2025,采购价:964.00]","通过","不高于中位价"]
[3115518,"XJ02ACA370B001010183093","注射用硫酸艾沙康唑","注射剂","0.2g(按C₂₂H₁₇F₂N₅OS计)","1","山西德元堂药业有限公司","山东力诺制药有限公司","国药准字H20254537",965,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:965.00],[来源省份:江苏省,来源年份:2025,采购价:965.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:965.00]","通过","不高于中位价"]
[3116086,"XJ02ACF059X006010101605","伏立康唑干混悬剂","口服混悬剂","45g:3g,配制成混悬液后伏立康唑浓度为40mg/ml","1","南京易亨制药有限公司","南京易亨制药有限公司","国药准字H20254630",900,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:960.00],[来源省份:湖北省,来源年份:2025,采购价:960.00],[来源省份:江苏省,来源年份:2025,采购价:960.00]","通过","不高于中位价"]
[3116488,"XJ04ABH107E001010184441","环丝氨酸胶囊","胶囊剂","0.25g","12","湖南华纳大药厂股份有限公司","湖南埃威格林医药科技有限公司","国药准字H20254423",273,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:273.60],[来源省份:贵州省,来源年份:2025,采购价:273.60],[来源省份:江西省,来源年份:2025,采购价:273.60]","通过","不高于中位价"]
[3116684,"XJ05AHA218N001010183916","磷酸奥司他韦颗粒","颗粒剂","0.9g(按C₁₆H₂₈N₂O₄计)","1","湖南嘉恒制药有限公司","湖南慧泽生物医药科技有限公司","国药准字H20254848",99,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:99.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:99.00],[来源省份:江苏省,来源年份:2025,采购价:99.00]","通过","不高于中位价"]
[3115502,"XJ06BBJ146B001010109590","静注乙型肝炎人免疫球蛋白(pH4)","注射剂","2500IU(50ml)/瓶","1","哈尔滨派斯菲科生物制药有限公司","哈尔滨派斯菲科生物制药有限公司","国药准字S20110019",2895,"不高于同质量层次药品最低价申报","[来源省份:江西省,来源年份:2025,采购价:2895.00],[来源省份:湖南省,来源年份:2025,采购价:2895.00],[来源省份:湖北省,来源年份:2025,采购价:2895.00]","通过","不高于同组最低价"]
[3116682,"XL01EAA427A001010178679","盐酸阿思尼布片","片剂(薄膜衣片)","40mg(按C₂₀H₁₈ClF₂N₅O₃计)","60","Novartis Pharma Stein AG","北京诺华制药有限公司","国药准字HJ20250056",26000,"已有10个省级平台挂网的独家药品","[来源省份:安徽省,来源年份:2025,采购价:26000.00],[来源省份:重庆市,来源年份:2025,采购价:26000.00],[来源省份:辽宁省,来源年份:2025,采购价:26000.00],[来源省份:江西省,来源年份:2025,采购价:26000.00],[来源省份:江苏省,来源年份:2025,采购价:26000.00],[来源省份:黑龙江省,来源年份:2025,采购价:26000.00],[来源省份:贵州省,来源年份:2025,采购价:26000.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:26000.00],[来源省份:广东省,来源年份:2025,采购价:26000.00],[来源省份:北京市,来源年份:2025,采购价:26000.00]","通过","独家"]
[3116485,"XL01EXN112E002020101292","乙磺酸尼达尼布软胶囊","软胶囊剂","100mg(按C₃₁H₃₃N₅O₄计)","30","沈阳红旗制药有限公司","沈阳红旗制药有限公司","国药准字H20254599",1020,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:1020.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:1020.00],[来源省份:贵州省,来源年份:2025,采购价:1020.00]","通过","不高于中位价"]
[3115513,"XL01FXW131B001010179406","注射用维恩妥尤单抗","注射剂","30mg/瓶","1","Baxter Oncology GmbH","科园信海（北京）医疗用品贸易有限公司","国药准字SJ20240035",7117,"本企业已挂网药品新增包装规格","[来源省份:浙江省,来源年份:2025,采购价:7117.00],[来源省份:贵州省,来源年份:2025,采购价:7117.00],[来源省份:广东省,来源年份:2025,采购价:7117.00]","通过","同厂家符合差比"]
[3116507,"XL01XAA215B002010101892","奥沙利铂注射液","注射液","10ml:50mg","1","吉斯美(武汉)制药有限公司","吉斯美（武汉）制药有限公司","国药准字H20244951",86,"国家集采非中选药品申报","[来源省份:贵州省,来源年份:2025,采购价:192.00],[来源省份:江苏省,来源年份:2025,采购价:192.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:192.00]","通过","不高于未中选最低价"]
[3115422,"XL01XAK014B002010101892","卡铂注射液","注射液","15ml:150mg","1","吉斯美(武汉)制药有限公司","吉斯美（武汉）制药有限公司","国药准字H20249664",106,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:150.00],[来源省份:贵州省,来源年份:2025,采购价:150.00],[来源省份:江西省,来源年份:2025,采购价:150.00]","通过","不高于中位价"]
[3115465,"XL02BBA292A001010183319","醋酸阿比特龙片","片剂","0.25g","120","武汉九珑人福药业有限责任公司","武汉九珑人福药业有限责任公司","国药准字H20244845",2675,"国家集采非中选药品申报","[来源省份:山东省,来源年份:2025,采购价:2675.00],[来源省份:安徽省,来源年份:2025,采购价:2675.00],[来源省份:江苏省,来源年份:2025,采购价:2675.00]","通过","不高于未中选最低价"]
[3115607,"XL04AAM033A012010284230","麦考酚钠肠溶片","片剂","0.18g(按C17H20O6计)","50","华益药业科技(安徽)有限公司","浙江美迪深生物医药有限公司","国药准字H20254003",290,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:290.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:290.00],[来源省份:贵州省,来源年份:2025,采购价:290.00]","通过","同厂家符合差比"]
[3114487,"XL04ADT002E001020185294","他克莫司胶囊","胶囊剂","0.5mg","100","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司","国药准字HJ20240167",796,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:796.00],[来源省份:贵州省,来源年份:2025,采购价:796.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:796.00]","通过","不高于中位价"]
[3114491,"XL04ADT002E001010185294","他克莫司胶囊","胶囊剂","1mg","100","Biocon Pharma Limited","天津康哲维盛医药科技发展有限公司","国药准字HJ20240166",1353.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:1353.20],[来源省份:贵州省,来源年份:2025,采购价:1353.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:1353.20]","通过","不高于中位价"]
[3116487,"XL04ADT002E003010183879","他克莫司缓释胶囊","胶囊剂","1mg","50","江苏和晨药业有限公司","江苏和晨药业有限公司","国药准字H20254680",919,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:919.00],[来源省份:贵州省,来源年份:2025,采购价:919.00],[来源省份:江苏省,来源年份:2025,采购价:919.00]","通过","不高于中位价"]
[3115169,"XM01ACM192B002010184444","美洛昔康注射液(Ⅱ)","注射剂","1ml:30mg","1","南京健友生化制药股份有限公司","南京清普生物科技有限公司","国药准字H20250012",466,"已有10个省级平台挂网的独家药品","[来源省份:广东省,来源年份:2025,采购价:466.00],[来源省份:海南省,来源年份:2025,采购价:466.00],[来源省份:安徽省,来源年份:2025,采购价:466.00],[来源省份:陕西省,来源年份:2025,采购价:466.00],[来源省份:黑龙江省,来源年份:2025,采购价:466.00],[来源省份:贵州省,来源年份:2025,采购价:466.00],[来源省份:辽宁省,来源年份:2025,采购价:466.00],[来源省份:河北省,来源年份:2025,采购价:466.00],[来源省份:江西省,来源年份:2025,采购价:466.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:466.00]","通过","独家"]
[3116453,"XM01ACM193B002010102777","美洛昔康注射液(Ⅲ)","注射剂","1ml:30mg","1","石药集团中诺药业(石家庄)有限公司","石药集团中诺药业（石家庄）有限公司","国药准字H20254568",468,"已有10个省级平台挂网的独家药品","[来源省份:安徽省,来源年份:2025,采购价:468.00],[来源省份:广东省,来源年份:2025,采购价:468.00],[来源省份:贵州省,来源年份:2025,采购价:468.00],[来源省份:海南省,来源年份:2025,采购价:468.00],[来源省份:河北省,来源年份:2025,采购价:468.00],[来源省份:黑龙江省,来源年份:2025,采购价:468.00],[来源省份:湖北省,来源年份:2025,采购价:468.00],[来源省份:江西省,来源年份:2025,采购价:468.00],[来源省份:辽宁省,来源年份:2025,采购价:468.00],[来源省份:陕西省,来源年份:2025,采购价:468.00]","通过","独家"]
[1004820,"XM01AEB173X002010104193","布洛芬混悬液","口服混悬剂","100ml:2g","1","山东益康药业股份有限公司","新华制药（高密）有限公司","国药准字H20233008",13.16,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山西省,来源年份:2024,采购价:13.16],[来源省份:广东省,来源年份:2023,采购价:13.16],[来源省份:山东省,来源年份:2023,采购价:13.16]","通过","不高于中位价"]
[3114326,"XM01AEL283V006010184552","洛索洛芬钠凝胶贴膏","贴膏剂","每贴(14cm×10cm)含膏体10g,含洛索洛芬钠100mg(以C₁₅H₁₇NaO₃计)","7","武汉法玛星制药有限公司","武汉法玛星制药有限公司","国药准字H20253634",109.06,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:109.06],[来源省份:广东省,来源年份:2025,采购价:109.06],[来源省份:湖南省,来源年份:2025,采购价:109.06]","通过","不高于中位价"]
[3116061,"XM01AET056V001010205491","酮洛芬贴片","贴剂","每片7cm×10cm,含酮洛芬20mg","5","贵州联盛药业有限公司","贵州联盛药业有限公司","国药准字H20173047",49.95,"本企业已挂网药品新增包装规格","[来源省份:湖南省,来源年份:2025,采购价:49.95],[来源省份:辽宁省,来源年份:2025,采购价:49.95],[来源省份:山东省,来源年份:2025,采购价:49.95]","通过","同厂家符合差比"]
[3116390,"XM01AXA165E001010509906","盐酸氨基葡萄糖胶囊","硬胶囊","0.24g(以盐酸氨基葡萄糖计)","180","北京葡立药业有限公司","北京葡立药业有限公司","国药准字H20173212",175.59,"本企业已挂网药品新增包装规格","[来源省份:云南省,来源年份:2024,采购价:175.59],[来源省份:山东省,来源年份:2025,采购价:175.59],[来源省份:陕西省,来源年份:2025,采购价:175.59]","通过","同厂家符合差比"]
[3116062,"XM01AXA267A001010409568","艾拉莫德片","片剂","按C₁₇H₁₄N₂O₆S计25mg","14","重庆圣华曦药业股份有限公司","重庆圣华曦药业股份有限公司","国药准字H20254383",125.97,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:125.97],[来源省份:广西壮族自治区,来源年份:2025,采购价:125.97],[来源省份:贵州省,来源年份:2025,采购价:125.97]","通过","不高于中位价"]
[3116063,"XM01AXA267A001010109568","艾拉莫德片","片剂","按C₁₇H₁₄N₂O₆S计25mg","7","重庆圣华曦药业股份有限公司","重庆圣华曦药业股份有限公司","国药准字H20254383",64.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:64.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:64.60],[来源省份:贵州省,来源年份:2025,采购价:64.60]","通过","不高于中位价"]
[3115838,"XM02AAS197U002010184221","双氯芬酸二乙胺乳胶剂","凝胶剂","1%(20g:0.2g,按C₁₄H₁₀Cl₂NNaO₂计)","3","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","国药准字H20254434",51.45,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:51.45],[来源省份:广西壮族自治区,来源年份:2025,采购价:51.45],[来源省份:湖北省,来源年份:2025,采购价:51.45]","通过","不高于中位价"]
[3115837,"XM02AAS197U002010284221","双氯芬酸二乙胺乳胶剂","凝胶剂","1%(20g:0.2g,按C₁₄H₁₀Cl₂NNaO₂计)","2","浙江赛默制药有限公司","浙江高跖医药科技股份有限公司","国药准字H20254434",34.3,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:34.30],[来源省份:广西壮族自治区,来源年份:2025,采购价:34.30],[来源省份:湖北省,来源年份:2025,采购价:34.30]","通过","不高于中位价"]
[3115464,"XM03BXT046A001010301510","盐酸替扎尼定片","片剂","1mg(按C₉H₈ClN₅S计)","48","江苏亚邦爱普森药业有限公司","江苏亚邦爱普森药业有限公司","国药准字H20041750",59.81,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:59.81],[来源省份:贵州省,来源年份:2025,采购价:59.81],[来源省份:广西壮族自治区,来源年份:2025,采购价:59.81]","通过","不高于中位价"]
[3116602,"XM04ACQ079A001010205650","秋水仙碱片","片剂","0.5mg","40","云南昊邦制药有限公司","云南昊邦制药有限公司","国药准字H53021798",6.9,"不高于同质量层次药品最低价申报","[来源省份:江苏省,来源年份:2024,采购价:6.90],[来源省份:吉林省,来源年份:2024,采购价:6.90],[来源省份:广东省,来源年份:2024,采购价:6.90]","通过","不高于同组最低价"]
[3116501,"XM09AXG112A001010201598","骨肽片","片剂","0.3g(每片含多肽类物质不低于40mg)","36","南京新百药业有限公司","南京新百药业有限公司","国药准字H32020002",21.6,"不高于同质量层次药品最低价申报","[来源省份:内蒙古自治区,来源年份:2025,采购价:21.60],[来源省份:湖南省,来源年份:2025,采购价:21.60],[来源省份:江苏省,来源年份:2025,采购价:21.60]","通过","不高于同组最低价"]
[3115496,"XN01AXY337B002010101749","依托咪酯中/长链脂肪乳注射液","注射剂","10ml:20mg","1","扬子江药业集团有限公司","扬子江药业集团有限公司","国药准字H20249023",33.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:33.60],[来源省份:贵州省,来源年份:2025,采购价:33.60],[来源省份:黑龙江省,来源年份:2025,采购价:33.60]","通过","不高于中位价"]
[3115535,"XN01BBL053F002010180651","利丙双卡因乳膏","乳膏剂","5g:利多卡因125mg与丙胺卡因125mg","1","福元药业有限公司","福元药业有限公司","国药准字H20254749",54.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:54.60],[来源省份:黑龙江省,来源年份:2025,采购价:54.60],[来源省份:江苏省,来源年份:2025,采购价:54.60]","通过","不高于中位价"]
[3115824,"XN01BBL053F002010484221","利丙双卡因乳膏","乳膏剂","5g:利多卡因125mg与丙胺卡因125mg","2","浙江鼎泰药业股份有限公司","浙江高跖医药科技股份有限公司","国药准字H20253877",149.9,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:149.90],[来源省份:黑龙江省,来源年份:2025,采购价:149.90],[来源省份:江苏省,来源年份:2025,采购价:149.90]","通过","不高于中位价"]
[3115452,"XN02ADP033B002010100951","喷他佐辛注射液","注射剂","1ml∶30mg","1","天津药物研究院药业有限责任公司","天津药物研究院药业有限责任公司","国药准字H20253995",118,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广东省,来源年份:2025,采购价:118.00],[来源省份:黑龙江省,来源年份:2025,采购价:118.00],[来源省份:重庆市,来源年份:2025,采购价:118.00]","通过","不高于中位价"]
[3116042,"XN02BAX092P001010102062","小儿贝诺酯散","散剂","0.2g","10","成都长青制药有限公司","成都长青制药有限公司","国药准字H51023837",65,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2024,采购价:65.00],[来源省份:广东省,来源年份:2018,采购价:65.00],[来源省份:湖南省,来源年份:2023,采购价:65.00],[来源省份:湖北省,来源年份:2022,采购价:65.00],[来源省份:内蒙古自治区,来源年份:2019,采购价:65.00],[来源省份:山西省,来源年份:2023,采购价:65.00],[来源省份:河北省,来源年份:2020,采购价:65.00],[来源省份:山东省,来源年份:2015,采购价:65.00],[来源省份:江苏省,来源年份:2023,采购价:65.00],[来源省份:辽宁省,来源年份:2022,采购价:65.00]","通过","独家"]
[3113700,"XN02CCF749A001010204036","琥珀酸呋罗曲坦片","片剂(薄膜衣片)","2.5mg(按C₁₄H₁₇N₃O 计)","4","青岛国信制药有限公司","正大制药（青岛）有限公司","国药准字H20244535",470.76,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:黑龙江省,来源年份:2025,采购价:470.76],[来源省份:江西省,来源年份:2025,采购价:470.76],[来源省份:安徽省,来源年份:2025,采购价:470.76],[来源省份:贵州省,来源年份:2025,采购价:470.76],[来源省份:海南省,来源年份:2025,采购价:470.76],[来源省份:辽宁省,来源年份:2025,采购价:470.76],[来源省份:广东省,来源年份:2025,采购价:470.76],[来源省份:广西壮族自治区,来源年份:2025,采购价:470.76],[来源省份:重庆市,来源年份:2025,采购价:470.76],[来源省份:四川省,来源年份:2025,采购价:470.76]","通过","独家，提供10省"]
[3116549,"XN03AEL250B002010201435","氯硝西泮注射液","注射剂","1ml:1mg","1","江苏恩华药业股份有限公司","江苏恩华药业股份有限公司","国药准字H20249045",79.8,"不高于同质量层次药品最低价申报","[来源省份:江西省,来源年份:2025,采购价:79.80],[来源省份:辽宁省,来源年份:2025,采购价:79.80],[来源省份:陕西省,来源年份:2025,采购价:79.80]","通过","不高于同组最低价"]
[3109044,"XN03AGB231A010010104971","丙戊酸钠缓释片(Ⅰ)","片剂","0.5g(以丙戊酸钠计)","30","湖南省湘中制药有限公司","湖南省湘中制药有限公司","国药准字H20249693",45.3,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:45.30],[来源省份:广东省,来源年份:2025,采购价:51.60],[来源省份:安徽省,来源年份:2025,采购价:51.60]","通过","不高于中位价"]
[3113709,"XN04BCL337A010010184206","盐酸罗匹尼罗缓释片","片剂","2mg(以C₁₆H₂₄N₂O计)","28","广州玻思韬控释药业有限公司","杭州和泽坤元药业有限公司","国药准字H20249538",195.16,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:195.16],[来源省份:安徽省,来源年份:2025,采购价:195.16],[来源省份:贵州省,来源年份:2025,采购价:195.16]","通过","不高于中位价"]
[3115480,"XN05ADF085A001010104658","氟哌啶醇片","片剂","2mg","100","浙江京新药业股份有限公司","浙江京新药业股份有限公司","国药准字H20254337",27.25,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:27.25],[来源省份:重庆市,来源年份:2025,采购价:27.25],[来源省份:广西壮族自治区,来源年份:2025,采购价:27.25]","通过","不高于中位价"]
[3116676,"XN05AEL375A001010101066","盐酸鲁拉西酮片","片剂(薄膜衣片)","按C₂₈H₃₆N₄O₂S·HCl计:40mg","30","重庆药友制药有限责任公司","重庆药友制药有限责任公司","国药准字H20243106",117,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:117.00],[来源省份:江西省,来源年份:2025,采购价:117.00],[来源省份:贵州省,来源年份:2025,采购价:117.00]","通过","不高于中选价"]
[3115474,"XN05AHA394E001040484817","奥氮平氟西汀胶囊","胶囊剂","奥氮平3mg与氟西汀25mg","7","江苏长泰药业股份有限公司","江苏长泰药业股份有限公司","国药准字H20233848",208.29,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:208.29],[来源省份:贵州省,来源年份:2025,采购价:208.29],[来源省份:江西省,来源年份:2025,采购价:208.29]","通过","同厂家符合差比"]
[3116633,"XN05CFZ077A001010100340","佐匹克隆片","薄膜衣片","7.5mg","7","广东华润顺峰药业有限公司","广东华润顺峰药业有限公司","国药准字H10980247",18.1,"本企业已挂网药品新增包装规格","[来源省份:安徽省,来源年份:2024,采购价:18.91],[来源省份:天津市,来源年份:2025,采购价:18.91],[来源省份:吉林省,来源年份:2022,采购价:18.10]","通过","同厂家符合差比"]
[3116499,"XN06ABA225A001030104646","草酸艾司西酞普兰片","片剂(薄膜衣片)","20mg(以C20H21FN2O计)","12","浙江赛默制药有限公司","浙江百代医药科技有限公司","国药准字H20213475",24.9,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:24.90],[来源省份:河北省,来源年份:2025,采购价:24.90],[来源省份:江苏省,来源年份:2025,采购价:24.90]","通过","不高于中选价"]
[3115588,"XN06ABF071A001020204339","马来酸氟伏沙明片","片剂(薄膜衣片)","100mg","30","安徽省先锋制药有限公司","安徽省先锋制药有限公司","国药准字H20249544",99.95,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:99.95],[来源省份:浙江省,来源年份:2025,采购价:99.95],[来源省份:黑龙江省,来源年份:2025,采购价:99.95]","通过","同厂家符合差比"]
[3115587,"XN06ABF071A001010304339","马来酸氟伏沙明片","片剂(薄膜衣片)","50mg","36","安徽省先锋制药有限公司","安徽省先锋制药有限公司","国药准字H20249543",70.08,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:浙江省,来源年份:2025,采购价:70.08],[来源省份:宁夏回族自治区,来源年份:2025,采购价:70.08],[来源省份:江苏省,来源年份:2025,采购价:70.08]","通过","同厂家符合差比"]
[3115659,"XN06ABF071A001010185085","马来酸氟伏沙明片","片剂","50mg","30","安徽艾立德制药有限公司","安徽艾立德制药有限公司","国药准字H20254643",60.5,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:60.50],[来源省份:贵州省,来源年份:2025,采购价:60.50],[来源省份:安徽省,来源年份:2025,采购价:60.50]","通过","不高于中位价"]
[3115605,"XN06AXA268A001010284874","阿戈美拉汀片","片剂(薄膜衣片)","25mg","14","杭州领业医药科技有限公司","杭州领业医药科技有限公司","国药准字H20249652",137.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:137.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:137.20],[来源省份:江苏省,来源年份:2025,采购价:137.20]","通过","不高于中位价"]
[3113743,"XN06AXQ113A001010183251","盐酸曲唑酮片","薄膜衣片","50mg","30","吉林天衡英睿制药有限公司","深圳市泛谷药业股份有限公司","国药准字H20254458",66,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:66.00],[来源省份:贵州省,来源年份:2025,采购价:66.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:66.00]","通过","不高于中位价"]
[3116064,"XN06AXQ113A001020183251","盐酸曲唑酮片","薄膜衣片","100mg","30","吉林天衡英睿制药有限公司","深圳市泛谷药业股份有限公司","国药准字H20254459",112.2,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:112.20],[来源省份:广西壮族自治区,来源年份:2025,采购价:112.20],[来源省份:贵州省,来源年份:2025,采购价:112.20]","通过","不高于中位价"]
[3116039,"XN06AXQ113A001010184736","盐酸曲唑酮片","片剂","50mg","20","江西科睿药业有限公司","江西科睿药业有限公司","国药准字H20254738",44.6,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:海南省,来源年份:2025,采购价:44.60],[来源省份:江苏省,来源年份:2025,采购价:44.60],[来源省份:贵州省,来源年份:2025,采购价:44.60]","通过","不高于中位价"]
[3116460,"XN06BXJ053E001010400225","盐酸甲氯芬酯胶囊","硬胶囊","0.1g","12","华润紫竹药业有限公司","华润紫竹药业有限公司","国药准字H11021375",69.6,"不高于同质量层次药品最低价申报","[来源省份:江苏省,来源年份:2025,采购价:69.60],[来源省份:贵州省,来源年份:2025,采购价:69.90],[来源省份:广西壮族自治区,来源年份:2025,采购价:69.60]","通过","不高于同组最低价"]
[3115586,"XN06BXJ053E001010300808","盐酸甲氯芬酯胶囊","胶囊剂","0.1g","12","上海旭东海普药业有限公司","上海旭东海普药业有限公司","国药准字H31022146",69.6,"不高于同质量层次药品最低价申报","[来源省份:广东省,来源年份:2025,采购价:69.60],[来源省份:江苏省,来源年份:2025,采购价:69.60],[来源省份:河北省,来源年份:2025,采购价:69.60]","通过","不高于同组最低价"]
[3114367,"XN07CAB046A001010284029","盐酸倍他司汀片","片剂","8mg","24","济南永宁制药股份有限公司","森淼(山东)药业有限公司","国药准字H20243912",53.72,"本企业已挂网药品新增包装规格","[来源省份:山东省,来源年份:2025,采购价:53.72],[来源省份:浙江省,来源年份:2025,采购价:53.72],[来源省份:黑龙江省,来源年份:2025,采购价:53.72]","通过","同厂家符合差比"]
[3115680,"XN07XXB220B002040102763","胞磷胆碱钠注射液","注射剂","2ml:0.5g(按C₁₄H₂₆N₄O₁₁P₂计)","1","石家庄四药有限公司","石家庄四药有限公司","国药准字H20258144",2.53,"本企业已挂网药品新增包装规格","[来源省份:江苏省,来源年份:2025,采购价:2.53],[来源省份:海南省,来源年份:2025,采购价:2.53],[来源省份:山东省,来源年份:2025,采购价:2.53]","通过","同厂家符合差比"]
[3112668,"XR01ADH105L001010104355","环索奈德气雾剂","气雾剂","每瓶100揿,每揿含环索奈德100μg","1","安徽威尔曼制药有限公司","安徽威尔曼制药有限公司","国药准字H20120114",226,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:226.00],[来源省份:辽宁省,来源年份:2025,采购价:226.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:226.00],[来源省份:黑龙江省,来源年份:2025,采购价:226.00],[来源省份:甘肃省,来源年份:2025,采购价:226.00],[来源省份:吉林省,来源年份:2025,采购价:226.00],[来源省份:贵州省,来源年份:2025,采购价:226.00],[来源省份:江苏省,来源年份:2025,采购价:226.00],[来源省份:云南省,来源年份:2025,采购价:226.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:226.00]","通过","独家"]
[3115523,"XR03ACB127L020020184231","盐酸丙卡特罗吸入溶液","吸入制剂","按C₁₆H₂₂N₂O₃·HCl·½H₂O计0.5ml:50μg","10","浙江赛默制药有限公司","国铭制药（海南）有限公司","国药准字H20253328",149.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:湖北省,来源年份:2025,采购价:149.80],[来源省份:江西省,来源年份:2025,采购价:149.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:149.80]","通过","不高于中位价"]
[3113186,"XR03ACF104L020010481450","富马酸福莫特罗吸入溶液","吸入制剂","2ml:20µg[按(C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计]","10","长风药业股份有限公司","长风药业股份有限公司","国药准字H20253076",430,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2025,采购价:435.00],[来源省份:黑龙江省,来源年份:2025,采购价:435.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:435.00]","通过","不高于中位价"]
[3115665,"XR03CCA199X001020184568","氨溴特罗口服溶液","口服溶液剂","60ml:盐酸氨溴索90mg与盐酸克仑特罗60μg","1","湖北午时药业股份有限公司","湖北午时药业股份有限公司","国药准字H20249809",23.88,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:23.88],[来源省份:广东省,来源年份:2025,采购价:23.88],[来源省份:黑龙江省,来源年份:2025,采购价:23.88]","通过","不高于中位价"]
[3109470,"XR03CCB127X001010104303","盐酸丙卡特罗口服溶液","口服溶液剂","60ml:0.30mg","1","安徽环球药业股份有限公司","安徽环球药业股份有限公司","国药准字H20244975",31,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:47.10],[来源省份:广西壮族自治区,来源年份:2025,采购价:47.10],[来源省份:湖北省,来源年份:2025,采购价:47.10],[来源省份:四川省,来源年份:2025,采购价:47.10]","通过","不高于中位价"]
[3115834,"XR03CCB127X001010183033","盐酸丙卡特罗口服溶液","口服溶液剂","100ml:0.5mg","1","河北仁合益康药业有限公司","仁合益康集团有限公司","国药准字H20254528",31.23,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:安徽省,来源年份:2025,采购价:31.23],[来源省份:贵州省,来源年份:2025,采购价:31.23],[来源省份:江苏省,来源年份:2025,采购价:31.23]","通过","不高于中位价"]
[3116475,"XR03DAD179B002010184568","多索茶碱注射液","注射剂","10ml︰0.1g","1","湖北午时药业股份有限公司","湖北午时药业股份有限公司","国药准字H20253668",3.24,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:3.24],[来源省份:江西省,来源年份:2025,采购价:3.24],[来源省份:重庆市,来源年份:2025,采购价:3.24]","通过","不高于中选价"]
[3113679,"XR03DCM082A005010202251","孟鲁司特钠咀嚼片","片剂","5mg(以孟鲁司特计)","10","四川依科制药有限公司","四川依科制药有限公司","国药准字H20244957",9.95,"国家集采非中选药品申报","[来源省份:安徽省,来源年份:2025,采购价:9.95],[来源省份:甘肃省,来源年份:2025,采购价:9.95],[来源省份:江西省,来源年份:2025,采购价:9.95],[来源省份:陕西省,来源年份:2025,采购价:9.95],[来源省份:湖北省,来源年份:2025,采购价:9.95],[来源省份:广东省,来源年份:2025,采购价:9.95]","通过","不高于未中选最低价"]
[3113680,"XR03DCM082A005010102251","孟鲁司特钠咀嚼片","片剂","5mg(以孟鲁司特计)","20","四川依科制药有限公司","四川依科制药有限公司","国药准字H20244957",19.9,"国家集采非中选药品申报","[来源省份:江西省,来源年份:2025,采购价:19.90],[来源省份:海南省,来源年份:2025,采购价:19.90],[来源省份:四川省,来源年份:2025,采购价:19.90],[来源省份:湖南省,来源年份:2025,采购价:19.90]","通过","不高于未中选最低价"]
[3116616,"XR05CBF100X001010101467","福多司坦口服溶液","口服溶液剂","100ml:8g(100ml/瓶)","1","南京海纳制药有限公司","江苏联环药业股份有限公司","国药准字H20253714",48,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:48.00],[来源省份:贵州省,来源年份:2025,采购价:48.00],[来源省份:江苏省,来源年份:2025,采购价:48.00]","通过","不高于中位价"]
[3116077,"XR05CBF100X001010184204","福多司坦口服溶液","口服溶液剂","100ml:8g(100ml/瓶)","1","太极集团四川太极制药有限公司","四川益生智同医药生物科技发展有限公司","国药准字H20253709",44.55,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:44.55],[来源省份:山东省,来源年份:2025,采购价:44.55],[来源省份:江西省,来源年份:2025,采购价:44.55]","通过","不高于中位价"]
[3114351,"XR05CBX169X001020183719","盐酸溴己新口服溶液","口服溶液剂","100ml:0.16g","1","安徽永生堂药业有限责任公司","合肥国药诺和药业有限公司","国药准字H20244507",29.67,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:35.80],[来源省份:江苏省,来源年份:2025,采购价:35.80],[来源省份:湖北省,来源年份:2025,采购价:35.80]","通过","不高于中位价"]
[3115507,"XR05CBX169X001010284160","盐酸溴己新口服溶液","口服溶液剂","100ml:0.2g","1","浙江赛默制药有限公司","海南康成药业有限公司","国药准字H20254405",35.18,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江苏省,来源年份:2025,采购价:35.18],[来源省份:湖北省,来源年份:2025,采购价:35.18],[来源省份:广西壮族自治区,来源年份:2025,采购价:35.18]","通过","不高于中位价"]
[3115906,"XR05CBY116L019010209592","吸入用乙酰半胱氨酸溶液","吸入制剂","3ml:0.3g","6","朗天药业(湖北)有限公司","朗天药业（湖北）有限公司","国药准字H20254647",55.8,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:山东省,来源年份:2025,采购价:55.80],[来源省份:江苏省,来源年份:2025,采购价:58.80],[来源省份:贵州省,来源年份:2025,采购价:58.80]","通过","不高于中位价"]
[3115639,"XR05FBF331K001010201859","复方桔梗麻黄碱糖浆","糖浆剂","复方(120ml/瓶)","1","湖北盛通药业有限公司","湖北盛通药业有限公司","国药准字H42022871",18.17,"已有10个省级平台挂网的独家药品","[来源省份:宁夏回族自治区,来源年份:2024,采购价:18.17],[来源省份:海南省,来源年份:2024,采购价:18.17],[来源省份:湖南省,来源年份:2025,采购价:18.17],[来源省份:吉林省,来源年份:2024,采购价:18.17],[来源省份:陕西省,来源年份:2024,采购价:18.17],[来源省份:云南省,来源年份:2024,采购价:18.17],[来源省份:内蒙古自治区,来源年份:2024,采购价:18.17],[来源省份:黑龙江省,来源年份:2024,采购价:18.17],[来源省份:江西省,来源年份:2024,采购价:18.17],[来源省份:广西壮族自治区,来源年份:2024,采购价:18.17]","通过","独家"]
[3116041,"XR05XXF275K001010102062","复方甘草氯化铵糖浆","糖浆剂","复方(100ml/瓶)","1","成都长青制药有限公司","成都长青制药有限公司","国药准字H51023320",39.8,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2024,采购价:39.80],[来源省份:辽宁省,来源年份:2022,采购价:39.80],[来源省份:江苏省,来源年份:2024,采购价:39.80],[来源省份:山东省,来源年份:2015,采购价:39.80],[来源省份:河北省,来源年份:2020,采购价:39.80],[来源省份:山西省,来源年份:2017,采购价:39.80],[来源省份:内蒙古自治区,来源年份:2020,采购价:39.80],[来源省份:湖北省,来源年份:2022,采购价:39.80],[来源省份:湖南省,来源年份:2016,采购价:39.80],[来源省份:广东省,来源年份:2021,采购价:39.80]","通过","独家"]
[3115058,"XR05XXK002A001030103916","咖酚伪麻片","片剂","每片含主要成份对乙酰氨基酚500毫克,盐酸伪麻黄碱20毫克,咖啡因10毫克。","36","内蒙古通辽制药股份有限公司","内蒙古通辽制药股份有限公司","国药准字H10960142",41.05,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:41.94],[来源省份:安徽省,来源年份:2025,采购价:41.94],[来源省份:湖南省,来源年份:2025,采购价:41.94]","通过","同厂家符合差比"]
[3116478,"XR05XXY222A001020102909","愈美片","薄膜衣片","愈创木酚甘油醚100mg、氢溴酸右美沙芬15mg","10","山西兰花药业股份有限公司","山西兰花药业股份有限公司","国药准字H19990039",30.65,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:30.65],[来源省份:江西省,来源年份:2025,采购价:30.65],[来源省份:黑龙江省,来源年份:2025,采购价:30.65]","通过","同厂家符合差比"]
[3115263,"XR06AAC010A001010501450","茶苯海明片","片剂","25mg","18","江苏黄河药业股份有限公司","江苏黄河药业股份有限公司","国药准字H32025845",35.47,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2024,采购价:35.47],[来源省份:云南省,来源年份:2024,采购价:35.47],[来源省份:新疆生产建设兵团,来源年份:2024,采购价:35.47],[来源省份:黑龙江省,来源年份:2024,采购价:35.47],[来源省份:辽宁省,来源年份:2025,采购价:35.47],[来源省份:江西省,来源年份:2024,采购价:35.47],[来源省份:湖北省,来源年份:2024,采购价:35.47],[来源省份:海南省,来源年份:2024,采购价:35.47],[来源省份:安徽省,来源年份:2024,采购价:35.47],[来源省份:内蒙古自治区,来源年份:2024,采购价:35.47]","通过","同厂家符合差比"]
[3116494,"XR06AXA016E001010301003","阿伐斯汀胶囊","硬胶囊","8mg","30","重庆华邦制药有限公司","重庆华邦制药有限公司","国药准字H20083406",30.33,"本企业已挂网药品新增包装规格","[来源省份:甘肃省,来源年份:2025,采购价:30.33],[来源省份:江苏省,来源年份:2025,采购价:30.33],[来源省份:浙江省,来源年份:2025,采购价:30.33]","通过","同厂家符合差比"]
[3116505,"XR06AXY065A001010800698","依巴斯汀片","片剂(薄膜衣片)","10mg","10","上海理想制药有限公司","上海理想制药有限公司","国药准字H20249121",16.89,"国家集采非中选药品申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:16.89],[来源省份:浙江省,来源年份:2025,采购价:16.89],[来源省份:贵州省,来源年份:2025,采购价:16.89]","通过","同厂家符合差比"]
[3115766,"XS01AAT125G010010100612","妥布霉素滴眼液","滴眼剂","0.4ml:1.2mg","10","珠海亿胜生物制药有限公司","珠海亿胜生物制药有限公司","国药准字H20163363",30,"本企业已挂网药品新增包装规格","[来源省份:北京市,来源年份:2024,采购价:30.00],[来源省份:湖北省,来源年份:2022,采购价:30.00],[来源省份:安徽省,来源年份:2023,采购价:30.00]","通过","同厂家符合差比"]
[2002313,"XS01BCP089G010010101503","普拉洛芬滴眼液","眼用制剂","0.1%(5ml:5mg)","1","江苏万高药业股份有限公司","江苏万高药业股份有限公司","国药准字H20244177",20.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:宁夏回族自治区,来源年份:2024,采购价:33.90],[来源省份:新疆维吾尔自治区,来源年份:2024,采购价:33.90],[来源省份:广西壮族自治区,来源年份:2024,采购价:33.90]","通过","不高于中位价"]
[3114482,"XS01BCP089G010010184019","普拉洛芬滴眼液","眼用制剂","0.1%(5ml﹕5mg)","1","杭州民生药业股份有限公司","广州仁恒医药科技股份有限公司","国药准字H20244176",20.45,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:辽宁省,来源年份:2025,采购价:20.45],[来源省份:广东省,来源年份:2025,采购价:20.45],[来源省份:广西壮族自治区,来源年份:2025,采购价:20.45]","通过","不高于中位价"]
[3004912,"XS01BCX230G010030109920","溴芬酸钠滴眼液","眼用制剂","0.1%(0.4ml:0.4mg,按C₁₅H₁₁BrNNaO₃•1½H₂O计)","10","中山万汉制药有限公司","中山万汉制药有限公司","国药准字H20243868",43.2,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:45.39],[来源省份:江西省,来源年份:2025,采购价:45.39],[来源省份:江苏省,来源年份:2025,采购价:45.39]","通过","同厂家符合差比"]
[3115503,"XS01EAX174G010010100371","酒石酸溴莫尼定滴眼液","眼用制剂","0.2%(5ml∶10mg)","1","广东众生药业股份有限公司","广东众生药业股份有限公司","国药准字H20253121",41.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:41.70],[来源省份:江苏省,来源年份:2025,采购价:41.70],[来源省份:湖北省,来源年份:2025,采购价:41.70]","通过","不高于中位价"]
[3116630,"XS01FAF508G010010101652","复方托吡卡胺滴眼液","眼用制剂","10ml∶托吡卡胺50mg与盐酸去氧肾上腺素50mg","1","苏州乐珠制药有限公司","苏州乐珠制药有限公司","国药准字H20253480",24.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:24.10],[来源省份:宁夏回族自治区,来源年份:2025,采购价:24.10],[来源省份:贵州省,来源年份:2025,采购价:24.10]","通过","不高于中位价"]
[3115681,"XV03AFY023B002010401066","亚叶酸钙注射液","注射液","10ml:0.1g","1","重庆药友制药有限责任公司","重庆药友制药有限责任公司","国药准字H20010615",24,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:新疆维吾尔自治区,来源年份:2022,采购价:24.00],[来源省份:四川省,来源年份:2021,采购价:24.00],[来源省份:贵州省,来源年份:2022,采购价:24.00]","通过","不高于中位价"]
[3113730,"XV03AFY023B002010184659","亚叶酸钙注射液","注射剂","10ml:0.1g(按C₂₀H₂₃N₇O₇计)","1","马鞍山丰原制药有限公司","江苏瑜兴医药科技有限公司","国药准字H20253950",23.97,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:贵州省,来源年份:2025,采购价:31.38],[来源省份:黑龙江省,来源年份:2025,采购价:31.38],[来源省份:江苏省,来源年份:2025,采购价:31.38]","通过","不高于中位价"]
[3114614,"XV08ABD117B002010102180","碘普罗胺注射液","注射剂","100ml:76.89g","1","四川科伦药业股份有限公司","四川科伦药业股份有限公司","国药准字H20249781",268.96,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:269.00],[来源省份:江苏省,来源年份:2025,采购价:269.00],[来源省份:重庆市,来源年份:2025,采购价:269.00]","通过","同厂家符合差比"]
[3115528,"ZA01AAG0120010405310","感冒清热颗粒","颗粒剂","每袋装3克","8","江西京通美联药业有限公司","江西京通美联药业有限公司","国药准字Z36021225",17.6,"本企业已挂网药品新增包装规格","[来源省份:山东省,来源年份:2023,采购价:17.60],[来源省份:湖南省,来源年份:2024,采购价:17.60],[来源省份:云南省,来源年份:2024,采购价:17.60]","通过","同厂家符合差比"]
[3116691,"ZA01BAX0344010100428","小儿保安丸","丸剂(大蜜丸)","每丸重1.5g","6","广州白云山中一药业有限公司","广州白云山中一药业有限公司","国药准字Z44020070",108,"已有10个省级平台挂网的独家药品","[来源省份:四川省,来源年份:2025,采购价:108.00],[来源省份:陕西省,来源年份:2025,采购价:108.00],[来源省份:海南省,来源年份:2025,采购价:108.00],[来源省份:贵州省,来源年份:2025,采购价:108.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:108.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:108.00],[来源省份:黑龙江省,来源年份:2025,采购价:108.00],[来源省份:江西省,来源年份:2025,采购价:108.00],[来源省份:广东省,来源年份:2025,采购价:108.00],[来源省份:安徽省,来源年份:2025,采购价:108.00]","通过","独家"]
[3115598,"ZA01BAX0377020405095","小儿感冒颗粒","颗粒剂","每袋装12g","15","恒拓集团南宁仁盛制药有限公司","恒拓集团南宁仁盛制药有限公司","国药准字Z45020936",17.55,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:17.55],[来源省份:安徽省,来源年份:2025,采购价:17.55],[来源省份:广东省,来源年份:2025,采购价:17.55]","通过","同厂家符合差比"]
[3115475,"ZA01CAF0010010302683","防风通圣丸","丸剂(水丸)","每20丸重1克,6g/袋","14","河北永丰药业有限公司","河北永丰药业有限公司","国药准字Z13020419",55.95,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:55.95],[来源省份:重庆市,来源年份:2025,采购价:55.95],[来源省份:广东省,来源年份:2025,采购价:55.95]","通过","同厂家符合差比"]
[3116456,"ZA01CAX0333020102140","小柴胡颗粒","颗粒剂","每袋装10g","15","四川逢春制药有限公司","四川逢春制药有限公司","国药准字Z51020112",8.7,"本企业已挂网药品新增包装规格","[来源省份:北京市,来源年份:2025,采购价:8.70],[来源省份:广东省,来源年份:2025,采购价:8.70],[来源省份:河北省,来源年份:2025,采购价:8.70]","通过","同厂家符合差比"]
[3115560,"ZA04AAX0759070205690","熊胆粉","散剂","0.3g/瓶","10","瑞丽彩云南集团药业有限公司","瑞丽彩云南集团药业有限公司","国药准字Z19991017",858,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:858.00],[来源省份:江苏省,来源年份:2025,采购价:858.00],[来源省份:湖南省,来源年份:2025,采购价:858.00],[来源省份:贵州省,来源年份:2025,采购价:858.00],[来源省份:安徽省,来源年份:2025,采购价:858.00],[来源省份:黑龙江省,来源年份:2025,采购价:858.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:858.00],[来源省份:海南省,来源年份:2025,采购价:858.00],[来源省份:湖北省,来源年份:2025,采购价:858.00],[来源省份:江西省,来源年份:2025,采购价:858.00]","通过","独家"]
[3111920,"ZA04BAJ0281010200608","解毒活血栓","栓剂","每粒重2g","8","珠海星光制药有限公司","珠海星光制药有限公司","国药准字Z20080064",40.63,"本企业已挂网药品新增包装规格","[来源省份:内蒙古自治区,来源年份:2024,采购价:40.63],[来源省份:陕西省,来源年份:2025,采购价:40.63],[来源省份:贵州省,来源年份:2025,采购价:40.63],[来源省份:湖北省,来源年份:2022,采购价:40.63],[来源省份:云南省,来源年份:2025,采购价:40.63],[来源省份:江西省,来源年份:2025,采购价:40.63],[来源省份:广西壮族自治区,来源年份:2024,采购价:40.63],[来源省份:湖南省,来源年份:2025,采购价:40.63],[来源省份:新疆生产建设兵团,来源年份:2025,采购价:40.63],[来源省份:河北省,来源年份:2023,采购价:40.63]","通过","同厂家符合差比"]
[3116400,"ZA04BAR0018020100150","热炎宁颗粒","颗粒剂","每袋装16g","6","河北康芝制药有限公司","康芝药业股份有限公司","国药准字Z11020047",39,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2024,采购价:39.00],[来源省份:贵州省,来源年份:2023,采购价:39.00],[来源省份:安徽省,来源年份:2024,采购价:39.00],[来源省份:黑龙江省,来源年份:2024,采购价:39.00],[来源省份:辽宁省,来源年份:2024,采购价:39.00],[来源省份:重庆市,来源年份:2025,采购价:39.00],[来源省份:宁夏回族自治区,来源年份:2024,采购价:39.00],[来源省份:陕西省,来源年份:2024,采购价:39.00],[来源省份:新疆维吾尔自治区,来源年份:2024,采购价:39.00],[来源省份:江西省,来源年份:2025,采购价:39.00]","通过","独家"]
[3116414,"ZA04BAX0475010100150","小儿清解颗粒","颗粒剂","每袋重10g","6","康芝药业股份有限公司","康芝药业股份有限公司","国药准字Z11020051",45.6,"已有10个省级平台挂网的独家药品","[来源省份:甘肃省,来源年份:2025,采购价:45.60],[来源省份:江苏省,来源年份:2025,采购价:45.60],[来源省份:吉林省,来源年份:2025,采购价:45.60],[来源省份:黑龙江省,来源年份:2025,采购价:45.60],[来源省份:海南省,来源年份:2025,采购价:45.60],[来源省份:重庆市,来源年份:2025,采购价:45.60],[来源省份:宁夏回族自治区,来源年份:2025,采购价:45.60],[来源省份:贵州省,来源年份:2025,采购价:45.60],[来源省份:广东省,来源年份:2025,采购价:45.60],[来源省份:广西壮族自治区,来源年份:2025,采购价:45.60]","通过","独家"]
[84309,"ZA04BAZ0349010105363","肿节风片","糖衣片","片心重0.25g","60","江西康恩贝天施康药业有限公司","江西康恩贝天施康药业有限公司","国药准字Z36021677",25.72,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2023,采购价:25.72],[来源省份:江西省,来源年份:2024,采购价:25.72],[来源省份:贵州省,来源年份:2022,采购价:25.72]","通过","不高于同组最低价"]
[3116391,"ZA04CAY0605010102210","鱼腥草注射液","注射液","2ml","1","四川升和药业股份有限公司","四川升和药业股份有限公司","国药准字Z51021473",5.8,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2023,采购价:5.80],[来源省份:辽宁省,来源年份:2022,采购价:5.80],[来源省份:广西壮族自治区,来源年份:2022,采购价:5.80]","通过","不高于同组最低价"]
[3114639,"ZA04CCD0021010210427","大黄利胆胶囊","胶囊剂","每粒装0.3g(相当于饮片0.3g)","36","贵州瑞和制药有限公司","贵州瑞和制药有限公司","国药准字Z20153052",69.23,"本企业已挂网药品新增包装规格","[来源省份:安徽省,来源年份:2025,采购价:69.23],[来源省份:广西壮族自治区,来源年份:2025,采购价:69.23],[来源省份:北京市,来源年份:2025,采购价:69.23],[来源省份:贵州省,来源年份:2025,采购价:69.23],[来源省份:黑龙江省,来源年份:2025,采购价:69.23],[来源省份:河北省,来源年份:2025,采购价:69.23],[来源省份:江西省,来源年份:2025,采购价:69.23],[来源省份:辽宁省,来源年份:2025,采购价:69.23],[来源省份:宁夏回族自治区,来源年份:2025,采购价:69.23],[来源省份:浙江省,来源年份:2024,采购价:69.23]","通过","同厂家符合差比"]
[3115654,"ZA04CCD0164010205633","胆胃康胶囊","硬胶囊剂","每粒装0.3g","36","云南保元堂药业有限责任公司","云南保元堂药业有限责任公司","国药准字Z20025134",43.37,"本企业已挂网药品新增包装规格","[来源省份:河北省,来源年份:2023,采购价:43.37],[来源省份:辽宁省,来源年份:2021,采购价:43.37],[来源省份:黑龙江省,来源年份:2022,采购价:43.37]","通过","同厂家符合差比"]
[3114718,"ZA05CAS0929010101833","四逆汤","合剂","每支装10ml","10","湖北民康制药有限公司","湖北民康制药有限公司","国药准字Z42021418",98,"已有10个省级平台挂网的独家药品","[来源省份:陕西省,来源年份:2023,采购价:98.00],[来源省份:山东省,来源年份:2024,采购价:98.00],[来源省份:广东省,来源年份:2021,采购价:98.00],[来源省份:福建省,来源年份:2020,采购价:98.00],[来源省份:新疆维吾尔自治区,来源年份:2022,采购价:98.00],[来源省份:海南省,来源年份:2023,采购价:98.00],[来源省份:河北省,来源年份:2023,采购价:98.00],[来源省份:湖南省,来源年份:2025,采购价:98.00],[来源省份:山西省,来源年份:2023,采购价:98.00],[来源省份:四川省,来源年份:2021,采购价:98.00]","通过","独家"]
[3115855,"ZA06BBB0495010178441","标准桃金娘油肠溶胶囊(儿童装)","胶囊剂(肠溶)","每粒装0.240g(含120mg标准桃金娘油)","10","G. Pohl-Boskamp GmbH & Co. KG","国药控股分销中心有限公司","国药准字ZJ20100007",36,"已有10个省级平台挂网的独家药品","[来源省份:北京市,来源年份:2023,采购价:36.00],[来源省份:云南省,来源年份:2023,采购价:36.00],[来源省份:四川省,来源年份:2023,采购价:36.00],[来源省份:广东省,来源年份:2022,采购价:36.00],[来源省份:广西壮族自治区,来源年份:2022,采购价:36.00],[来源省份:贵州省,来源年份:2022,采购价:36.00],[来源省份:河北省,来源年份:2023,采购价:36.00],[来源省份:湖南省,来源年份:2023,采购价:36.00],[来源省份:江西省,来源年份:2023,采购价:36.00],[来源省份:陕西省,来源年份:2022,采购价:36.00]","通过","独家"]
[3115635,"ZA06DAX0488020103767","小儿清热止咳颗粒","颗粒剂","每1克相当于饮片1.7克(每袋装3g)","9","天大药业(珠海)有限公司","天大药业（珠海）有限公司","国药准字Z20033093",58.8,"已有10个省级平台挂网的独家药品","[来源省份:西藏自治区,来源年份:2022,采购价:58.80],[来源省份:重庆市,来源年份:2021,采购价:58.80],[来源省份:湖南省,来源年份:2025,采购价:58.80],[来源省份:广东省,来源年份:2024,采购价:58.80],[来源省份:甘肃省,来源年份:2021,采购价:58.80],[来源省份:青海省,来源年份:2023,采购价:58.80],[来源省份:江苏省,来源年份:2022,采购价:58.80],[来源省份:山东省,来源年份:2020,采购价:58.80],[来源省份:山西省,来源年份:2021,采购价:58.80],[来源省份:云南省,来源年份:2022,采购价:58.80]","通过","独家"]
[3114637,"ZA08BAX0372010100150","小儿腹泻散","散剂","每袋装2g","10","北京顺鑫祥云药业有限责任公司","北京顺鑫祥云药业有限责任公司","国药准字Z11020050",66,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2025,采购价:66.00],[来源省份:安徽省,来源年份:2025,采购价:66.00],[来源省份:广东省,来源年份:2025,采购价:66.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:66.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:66.00],[来源省份:陕西省,来源年份:2025,采购价:66.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:66.00],[来源省份:重庆市,来源年份:2025,采购价:66.00],[来源省份:湖南省,来源年份:2025,采购价:66.00],[来源省份:贵州省,来源年份:2025,采购价:66.00]","通过","独家"]
[3114719,"ZA09BAA0005020106016","阿胶","胶剂","250g/盒","1","伊犁全鹿制药有限公司","伊犁全鹿制药有限公司","国药准字Z65020138",700,"不高于同质量层次药品最低价申报","[来源省份:安徽省,来源年份:2025,采购价:700.00],[来源省份:重庆市,来源年份:2025,采购价:700.00],[来源省份:贵州省,来源年份:2025,采购价:700.00]","通过","不高于同组最低价"]
[3115583,"ZA09BAG0395010404339","归脾胶囊","胶囊剂","每粒装0.3g","180","安徽省先锋制药有限公司,宝龙药业有限公司","安徽省先锋制药有限公司","国药准字Z20123063",279.27,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2024,采购价:300.60],[来源省份:吉林省,来源年份:2024,采购价:300.60],[来源省份:安徽省,来源年份:2025,采购价:300.60]","通过","同厂家符合差比"]
[3115524,"ZA09BAG0398010403136","归脾丸(浓缩丸)","浓缩丸","每8丸相当于饮片3克","296","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021321",22.94,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:22.94],[来源省份:广东省,来源年份:2025,采购价:22.94],[来源省份:黑龙江省,来源年份:2025,采购价:22.94]","通过","同厂家符合差比"]
[3115525,"ZA09CAZ0151020803136","知柏地黄丸(浓缩丸)","浓缩丸","每10丸重1.7克(每8丸相当于原生药3克)","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021330",19.76,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:19.76],[来源省份:广东省,来源年份:2025,采购价:19.76],[来源省份:黑龙江省,来源年份:2025,采购价:19.76]","通过","同厂家符合差比"]
[3115515,"ZA09CCQ0124011003136","杞菊地黄丸(浓缩丸)","浓缩丸","每8丸相当于原药材3克","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021332",19.38,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:19.38],[来源省份:广东省,来源年份:2025,采购价:19.38],[来源省份:广西壮族自治区,来源年份:2025,采购价:19.38]","通过","同厂家符合差比"]
[3115519,"ZA09DBG0448020903136","桂附地黄丸(浓缩丸)","浓缩丸","每8丸相当于原生药3克","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021322",22.8,"本企业已挂网药品新增包装规格","[来源省份:广东省,来源年份:2025,采购价:22.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:22.80],[来源省份:黑龙江省,来源年份:2025,采购价:22.80]","通过","同厂家符合差比"]
[3116681,"ZA09EAB0440010505032","补肾益寿片","片剂","每片重0.4g","180","康普药业股份有限公司","康普药业股份有限公司","国药准字Z20060306",598,"已有10个省级平台挂网的独家药品","[来源省份:重庆市,来源年份:2025,采购价:598.00],[来源省份:四川省,来源年份:2025,采购价:598.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:598.00],[来源省份:吉林省,来源年份:2025,采购价:598.00],[来源省份:黑龙江省,来源年份:2025,采购价:598.00],[来源省份:贵州省,来源年份:2025,采购价:598.00],[来源省份:广东省,来源年份:2025,采购价:598.00],[来源省份:陕西省,来源年份:2025,采购价:598.00],[来源省份:江西省,来源年份:2025,采购价:598.00],[来源省份:西藏自治区,来源年份:2025,采购价:598.00]","通过","独家"]
[3115601,"ZA09FAR0053010481049","人参养荣丸","丸剂(水蜜丸)","每袋装6克","6","石家庄御和堂药业股份有限公司","石家庄御和堂药业股份有限公司","国药准字Z20194085",98.4,"本企业已挂网药品新增包装规格","[来源省份:湖北省,来源年份:2024,采购价:328.00],[来源省份:辽宁省,来源年份:2024,采购价:328.00],[来源省份:陕西省,来源年份:2023,采购价:328.00]","通过","同厂家符合差比"]
[3116469,"ZA10AAZ0011010204579","枣仁安神颗粒","颗粒剂","每袋装5g","10","台州南峰药业有限公司","台州南峰药业有限公司","国药准字Z20003313",48.22,"不高于同质量层次药品最低价申报","[来源省份:贵州省,来源年份:2025,采购价:48.22],[来源省份:湖南省,来源年份:2025,采购价:48.22],[来源省份:河北省,来源年份:2024,采购价:48.22]","通过","不高于同组最低价"]
[68850,"ZA10AAZ0011010104579","枣仁安神颗粒","颗粒剂","每袋装5g","6","台州南峰药业有限公司","台州南峰药业有限公司","国药准字Z20003313",28.93,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2024,采购价:28.93],[来源省份:贵州省,来源年份:2025,采购价:28.93],[来源省份:湖南省,来源年份:2025,采购价:28.93]","通过","不高于同组最低价"]
[3006047,"ZA10AAZ0012010101090","枣仁安神液","口服液","每支装10ml","7","辽宁仙草堂药业有限公司","辽宁仙草堂药业有限公司","国药准字Z20044140",65.19,"不高于同质量层次药品最低价申报","[来源省份:吉林省,来源年份:2025,采购价:65.19],[来源省份:北京市,来源年份:2025,采购价:65.19],[来源省份:广西壮族自治区,来源年份:2025,采购价:65.19],[来源省份:云南省,来源年份:2025,采购价:65.19],[来源省份:江西省,来源年份:2025,采购价:65.19],[来源省份:黑龙江省,来源年份:2025,采购价:65.19],[来源省份:内蒙古自治区,来源年份:2025,采购价:65.19],[来源省份:浙江省,来源年份:2025,采购价:65.19],[来源省份:辽宁省,来源年份:2025,采购价:65.19],[来源省份:湖北省,来源年份:2025,采购价:65.19]","通过","不高于同组最低价"]
[3004548,"ZA12BAH0345010102927","黄杨宁片","片剂","每片含环维黄杨星D1mg","24","山西同达药业有限公司","山西同达药业有限公司","国药准字Z20083153",25.92,"已有10个省级平台挂网的独家药品","[来源省份:海南省,来源年份:2025,采购价:25.92],[来源省份:宁夏回族自治区,来源年份:2024,采购价:25.92],[来源省份:山西省,来源年份:2024,采购价:25.92],[来源省份:四川省,来源年份:2025,采购价:25.92],[来源省份:湖南省,来源年份:2025,采购价:25.92],[来源省份:云南省,来源年份:2025,采购价:25.92],[来源省份:新疆生产建设兵团,来源年份:2025,采购价:25.92],[来源省份:内蒙古自治区,来源年份:2024,采购价:25.92],[来源省份:河北省,来源年份:2024,采购价:25.92],[来源省份:北京市,来源年份:2024,采购价:25.92]","通过","独家"]
[3113428,"ZA12BAL0094010503450","利脑心片","薄膜衣片","每片重0.42g","42","吉林省通化博祥药业股份有限公司","吉林省通化博祥药业股份有限公司","国药准字Z20090470",71.21,"本企业已挂网药品新增包装规格","[来源省份:北京市,来源年份:2025,采购价:71.21],[来源省份:天津市,来源年份:2025,采购价:71.21],[来源省份:河北省,来源年份:2025,采购价:71.21]","通过","同厂家符合差比"]
[3115563,"ZA12HAX0271010202477","消栓通络胶囊","胶囊剂","0.35g","60","西安高科陕西金方药业公司","西安高科陕西金方药业公司","国药准字Z20043707",28.4,"不高于同质量层次药品最低价申报","[来源省份:河北省,来源年份:2025,采购价:28.40],[来源省份:北京市,来源年份:2020,采购价:28.40],[来源省份:陕西省,来源年份:2020,采购价:28.40]","通过","不高于同组最低价"]
[3115494,"ZA13AAK0048010203767","康媛颗粒","颗粒剂","每袋装18g","9","黑龙江省济仁药业有限公司","黑龙江省济仁药业有限公司","国药准字Z20053338",98,"已有10个省级平台挂网的独家药品","[来源省份:广东省,来源年份:2025,采购价:98.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:98.00],[来源省份:贵州省,来源年份:2025,采购价:98.00],[来源省份:黑龙江省,来源年份:2025,采购价:98.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:98.00],[来源省份:湖南省,来源年份:2025,采购价:98.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:98.00],[来源省份:陕西省,来源年份:2025,采购价:98.00],[来源省份:四川省,来源年份:2025,采购价:98.00],[来源省份:天津市,来源年份:2025,采购价:98.00]","通过","独家"]
[3115516,"ZA13AAM0074010200994","慢肝解郁胶囊","胶囊剂(硬胶囊)","每粒装0.25g","36","重庆迪康中药制药有限公司","重庆迪康中药制药有限公司","国药准字Z50020041",36.8,"已有10个省级平台挂网的独家药品","[来源省份:安徽省,来源年份:2025,采购价:36.80],[来源省份:江西省,来源年份:2025,采购价:36.80],[来源省份:广西壮族自治区,来源年份:2025,采购价:36.80],[来源省份:贵州省,来源年份:2025,采购价:36.80],[来源省份:辽宁省,来源年份:2025,采购价:36.80],[来源省份:重庆市,来源年份:2025,采购价:36.80],[来源省份:广东省,来源年份:2025,采购价:36.80],[来源省份:内蒙古自治区,来源年份:2025,采购价:36.80],[来源省份:湖南省,来源年份:2025,采购价:36.80],[来源省份:黑龙江省,来源年份:2025,采购价:36.80]","通过","独家"]
[3115508,"ZA14BAB0244010100347","保和片","片剂","无","80","广东万年青制药股份有限公司","广东万年青制药股份有限公司","国药准字Z44021184",25.36,"不高于同质量层次药品最低价申报","[来源省份:内蒙古自治区,来源年份:2023,采购价:25.36],[来源省份:四川省,来源年份:2024,采购价:25.36],[来源省份:云南省,来源年份:2023,采购价:25.36]","通过","不高于同组最低价"]
[3116048,"ZA15AAQ0570010302537","祛风止痛胶囊","胶囊剂","每粒装0.3g","72","陕西步长制药有限公司","陕西步长制药有限公司","国药准字Z10970038",35.4,"本企业已挂网药品新增包装规格","[来源省份:黑龙江省,来源年份:2025,采购价:35.40],[来源省份:贵州省,来源年份:2025,采购价:35.40],[来源省份:辽宁省,来源年份:2025,采购价:35.40]","通过","同厂家符合差比"]
[3116663,"ZB01CAZ0299010101343","痔疮外洗药","散剂","50g","1","沈阳红药集团股份有限公司","沈阳红药集团股份有限公司","国药准字Z21021859",78,"已有10个省级平台挂网的独家药品","[来源省份:广西壮族自治区,来源年份:2025,采购价:78.00],[来源省份:安徽省,来源年份:2025,采购价:78.00],[来源省份:贵州省,来源年份:2025,采购价:78.00],[来源省份:海南省,来源年份:2025,采购价:78.00],[来源省份:广东省,来源年份:2025,采购价:78.00],[来源省份:江西省,来源年份:2025,采购价:78.00],[来源省份:陕西省,来源年份:2025,采购价:78.00],[来源省份:四川省,来源年份:2025,采购价:78.00],[来源省份:重庆市,来源年份:2025,采购价:78.00],[来源省份:新疆维吾尔自治区,来源年份:2025,采购价:78.00]","通过","独家"]
[3116046,"ZB02AAN0067020103503","内消瘰疬丸","水丸","每袋装9g","10","吉林紫鑫药业股份有限公司","吉林紫鑫药业股份有限公司","国药准字Z22022806",25.9,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:25.90],[来源省份:浙江省,来源年份:2025,采购价:25.90],[来源省份:广西壮族自治区,来源年份:2025,采购价:25.90]","通过","同厂家符合差比"]
[3116045,"ZB02AAN0067020203503","内消瘰疬丸","水丸","每袋装9g","18","吉林紫鑫药业股份有限公司","吉林紫鑫药业股份有限公司","国药准字Z22022806",46.62,"本企业已挂网药品新增包装规格","[来源省份:贵州省,来源年份:2025,采购价:46.62],[来源省份:广西壮族自治区,来源年份:2025,采购价:46.62],[来源省份:浙江省,来源年份:2025,采购价:46.62]","通过","同厂家符合差比"]
[3115633,"ZC02AAQ0328010105794","清肺散结丸","丸剂","3g(每100丸重0.45g)","6","海南国瑞制药有限公司","海南龙圣堂制药有限公司","国药准字Z20026833",700,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2021,采购价:700.00],[来源省份:安徽省,来源年份:2019,采购价:700.00],[来源省份:宁夏回族自治区,来源年份:2025,采购价:700.00],[来源省份:陕西省,来源年份:2024,采购价:700.00],[来源省份:云南省,来源年份:2025,采购价:700.00],[来源省份:湖北省,来源年份:2022,采购价:700.00],[来源省份:广西壮族自治区,来源年份:2022,采购价:700.00],[来源省份:山西省,来源年份:2021,采购价:700.00],[来源省份:四川省,来源年份:2021,采购价:700.00],[来源省份:西藏自治区,来源年份:2022,采购价:700.00]","通过","独家"]
[3116067,"ZD01BAS0300010303946","少腹逐瘀胶囊","胶囊剂","每粒装0.45g","54","杨凌生物医药科技股份有限公司","山东济仁堂制药有限公司","国药准字Z20000085",37.46,"本企业已挂网药品新增包装规格","[来源省份:浙江省,来源年份:2025,采购价:37.46],[来源省份:贵州省,来源年份:2025,采购价:37.46],[来源省份:陕西省,来源年份:2025,采购价:37.46]","通过","同厂家符合差比"]
[3115848,"ZD03AAA0073010381049","安坤赞育丸","丸剂(大蜜丸)","每丸重9g","2","石家庄御和堂药业股份有限公司","石家庄御和堂药业股份有限公司","国药准字Z20204062",199.6,"本企业已挂网药品新增包装规格","[来源省份:江苏省,来源年份:2023,采购价:998.00],[来源省份:浙江省,来源年份:2021,采购价:998.00],[来源省份:辽宁省,来源年份:2024,采购价:998.00]","通过","同厂家符合差比"]
[3116381,"ZD03AAL0040010202369","乐孕宁口服液","合剂","10ml","9","陕西关爱制药有限公司","陕西关爱制药有限公司","国药准字Z20043697",168,"已有10个省级平台挂网的独家药品","[来源省份:贵州省,来源年份:2023,采购价:168.00],[来源省份:四川省,来源年份:2023,采购价:168.00],[来源省份:广东省,来源年份:2022,采购价:168.00],[来源省份:广西壮族自治区,来源年份:2023,采购价:168.00],[来源省份:海南省,来源年份:2023,采购价:168.00],[来源省份:黑龙江省,来源年份:2023,采购价:168.00],[来源省份:辽宁省,来源年份:2023,采购价:168.00],[来源省份:陕西省,来源年份:2023,采购价:168.00],[来源省份:西藏自治区,来源年份:2023,采购价:168.00],[来源省份:云南省,来源年份:2023,采购价:168.00]","通过","独家"]
[3115656,"ZE01AAB0185020180473","板蓝根滴眼液","眼用制剂","每1ml相当于饮片0.5g(每瓶装8ml)","2","四川禾亿制药有限公司","四川禾亿制药有限公司","国药准字Z20153072",75.66,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2025,采购价:75.66],[来源省份:北京市,来源年份:2025,采购价:75.66],[来源省份:广西壮族自治区,来源年份:2025,采购价:75.66]","通过","同厂家符合差比"]
[3115520,"ZE02AAM0144020603136","明目地黄丸(浓缩丸)","浓缩丸","每8丸相当于原生药3克","380","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021326",21.28,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:21.28],[来源省份:广东省,来源年份:2025,采购价:21.28],[来源省份:黑龙江省,来源年份:2025,采购价:21.28]","通过","同厂家符合差比"]
[3115512,"ZF01AAE0037020903136","耳聋左慈丸(浓缩丸)","浓缩丸","每8丸相当于原生药3克","296","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z10983071",17.23,"本企业已挂网药品新增包装规格","[来源省份:广西壮族自治区,来源年份:2025,采购价:17.23],[来源省份:黑龙江省,来源年份:2025,采购价:17.23],[来源省份:广东省,来源年份:2025,采购价:17.23]","通过","同厂家符合差比"]
[3116389,"ZF02AAB0509010100374","鼻咽清毒颗粒","颗粒剂","每袋装20g","10","广州白云山和记黄埔中药有限公司","广州白云山和记黄埔中药有限公司","国药准字Z44022139",602.68,"已有10个省级平台挂网的独家药品","[来源省份:陕西省,来源年份:2022,采购价:602.68],[来源省份:宁夏回族自治区,来源年份:2022,采购价:602.68],[来源省份:北京市,来源年份:2021,采购价:602.68],[来源省份:甘肃省,来源年份:2022,采购价:602.68],[来源省份:内蒙古自治区,来源年份:2022,采购价:602.68],[来源省份:广东省,来源年份:2022,采购价:602.68],[来源省份:山东省,来源年份:2022,采购价:602.68],[来源省份:江西省,来源年份:2022,采购价:602.68],[来源省份:吉林省,来源年份:2022,采购价:602.68],[来源省份:四川省,来源年份:2022,采购价:602.68]","通过","独家"]
[3115683,"ZF03AAX0537010503750","小儿咽扁颗粒","颗粒剂","每袋装4g","12","黑龙江龙桂制药有限公司","黑龙江龙桂制药有限公司","国药准字Z23021992",7.34,"不高于同质量层次药品最低价申报","[来源省份:湖南省,来源年份:2025,采购价:7.34],[来源省份:广西壮族自治区,来源年份:2023,采购价:7.34],[来源省份:贵州省,来源年份:2025,采购价:7.34]","通过","不高于同组最低价"]
[129136,"ZF03AAX0537010303750","小儿咽扁颗粒","颗粒剂","每袋装4g","10","黑龙江龙桂制药有限公司","黑龙江龙桂制药有限公司","国药准字Z23021992",6.12,"不高于同质量层次药品最低价申报","[来源省份:湖南省,来源年份:2025,采购价:6.12],[来源省份:广西壮族自治区,来源年份:2023,采购价:6.12],[来源省份:四川省,来源年份:2025,采购价:6.12]","通过","不高于同组最低价"]
[3116655,"ZF04AAF0703030105535","复方牙痛酊","酊剂","每瓶装5毫升","1","国药集团同济堂(贵州)制药有限公司","国药集团同济堂（贵州）制药有限公司","国药准字Z20025807",41.58,"本企业已挂网药品新增包装规格","[来源省份:重庆市,来源年份:2025,采购价:41.58],[来源省份:陕西省,来源年份:2025,采购价:41.58],[来源省份:贵州省,来源年份:2024,采购价:49.80]","通过","同厂家符合差比"]
[3115510,"ZH01AAF0497010103097","复方硫黄乳膏","软膏剂","每盒250g","1","上海金不换兰考制药有限公司","上海金不换兰考制药有限公司","国药准字Z41021466",25,"不高于同质量层次药品最低价申报","[来源省份:广西壮族自治区,来源年份:2025,采购价:25.00],[来源省份:江西省,来源年份:2025,采购价:25.00],[来源省份:重庆市,来源年份:2025,采购价:25.00]","通过","不高于同组最低价"]
[3115553,"ZZ01AAC0571010103649","参芪温阳阴道膨胀栓","阴道膨胀栓","每粒含药基质重2.3g","1","哈尔滨田美药业股份有限公司","哈尔滨田美药业股份有限公司","国药准字B20020476",158,"已有10个省级平台挂网的独家药品","[来源省份:黑龙江省,来源年份:2025,采购价:158.00],[来源省份:内蒙古自治区,来源年份:2025,采购价:158.00],[来源省份:四川省,来源年份:2025,采购价:158.00],[来源省份:江苏省,来源年份:2025,采购价:158.00],[来源省份:广东省,来源年份:2025,采购价:158.00],[来源省份:贵州省,来源年份:2025,采购价:158.00],[来源省份:安徽省,来源年份:2025,采购价:158.00],[来源省份:广西壮族自治区,来源年份:2025,采购价:158.00],[来源省份:北京市,来源年份:2025,采购价:158.00],[来源省份:湖北省,来源年份:2025,采购价:158.00]","通过","独家"]
[3115634,"XB03AAF611E001010103543","富马酸亚铁胶囊","胶囊剂","0.2克(以铁计66毫克)","12","钓鱼台医药集团吉林长青药业股份有限公司","钓鱼台医药集团吉林长青药业股份有限公司","国药准字H22022074",44.5,"本企业已挂网药品新增包装规格","[来源省份:内蒙古自治区,来源年份:2024,采购价:89.00],[来源省份:黑龙江省,来源年份:2024,采购价:89.00],[来源省份:陕西省,来源年份:2024,采购价:89.00]","通过","同厂家符合差比"]
[3116040,"XB03BAJ038A001010204145","甲钴胺片","片剂","0.5mg","30","山东齐都药业有限公司","山东齐都药业有限公司","国药准字H20254372",9.07,"国家集采非中选药品申报","[来源省份:江苏省,来源年份:2025,采购价:9.07],[来源省份:山东省,来源年份:2025,采购价:9.07],[来源省份:贵州省,来源年份:2025,采购价:9.07]","通过","同厂家符合差比"]
[3115682,"XL01EAD246A001010178377","达沙替尼片","片剂(薄膜衣片)","20mg","60","Dr. Reddy's Laboratories Limited","昆山龙灯瑞迪医药有限公司","国药准字HJ20240086",742.31,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:广西壮族自治区,来源年份:2025,采购价:742.31],[来源省份:贵州省,来源年份:2025,采购价:742.31],[来源省份:重庆市,来源年份:2025,采购价:742.31]","通过","过评，同厂家符合差比"]
[3112003,"XM01ABS120D001010201534","双氯芬酸钾栓","栓剂","12.5mg","10","昆山培力药品有限公司","昆山培力药品有限公司","国药准字H20040193",24.57,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:吉林省,来源年份:无,采购价:45.83],[来源省份:上海市,来源年份:无,采购价:45.83],[来源省份:陕西省,来源年份:2025,采购价:24.57],[来源省份:山东省,来源年份:2025,采购价:24.57],[来源省份:云南省,来源年份:无,采购价:45.83],[来源省份:安徽省,来源年份:无,采购价:45.83],[来源省份:北京市,来源年份:无,采购价:45.83],[来源省份:贵州省,来源年份:无,采购价:45.83],[来源省份:甘肃省,来源年份:2025,采购价:24.57],[来源省份:辽宁省,来源年份:无,采购价:45.83]","通过","同厂家符合差比"]
[3111775,"XM01ABS120D001010101534","双氯芬酸钾栓","栓剂","12.5mg","6","昆山培力药品有限公司","昆山培力药品有限公司","国药准字H20040193",14.74,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:甘肃省,来源年份:2025,采购价:14.74],[来源省份:云南省,来源年份:2024,采购价:27.50],[来源省份:上海市,来源年份:2024,采购价:27.50],[来源省份:陕西省,来源年份:2025,采购价:14.74],[来源省份:山东省,来源年份:2025,采购价:14.74],[来源省份:辽宁省,来源年份:2024,采购价:27.50],[来源省份:吉林省,来源年份:2024,采购价:27.50],[来源省份:安徽省,来源年份:2024,采购价:27.50],[来源省份:北京市,来源年份:2024,采购价:27.50],[来源省份:贵州省,来源年份:2024,采购价:27.50]","通过","同厂家符合差比"]
[3005276,"XS01XAJ166G010010583150","聚乙烯醇滴眼液","眼用制剂","1.4%(0.4毫升:5.6毫克)","15","浙江赛默制药有限公司","四川海梦智森生物制药有限公司","国药准字H20249198",62.1,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:吉林省,来源年份:2025,采购价:62.10],[来源省份:陕西省,来源年份:2025,采购价:62.10],[来源省份:海南省,来源年份:2025,采购价:62.10]","通过","《关于进一步规范我省药品挂网采购工作的通知》（豫医保办【2022】45号）“同质量层次、同通用名、同剂型的药品视为同一品种，同品种、同一企业不同规格的按照相关药品差比价规则进行折算，差比价计算参照国家发展改革委《关于印发《药品差比价规则》的通知》（发改价格[2011]2452号）中规格（装量差异按照含量差比价计算）”同厂家不同规格，装量差异按照含量差比计算，同厂家符合差比。"]
[3006775,"XS01XAJ166G010010283150","聚乙烯醇滴眼液","眼用制剂","1.4%(0.4毫升:5.6毫克)","10","浙江赛默制药有限公司","四川海梦智森生物制药有限公司","国药准字H20249198",41.4,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:海南省,来源年份:2025,采购价:41.40],[来源省份:吉林省,来源年份:2025,采购价:41.40],[来源省份:陕西省,来源年份:2025,采购价:41.40],[来源省份:江西省,来源年份:2025,采购价:41.40],[来源省份:黑龙江省,来源年份:2025,采购价:41.40],[来源省份:甘肃省,来源年份:2025,采购价:41.40],[来源省份:四川省,来源年份:2025,采购价:41.40],[来源省份:北京市,来源年份:2025,采购价:41.40]","通过"]
[3111475,"XS01XAJ166G010010383150","聚乙烯醇滴眼液","眼用制剂","1.4%(0.4毫升:5.6毫克)","5","浙江赛默制药有限公司","四川海梦智森生物制药有限公司","国药准字H20249198",20.7,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:江西省,来源年份:2025,采购价:20.70],[来源省份:北京市,来源年份:2025,采购价:20.70],[来源省份:四川省,来源年份:2025,采购价:20.70],[来源省份:甘肃省,来源年份:2025,采购价:20.70],[来源省份:吉林省,来源年份:2025,采购价:20.70],[来源省份:黑龙江省,来源年份:2025,采购价:20.70],[来源省份:海南省,来源年份:2025,采购价:20.70],[来源省份:陕西省,来源年份:2025,采购价:20.70]","通过"]
[3116424,"XS01XAJ166G010010484211","聚乙烯醇滴眼液","眼用制剂","1.4%(0.4ml:5.6mg)","20","浙江赛默制药有限公司","浙江百代医药科技有限公司","国药准字H20254877",60,"创新化学药品：改良型新药、仿制药、过评药品、参比制剂","[来源省份:重庆市,来源年份:2025,采购价:60.00],[来源省份:贵州省,来源年份:2025,采购价:60.00],[来源省份:江苏省,来源年份:2025,采购价:60.00]","通过","《关于进一步规范我省药品挂网采购工作的通知》（豫医保办【2022】45号）“同质量层次、同通用名、同剂型的药品视为同一品种，同品种、同一企业不同规格的按照相关药品差比价规则进行折算，差比价计算参照国家发展改革委《关于印发《药品差比价规则》的通知》（发改价格[2011]2452号）中规格（装量差异按照含量差比价计算）”同厂家不同规格，装量差异按照含量差比计算，不高于中位价。"]